x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
New York | 13-5570651 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
1290 Avenue of the Americas, New York, New York | 10104 | |
(Address of principal executive offices) | (Zip Code) |
Large accelerated filer | ¨ | Accelerated filer | ¨ |
Non-accelerated filer | x | Smaller reporting company | ¨ |
Emerging growth company | ¨ | ||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ¨ |
Title of each class | Trading Symbol | Name of Exchange on which registered | ||
Not Applicable | Not Applicable | Not Applicable |
Page | ||
Item 1. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 1. | ||
Item 1A. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 5. | ||
Item 6. | ||
March 31, 2019 | December 31, 2018 | ||||||
(in millions, except share data) | |||||||
ASSETS | |||||||
Investments: | |||||||
Fixed maturities available-for-sale, at fair value (amortized cost of $44,926 and $42,492) | $ | 45,929 | $ | 41,915 | |||
Mortgage loans on real estate (net of valuation allowance of $0 and $7) | 12,100 | 11,818 | |||||
Real estate held for production of income (1) | 68 | 52 | |||||
Policy loans | 3,253 | 3,267 | |||||
Other equity investments (1) | 1,129 | 1,144 | |||||
Trading securities, at fair value | 12,704 | 15,166 | |||||
Other invested assets | 1,749 | 1,554 | |||||
Total investments | 76,932 | 74,916 | |||||
Cash and cash equivalents | 2,922 | 2,622 | |||||
Deferred policy acquisition costs | 4,338 | 5,011 | |||||
Amounts due from reinsurers | 3,093 | 3,124 | |||||
Loans to affiliates | 600 | 600 | |||||
GMIB reinsurance contract asset, at fair value | 2,009 | 1,991 | |||||
Current and deferred income taxes | 184 | 438 | |||||
Other assets | 3,031 | 2,763 | |||||
Separate Accounts assets | 118,130 | 108,487 | |||||
Total Assets | $ | 211,239 | $ | 199,952 | |||
LIABILITIES | |||||||
Policyholders’ account balances | $ | 48,593 | $ | 46,403 | |||
Future policy benefits and other policyholders' liabilities | 30,294 | 29,808 | |||||
Broker-dealer related payables | 147 | 69 | |||||
Securities sold under agreements to repurchase | — | 573 | |||||
Amounts due to reinsurers | 57 | 113 | |||||
Loans from affiliates | — | 572 | |||||
Other liabilities | 1,600 | 1,460 | |||||
Separate Accounts liabilities | 118,130 | 108,487 | |||||
Total Liabilities | $ | 198,821 | $ | 187,485 | |||
Redeemable noncontrolling interest | 48 | 39 | |||||
Commitments and contingent liabilities (Note 12) | |||||||
EQUITY | |||||||
Equity attributable to AXA Equitable: | |||||||
Common stock, $1.25 par value; 2,000,000 shares authorized, issued and outstanding | $ | 2 | $ | 2 | |||
Additional paid-in capital | 7,815 | 7,807 | |||||
Retained earnings | 4,268 | 5,098 | |||||
Accumulated other comprehensive income (loss) | 273 | (491 | ) | ||||
Total equity attributable to AXA Equitable | 12,358 | 12,416 | |||||
Noncontrolling interest | 12 | 12 | |||||
Total Equity | 12,370 | 12,428 | |||||
Total Liabilities, Redeemable Noncontrolling Interest and Equity | $ | 211,239 | $ | 199,952 |
(1) | See Note 2 for details of balances with variable interest entities. |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
REVENUES | |||||||
Policy charges and fee income | $ | 859 | $ | 861 | |||
Premiums | 232 | 223 | |||||
Net derivative gains (losses) | (1,555 | ) | (817 | ) | |||
Net investment income (loss) | 904 | 509 | |||||
Investment gains (losses), net | (8 | ) | 87 | ||||
Investment management and service fees | 248 | 254 | |||||
Other income | 10 | 22 | |||||
Total revenues | 690 | 1,139 | |||||
BENEFITS AND OTHER DEDUCTIONS | |||||||
Policyholders’ benefits | 819 | 480 | |||||
Interest credited to policyholders’ account balances | 269 | 255 | |||||
Compensation and benefits | 82 | 149 | |||||
Commissions | 157 | 160 | |||||
Interest expense | 4 | 9 | |||||
Amortization of deferred policy acquisition costs | 165 | 209 | |||||
Other operating costs and expenses | 184 | 250 | |||||
Total benefits and other deductions | 1,680 | 1,512 | |||||
Income (loss) from continuing operations, before income taxes | (990 | ) | (373 | ) | |||
Income tax (expense) benefit from continuing operations | 162 | 80 | |||||
Net income (loss) from continuing operations | (828 | ) | (293 | ) | |||
Net income (loss) from discontinued operations, net of taxes and noncontrolling interest | — | 29 | |||||
Net income (loss) | (828 | ) | (264 | ) | |||
Less: Net (income) loss attributable to the noncontrolling interest | (2 | ) | 1 | ||||
Net income (loss) attributable to AXA Equitable | $ | (830 | ) | $ | (263 | ) |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
COMPREHENSIVE INCOME (LOSS) | |||||||
Net income (loss) | $ | (828 | ) | $ | (264 | ) | |
Other comprehensive income (loss) net of income taxes: | |||||||
Change in unrealized gains (losses), net of reclassification adjustment | 764 | (742 | ) | ||||
Changes in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment | — | (4 | ) | ||||
Other comprehensive income (loss) from discontinued operations | — | (10 | ) | ||||
Total other comprehensive income (loss), net of income taxes | 764 | (756 | ) | ||||
Comprehensive income (loss) attributable to AXA Equitable | $ | (64 | ) | $ | (1,020 | ) |
Three Months Ended March 31, | |||||||||||||||||||||||||||||||||||
AXA Equitable Equity | Noncontrolling Interest | Total Equity | |||||||||||||||||||||||||||||||||
Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Total | Continuing Operations | Discontinued Operations | Total | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
January 1, 2019 | $ | 2 | $ | 7,807 | $ | 5,098 | $ | (491 | ) | $ | 12,416 | $ | 12 | $ | — | $ | 12 | $ | 12,428 | ||||||||||||||||
Net income (loss) | — | — | (830 | ) | — | (830 | ) | — | — | — | (830 | ) | |||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | 764 | 764 | — | — | — | 764 | ||||||||||||||||||||||||||
Other | — | 8 | — | — | 8 | — | — | — | 8 | ||||||||||||||||||||||||||
March 31, 2019 | $ | 2 | $ | 7,815 | $ | 4,268 | $ | 273 | $ | 12,358 | $ | 12 | $ | — | $ | 12 | $ | 12,370 |
January 1, 2018 | $ | 2 | $ | 6,859 | $ | 8,938 | $ | 598 | $ | 16,397 | $ | 19 | $ | 3,076 | $ | 3,095 | $ | 19,492 | |||||||||||||||||
Cumulative effect of adoption of revenue recognition standard ASC 606 | — | — | 8 | — | 8 | — | 25 | 25 | 33 | ||||||||||||||||||||||||||
Deconsolidation of real estate joint ventures | — | — | — | — | — | (8 | ) | — | (8 | ) | (8 | ) | |||||||||||||||||||||||
Repurchase of AB Holding units | — | — | — | — | — | — | (2 | ) | (2 | ) | (2 | ) | |||||||||||||||||||||||
Dividends paid to noncontrolling interest | — | — | — | — | — | — | (176 | ) | (176 | ) | (176 | ) | |||||||||||||||||||||||
Net income (loss) | — | — | (263 | ) | — | (263 | ) | 1 | 133 | 134 | (129 | ) | |||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | (756 | ) | (756 | ) | — | 7 | 7 | (749 | ) | |||||||||||||||||||||||
Other | — | 18 | — | — | 18 | — | 13 | 13 | 31 | ||||||||||||||||||||||||||
March 31, 2018 | $ | 2 | $ | 6,877 | $ | 8,683 | $ | (158 | ) | $ | 15,404 | $ | 12 | $ | 3,076 | $ | 3,088 | $ | 18,492 |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
Cash flows from operating activities: | |||||||
Net income (loss) (1) | $ | (828 | ) | $ | (109 | ) | |
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: | |||||||
Interest credited to policyholders’ account balances | 269 | 255 | |||||
Policy charges and fee income | (859 | ) | (861 | ) | |||
Net derivative (gains) losses | 1,555 | 815 | |||||
Investment (gains) losses, net | 8 | (87 | ) | ||||
Realized and unrealized (gains) losses on trading securities | (250 | ) | 63 | ||||
Non-cash long-term incentive compensation expense | 8 | 12 | |||||
Amortization and depreciation (2) | 143 | 201 | |||||
Amortization of deferred cost of reinsurance asset | — | 46 | |||||
Equity (income) loss from limited partnerships (2) | (11 | ) | (39 | ) | |||
Changes in: | |||||||
Net broker-dealer and customer related receivables/payables | — | 283 | |||||
Reinsurance recoverable | (97 | ) | (147 | ) | |||
Segregated cash and securities, net | — | (208 | ) | ||||
Capitalization of deferred policy acquisition costs (2) | (145 | ) | (135 | ) | |||
Future policy benefits | 41 | (198 | ) | ||||
Current and deferred income taxes | 54 | 80 | |||||
Other, net | (36 | ) | 12 | ||||
Net cash provided by (used in) operating activities | $ | (148 | ) | $ | (17 | ) | |
Cash flows from investing activities: | |||||||
Proceeds from the sale/maturity/prepayment of: | |||||||
Fixed maturities, available-for-sale | $ | 2,662 | $ | 3,238 | |||
Mortgage loans on real estate | 216 | 68 | |||||
Trading account securities | 3,376 | 1,683 | |||||
Real estate joint ventures | 1 | 140 | |||||
Short-term investments (2) | 747 | 688 | |||||
Other | 41 | (86 | ) | ||||
Payment for the purchase/origination of: | |||||||
Fixed maturities, available-for-sale | (5,065 | ) | (2,313 | ) | |||
Mortgage loans on real estate | (517 | ) | (447 | ) | |||
Trading account securities | (518 | ) | (2,595 | ) | |||
Short-term investments (2) | (681 | ) | (377 | ) | |||
Other | (62 | ) | (48 | ) | |||
Cash settlements related to derivative instruments | (978 | ) | (503 | ) | |||
Investment in capitalized software, leasehold improvements and EDP equipment | (13 | ) | (24 | ) | |||
Other, net | 97 | (407 | ) | ||||
Net cash provided by (used in) investing activities | $ | (694 | ) | $ | (983 | ) |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
Cash flows from financing activities: | |||||||
Policyholders’ account balances: | |||||||
Deposits | $ | 2,271 | $ | 1,898 | |||
Withdrawals | (1,048 | ) | (1,081 | ) | |||
Transfers (to) from Separate Accounts | 445 | 452 | |||||
Change in short-term financings | — | (76 | ) | ||||
Change in collateralized pledged assets | (6 | ) | (5 | ) | |||
Change in collateralized pledged liabilities | 625 | (31 | ) | ||||
Increase (decrease) in overdrafts payable | — | 7 | |||||
Repurchase of AB Holding Units | — | (2 | ) | ||||
Purchase (redemption) of noncontrolling interests of consolidated company-sponsored investment funds | — | 373 | |||||
Distribution to noncontrolling interests in consolidated subsidiaries | — | (176 | ) | ||||
Repayment of loans from affiliates | (572 | ) | — | ||||
Increase (decrease) in securities sold under agreement to repurchase | (573 | ) | 17 | ||||
Other, net | — | 4 | |||||
Net cash provided by (used in) financing activities | $ | 1,142 | $ | 1,380 | |||
Effect of exchange rate changes on Cash and cash equivalents | — | 8 | |||||
Change in Cash and cash equivalents | 300 | 388 | |||||
Cash and cash equivalents, beginning of year | 2,622 | 3,409 | |||||
Cash and cash equivalents, end of period | $ | 2,922 | $ | 3,797 | |||
Cash and cash equivalents of disposed subsidiary: | |||||||
Beginning of year | $ | 1,009 | |||||
End of period | $ | 1,235 | |||||
Cash and cash equivalents of continuing operations: | |||||||
Beginning of year | $ | 3,409 | |||||
End of period | $ | 3,797 | |||||
Cash flows of disposed subsidiary: | |||||||
Net cash provided by (used in): | |||||||
Operating activities | $ | 274 | |||||
Investing activities | $ | (182 | ) | ||||
Financing activities | $ | 126 | |||||
Effect of exchange rate changes on Cash and cash equivalents | $ | 8 | |||||
Non-cash transactions during the period: | |||||||
(Settlement) issuance of long-term debt | $ | (202 | ) | ||||
Transfer of assets to reinsurer | $ | (604 | ) |
(1) | Net income (loss) includes $155 million in the three months ended March 31, 2018 of the discontinued operations that are not included in Net income (loss) in the Consolidated Statements of Income (Loss). |
(2) | Prior period amounts have been reclassified to conform to the current period’s presentation. See Note 14 for further information. |
Description | Effect on the Financial Statement or Other Significant Matters |
ASU 2017-12: Derivatives and Hedging (Topic 815) | |
The amendments in this ASU better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results. | On January 1, 2019, the Company adopted the new hedging guidance. Adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. |
Description | Effect on the Financial Statement or Other Significant Matters |
ASU 2017-08: Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20) | |
This ASU requires certain premiums on callable debt securities to be amortized to the earliest call date and is intended to better align interest income recognition with the manner in which market participants price these instruments. | On January 1, 2019, the Company adopted the new guidance on accounting for certain premiums on callable debt securities. As the Company’s existing accounting practices aligned with the guidance in the ASU, adoption of the new standard did not have a material impact on the Company’s consolidated financial statements. |
ASU 2016-02: Leases (Topic 842) | |
This ASU contains revised guidance to lease accounting that will require lessees to recognize on the balance sheet a “right-of-use” asset and a lease liability for virtually all lease arrangements, including those embedded in other contracts. Lessor accounting will remain substantially unchanged from the current model but has been updated to align with certain changes made to the lessee model. | On January 1, 2019, the Company adopted the new leases standard using the simplified modified retrospective transition method, as of the adoption date. Prior comparable periods will not be adjusted or presented under this method. We applied several practical expedients offered by ACS 842 upon adoption of this standard. These included continuing to account for existing leases based on judgment made under legacy U.S. GAAP as it relates to determining classification of leases, unamortized initial direct costs and whether contracts are leases or contain leases. We also used the practical expedient to use hindsight in determining lease terms (using knowledge and expectations as of the standard’s adoption date instead of the previous assumptions under legacy U.S. GAAP) and evaluated impairment of our right-of-use (“RoU”) assets in the transition period (using most up-to-date information.) Adoption of this standard resulted in the recognition, as of January 1, 2019, of additional RoU operating lease assets of $347 million reported in Other assets and operating lease liabilities of $439 million reported in Other liabilities in accompanying consolidated balance sheets. The operating RoU assets recognized as of January 1, 2019 are net of deferred rent of $58 million and liabilities associated with previously recognized impairments of $34 million. See Note 8 for additional information. |
Description | Effective Date and Method of Adoption | Effect on the Financial Statement or Other Significant Matters |
ASU 2018-17: Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities | ||
This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. | Effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. All entities are required to apply the amendments in this update retrospectively with a cumulative-effect adjustment to retained earnings at the beginning of the earliest period presented. | Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. |
ASU 2018-13: Fair Value Measurement (Topic 820) | ||
This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU modify disclosure requirements in Topic 820, including the removal of certain disclosure requirements, modification of certain disclosures, and the addition of new requirements. | Effective for fiscal years beginning after December 15, 2019. Early adoption is permitted, with the option to early adopt amendments to remove or modify disclosures, with full adoption of additional requirements delayed until their effective date. Amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively. | Management currently is evaluating the impact of the guidance on the Company’s financial statement disclosures but has concluded that this guidance will not impact the Company’s consolidated financial position or results of operations. |
Description | Effective Date and Method of Adoption | Effect on the Financial Statement or Other Significant Matters |
ASU 2018-12: Financial Services - Insurance (Topic 944) | ||
This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: | Effective for fiscal years beginning after December 31, 2020. Early adoption is permitted. | Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements, however the adoption of the ASU is expected to have a significant impact on our consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. |
Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary update, cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. | For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. |
Description | Effective Date and Method of Adoption | Effect on the Financial Statement or Other Significant Matters |
Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred policy acquisition costs. The ASU simplifies the amortization of deferred policy acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. Expanded footnote disclosures. The ASU requires additional disclosures including disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, MRBs, Separate Accounts liabilities and deferred policy acquisition costs. Companies will also be required to disclose information about significant inputs, judgements, assumptions and methods used in measurement. MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. | The same adoption method must be used for deferred policy acquisition costs. For MRBs, the ASU should be applied retrospectively as of the beginning of the earliest period presented. For deferred policy acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. |
Description | Effective Date and Method of Adoption | Effect on the Financial Statement or Other Significant Matters |
ASU 2016-13: Financial Instruments - Credit Losses (Topic 326) | ||
This ASU contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. | Effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. These amendments should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. | Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements. |
Three Months Ended March 31, 2018 | |||
(in millions) | |||
Reductions to expense line items: | |||
Compensation and benefits | $ | 33 | |
Commissions | 101 | ||
Other operating costs and expenses | 1 | ||
Total reductions | $ | 135 | |
Increase to expense line item: | |||
Amortization of deferred policy acquisition costs | $ | 135 |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
Investment management and service fees: | |||||||
Base fees | $ | 178 | $ | 182 | |||
Distribution services | 70 | 72 | |||||
Total investment management and service fees | $ | 248 | $ | 254 | |||
Other income | $ | 5 | $ | 7 |
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | OTTI in AOCI (4) | |||||||||||||||
(in millions) | |||||||||||||||||||
March 31, 2019: | |||||||||||||||||||
Fixed Maturities: | |||||||||||||||||||
Corporate (1) | $ | 30,106 | $ | 867 | $ | 208 | $ | 30,765 | $ | — | |||||||||
U.S. Treasury, government and agency | 12,719 | 462 | 213 | 12,968 | — | ||||||||||||||
States and political subdivisions | 408 | 55 | — | 463 | — | ||||||||||||||
Foreign governments | 478 | 27 | 7 | 498 | — | ||||||||||||||
Residential mortgage-backed (2) | 185 | 10 | — | 195 | — | ||||||||||||||
Asset-backed (3) | 608 | 1 | 4 | 605 | 2 | ||||||||||||||
Redeemable preferred stock | 422 | 16 | 3 | 435 | — | ||||||||||||||
Total at March 31, 2019 | $ | 44,926 | $ | 1,438 | $ | 435 | $ | 45,929 | $ | 2 | |||||||||
December 31, 2018: | |||||||||||||||||||
Fixed Maturities: | |||||||||||||||||||
Corporate (1) | $ | 26,690 | $ | 385 | $ | 699 | $ | 26,376 | $ | — | |||||||||
U.S. Treasury, government and agency | 13,646 | 143 | 454 | 13,335 | — | ||||||||||||||
States and political subdivisions | 408 | 47 | 1 | 454 | — | ||||||||||||||
Foreign governments | 515 | 17 | 13 | 519 | — | ||||||||||||||
Residential mortgage-backed (2) | 193 | 9 | — | 202 | — | ||||||||||||||
Asset-backed (3) | 600 | 1 | 11 | 590 | 2 | ||||||||||||||
Redeemable preferred stock | 440 | 16 | 17 | 439 | — | ||||||||||||||
Total at December 31, 2018 | $ | 42,492 | $ | 618 | $ | 1,195 | $ | 41,915 | $ | 2 |
(1) | Corporate fixed maturities include both public and private issues. |
(2) | Includes publicly traded agency pass-through securities and collateralized obligations. |
(3) | Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. |
(4) | Amounts represent OTTI losses in AOCI, which were not included in Net income (loss). |
Amortized Cost | Fair Value | ||||||
(in millions) | |||||||
March 31, 2019: | |||||||
Due in one year or less | $ | 1,817 | $ | 1,829 | |||
Due in years two through five | 10,322 | 10,519 | |||||
Due in years six through ten | 14,953 | 15,367 | |||||
Due after ten years | 16,619 | 16,979 | |||||
Subtotal | 43,711 | 44,694 | |||||
Residential mortgage-backed | 185 | 195 | |||||
Asset-backed | 608 | 605 | |||||
Redeemable preferred stock | 422 | 435 | |||||
Total at March 31, 2019 | $ | 44,926 | $ | 45,929 |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
Proceeds from sales | $ | 1,361 | $ | 3,428 | |||
Gross gains on sales | $ | 8 | $ | 127 | |||
Gross losses on sales | $ | (15 | ) | $ | (41 | ) | |
Total OTTI | $ | — | $ | — | |||
Non-credit losses recognized in OCI | — | — | |||||
Credit losses recognized in Net income (loss) | $ | — | $ | — |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
Balances at January 1, | $ | (46 | ) | $ | (10 | ) | |
Previously recognized impairments on securities that matured, paid, prepaid or sold | 28 | — | |||||
Recognized impairments on securities impaired to fair value this period (1) | — | — | |||||
Impairments recognized this period on securities not previously impaired | — | — | |||||
Additional impairments this period on securities previously impaired | — | — | |||||
Increases due to passage of time on previously recorded credit losses | — | — | |||||
Accretion of previously recognized impairments due to increases in expected cash flows | — | — | |||||
Balances at March 31, | $ | (18 | ) | $ | (10 | ) |
(1) | Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost. |
March 31, 2019 | December 31, 2018 | ||||||
(in millions) | |||||||
Fixed maturities available-for-sale: | |||||||
With OTTI loss | $ | — | $ | — | |||
All other | 1,003 | (577 | ) | ||||
Net unrealized gains (losses) | $ | 1,003 | $ | (577 | ) |
Net Unrealized Gains (Losses) on Investments | DAC | Policyholders’ Liabilities | Deferred Income Tax Asset (Liability) | AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) | |||||||||||||||
(in millions) | |||||||||||||||||||
Balances at January 1, 2019 | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||
Net investment gains (losses) arising during the period | (10 | ) | — | — | — | (10 | ) | ||||||||||||
Reclassification adjustment: | |||||||||||||||||||
Included in Net income (loss) | 10 | — | — | — | 10 | ||||||||||||||
Impact of net unrealized investment gains (losses) on: | |||||||||||||||||||
DAC | — | — | — | — | — | ||||||||||||||
Deferred income taxes | — | — | — | — | — | ||||||||||||||
Policyholders’ liabilities | — | — | — | — | — | ||||||||||||||
Balances at March 31, 2019 | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||
Balances at January 1, 2018 | $ | 1 | $ | 1 | $ | (1 | ) | $ | (5 | ) | $ | (4 | ) | ||||||
Net investment gains (losses) arising during the period | — | — | — | — | — | ||||||||||||||
Reclassification adjustment: | |||||||||||||||||||
Included in Net income (loss) | (2 | ) | — | — | — | (2 | ) | ||||||||||||
Impact of net unrealized investment gains (losses) on: | |||||||||||||||||||
DAC | — | (1 | ) | — | — | (1 | ) | ||||||||||||
Deferred income taxes | — | — | — | — | — | ||||||||||||||
Policyholders’ liabilities | — | — | 1 | — | 1 | ||||||||||||||
Balances at March 31, 2018 | $ | (1 | ) | $ | — | $ | — | $ | (5 | ) | $ | (6 | ) |
Net Unrealized Gains (Losses) on Investments | DAC | Policyholders’ Liabilities | Deferred Income Tax Asset (Liability) | AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) | |||||||||||||||
(in millions) | |||||||||||||||||||
Balances at January 1, 2019 | $ | (577 | ) | $ | 39 | $ | (55 | ) | $ | 125 | $ | (468 | ) | ||||||
Net investment gains (losses) arising during the period | 1,583 | — | — | — | 1,583 | ||||||||||||||
Reclassification adjustment: | — | ||||||||||||||||||
Included in Net income (loss) | (3 | ) | — | — | — | (3 | ) | ||||||||||||
Impact of net unrealized investment gains (losses) on: | |||||||||||||||||||
DAC | — | (655 | ) | — | — | (655 | ) | ||||||||||||
Deferred income taxes | — | — | — | (211 | ) | (211 | ) | ||||||||||||
Policyholders’ liabilities | — | — | 77 | — | 77 | ||||||||||||||
Balances at March 31, 2019 | $ | 1,003 | $ | (616 | ) | $ | 22 | $ | (86 | ) | $ | 323 | |||||||
Balances at January 1, 2018 | $ | 1,526 | $ | (315 | ) | $ | (232 | ) | $ | (300 | ) | $ | 679 | ||||||
Net investment gains (losses) arising during the period | (1,245 | ) | — | — | — | (1,245 | ) | ||||||||||||
Reclassification adjustment: | |||||||||||||||||||
Included in Net income (loss) | (88 | ) | — | — | — | (88 | ) | ||||||||||||
Impact of net unrealized investment gains (losses) on: | |||||||||||||||||||
DAC | — | 288 | — | — | 288 | ||||||||||||||
Deferred income taxes | — | — | — | 197 | 197 | ||||||||||||||
Policyholders’ liabilities | — | — | 108 | — | 108 | ||||||||||||||
Balances at March 31, 2018 | $ | 193 | $ | (27 | ) | $ | (124 | ) | $ | (103 | ) | $ | (61 | ) |
Less Than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||
Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | ||||||||||||||||||
(in millions) | |||||||||||||||||||||||
March 31, 2019: | |||||||||||||||||||||||
Fixed Maturities: | |||||||||||||||||||||||
Corporate | $ | 653 | $ | 6 | $ | 5,387 | $ | 202 | $ | 6,040 | $ | 208 | |||||||||||
U.S. Treasury, government and agency | — | — | 3,163 | 213 | 3,163 | 213 | |||||||||||||||||
Foreign governments | — | — | 67 | 7 | 67 | 7 | |||||||||||||||||
Asset-backed | 279 | 1 | 249 | 3 | 528 | 4 | |||||||||||||||||
Redeemable preferred stock | 44 | 1 | 35 | 2 | 79 | 3 | |||||||||||||||||
Total at March 31, 2019 | $ | 976 | $ | 8 | $ | 8,901 | $ | 427 | $ | 9,877 | $ | 435 | |||||||||||
December 31, 2018: | |||||||||||||||||||||||
Fixed Maturities: | |||||||||||||||||||||||
Corporate | $ | 8,369 | $ | 306 | $ | 6,161 | $ | 393 | $ | 14,530 | $ | 699 | |||||||||||
U.S. Treasury, government and agency | 2,636 | 68 | 3,154 | 386 | 5,790 | 454 | |||||||||||||||||
States and political subdivisions | — | — | 19 | 1 | 19 | 1 | |||||||||||||||||
Foreign governments | 109 | 3 | 76 | 10 | 185 | 13 | |||||||||||||||||
Residential mortgage-backed | — | — | 13 | — | 13 | — | |||||||||||||||||
Asset-backed | 558 | 11 | 6 | — | 564 | 11 | |||||||||||||||||
Redeemable preferred stock | 160 | 12 | 31 | 5 | 191 | 17 | |||||||||||||||||
Total at December 31, 2018 | $ | 11,832 | $ | 400 | $ | 9,460 | $ | 795 | $ | 21,292 | $ | 1,195 |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
Net investment gains (losses) recognized during the period on securities held at the end of the period | $ | 274 | $ | (96 | ) | ||
Net investment gains (losses) recognized on securities sold during the period | (24 | ) | (1 | ) | |||
Net investment gains (losses) on trading account securities arising during the period | 250 | (97 | ) | ||||
Interest and dividend income from trading account securities | 90 | 66 | |||||
Net investment income (loss) from trading account securities | $ | 340 | $ | (31 | ) |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
Allowance for credit losses: | |||||||
Beginning balance, January 1, | $ | 7 | $ | 8 | |||
Charge-offs | (7 | ) | — | ||||
Recoveries | — | (1 | ) | ||||
Provision | — | — | |||||
Ending balance, March 31, | $ | — | $ | 7 | |||
March 31, Individually Evaluated for Impairment | $ | — | $ | 7 |
Debt Service Coverage Ratio (1) | Total Mortgage Loans | ||||||||||||||||||||||||||
Loan-to-Value Ratio: (2) | Greater than 2.0x | 1.8x to 2.0x | 1.5x to 1.8x | 1.2x to 1.5x | 1.0x to 1.2x | Less than 1.0x | |||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||
March 31, 2019: | |||||||||||||||||||||||||||
Commercial Mortgage Loans | |||||||||||||||||||||||||||
0% - 50% | $ | 764 | $ | 21 | $ | 215 | $ | 24 | $ | — | $ | — | $ | 1,024 | |||||||||||||
50% - 70% | 4,933 | 806 | 1,284 | 474 | — | — | 7,497 | ||||||||||||||||||||
70% - 90% | 266 | — | 117 | 334 | 132 | — | 849 | ||||||||||||||||||||
90% plus | — | — | — | — | — | — | — | ||||||||||||||||||||
Total Commercial Mortgage Loans | $ | 5,963 | $ | 827 | $ | 1,616 | $ | 832 | $ | 132 | $ | — | $ | 9,370 | |||||||||||||
Agricultural Mortgage Loans | |||||||||||||||||||||||||||
0% - 50% | $ | 278 | $ | 130 | $ | 276 | $ | 563 | $ | 350 | $ | 49 | $ | 1,646 | |||||||||||||
50% - 70% | 119 | 70 | 248 | 357 | 237 | 34 | 1,065 | ||||||||||||||||||||
70% - 90% | — | — | — | 19 | — | — | 19 | ||||||||||||||||||||
90% plus | — | — | — | — | — | — | — | ||||||||||||||||||||
Total Agricultural Mortgage Loans | $ | 397 | $ | 200 | $ | 524 | $ | 939 | $ | 587 | $ | 83 | $ | 2,730 | |||||||||||||
Total Mortgage Loans | |||||||||||||||||||||||||||
0% - 50% | $ | 1,042 | $ | 151 | $ | 491 | $ | 587 | $ | 350 | $ | 49 | $ | 2,670 | |||||||||||||
50% - 70% | 5,052 | 876 | 1,532 | 831 | 237 | 34 | 8,562 | ||||||||||||||||||||
70% - 90% | 266 | — | 117 | 353 | 132 | — | 868 | ||||||||||||||||||||
90% plus | — | — | — | — | — | — | — | ||||||||||||||||||||
Total Mortgage Loans | $ | 6,360 | $ | 1,027 | $ | 2,140 | $ | 1,771 | $ | 719 | $ | 83 | $ | 12,100 | |||||||||||||
December 31, 2018: | |||||||||||||||||||||||||||
Commercial Mortgage Loans | |||||||||||||||||||||||||||
0% - 50% | $ | 780 | $ | 21 | $ | 247 | $ | 24 | $ | — | $ | — | $ | 1,072 | |||||||||||||
50% - 70% | 4,908 | 656 | 1,146 | 325 | 151 | — | 7,186 | ||||||||||||||||||||
70% - 90% | 260 | — | 117 | 370 | 98 | — | 845 | ||||||||||||||||||||
90% plus | — | — | — | 27 | — | — | 27 | ||||||||||||||||||||
Total Commercial Mortgage Loans | $ | 5,948 | $ | 677 | $ | 1,510 | $ | 746 | $ | 249 | $ | — | $ | 9,130 | |||||||||||||
Agricultural Mortgage Loans | |||||||||||||||||||||||||||
0% - 50% | $ | 282 | $ | 147 | $ | 267 | $ | 543 | $ | 321 | $ | 51 | $ | 1,611 | |||||||||||||
50% - 70% | 112 | 46 | 246 | 379 | 224 | 31 | 1,038 | ||||||||||||||||||||
70% - 90% | — | — | — | 19 | 27 | — | 46 | ||||||||||||||||||||
90% plus | — | — | — | — | — | — | — | ||||||||||||||||||||
Total Agricultural Mortgage Loans | $ | 394 | $ | 193 | $ | 513 | $ | 941 | $ | 572 | $ | 82 | $ | 2,695 | |||||||||||||
Total Mortgage Loans | |||||||||||||||||||||||||||
0% - 50% | $ | 1,062 | $ | 168 | $ | 514 | $ | 567 | $ | 321 | $ | 51 | $ | 2,683 | |||||||||||||
50% - 70% | 5,020 | 702 | 1,392 | 704 | 375 | 31 | 8,224 | ||||||||||||||||||||
70% - 90% | 260 | — | 117 | 389 | 125 | — | 891 | ||||||||||||||||||||
90% plus | — | — | — | 27 | — | — | 27 | ||||||||||||||||||||
Total Mortgage Loans | $ | 6,342 | $ | 870 | $ | 2,023 | $ | 1,687 | $ | 821 | $ | 82 | $ | 11,825 |
(1) | The debt service coverage ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. |
(2) | The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually. |
30-59 Days | 60-89 Days | 90 Days or More | Total | Current | Total Financing Receivables | Recorded Investment 90 Days or More and Accruing | |||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||
March 31, 2019 | |||||||||||||||||||||||||||
Commercial | $ | — | $ | — | $ | — | $ | — | $ | 9,370 | $ | 9,370 | $ | — | |||||||||||||
Agricultural | 9 | 26 | 55 | 90 | 2,640 | 2,730 | 54 | ||||||||||||||||||||
Total Mortgage Loans | $ | 9 | $ | 26 | $ | 55 | $ | 90 | $ | 12,010 | $ | 12,100 | $ | 54 | |||||||||||||
December 31, 2018 | |||||||||||||||||||||||||||
Commercial | $ | — | $ | — | $ | 27 | $ | 27 | $ | 9,103 | $ | 9,130 | $ | — | |||||||||||||
Agricultural | 18 | 8 | 42 | 68 | 2,627 | 2,695 | 40 | ||||||||||||||||||||
Total Mortgage Loans | $ | 18 | $ | 8 | $ | 69 | $ | 95 | $ | 11,730 | $ | 11,825 | $ | 40 |
Recorded Investment | Unpaid Principal Balance | Related Allowance | Average Recorded Investment (1) | Interest Income Recognized | |||||||||||||||
(in millions) | |||||||||||||||||||
March 31, 2019: | |||||||||||||||||||
With no related allowance recorded: | |||||||||||||||||||
Agricultural mortgage loans | $ | 2 | $ | 2 | $ | — | $ | 2 | $ | — | |||||||||
Total | $ | 2 | $ | 2 | $ | — | $ | 2 | $ | — | |||||||||
With related allowance recorded: | |||||||||||||||||||
Commercial mortgage loans - other | $ | — | $ | — | $ | — | $ | 13 | $ | — | |||||||||
Total | $ | — | $ | — | $ | — | $ | 13 | $ | — | |||||||||
December 31, 2018: | |||||||||||||||||||
With no related allowance recorded: | |||||||||||||||||||
Agricultural mortgage loans | $ | 2 | $ | 2 | $ | — | $ | — | $ | — | |||||||||
Total | $ | 2 | $ | 2 | $ | — | $ | — | $ | — | |||||||||
With related allowance recorded: | |||||||||||||||||||
Commercial mortgage loans - other | $ | 27 | $ | 31 | $ | (7 | ) | $ | 27 | $ | — | ||||||||
Total | $ | 27 | $ | 31 | $ | (7 | ) | $ | 27 | $ | — |
(1) | Represents a two-quarter and five-quarter average of recorded amortized cost at March 31, 2019 and December 31, 2018, respectively. |
At March 31, 2019 | Gains (Losses) Reported in Net Income (Loss) Three Months Ended March 31, 2019 | ||||||||||||||
Fair Value | |||||||||||||||
Notional Amount | Asset Derivatives | Liability Derivatives | |||||||||||||
(in millions) | |||||||||||||||
Freestanding Derivatives (1) (2): | |||||||||||||||
Equity contracts: | |||||||||||||||
Futures | $ | 6,544 | $ | — | $ | — | $ | (738 | ) | ||||||
Swaps | 8,065 | 6 | 371 | (973 | ) | ||||||||||
Options | 37,417 | 3,474 | 1,310 | 1,101 | |||||||||||
Interest rate contracts: | |||||||||||||||
Swaps | 28,153 | 910 | 209 | 648 | |||||||||||
Futures | 16,385 | — | — | 55 | |||||||||||
Credit contracts: | |||||||||||||||
Credit default swaps | 1,242 | 22 | — | 10 | |||||||||||
Other freestanding contracts: | |||||||||||||||
Foreign currency contracts | 1,796 | 24 | 1 | 10 | |||||||||||
Margin | — | 16 | — | — | |||||||||||
Collateral | — | 9 | 2,556 | — | |||||||||||
Embedded Derivatives (2): | |||||||||||||||
GMIB reinsurance contracts | — | 2,009 | — | 27 | |||||||||||
GMxB derivative features liability (3) | — | — | 5,944 | (409 | ) | ||||||||||
SCS, SIO, MSO and IUL indexed features (4) | — | — | 1,992 | (1,286 | ) | ||||||||||
Total | $ | 99,602 | $ | 6,470 | $ | 12,383 | $ | (1,555 | ) |
(1) | Reported in Other invested assets in the consolidated balance sheets. |
(2) | Reported in Net derivative gains (losses) in the consolidated statements of income (loss). |
(3) | Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. |
(4) | SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. |
At December 31, 2018 | Gains (Losses) Reported in Net Income (Loss) Three Months Ended March 31, 2018 | ||||||||||||||
Fair Value | |||||||||||||||
Notional Amount | Asset Derivatives | Liability Derivatives | |||||||||||||
(in millions) | |||||||||||||||
Freestanding Derivatives (1) (2): | |||||||||||||||
Equity contracts: | |||||||||||||||
Futures | $ | 10,411 | $ | — | $ | — | $ | (29 | ) | ||||||
Swaps | 7,697 | 140 | 168 | 64 | |||||||||||
Options | 21,698 | 2,119 | 1,163 | (15 | ) | ||||||||||
Interest rate contracts: | |||||||||||||||
Swaps | 27,003 | 632 | 194 | (490 | ) | ||||||||||
Futures | 11,448 | — | — | 40 | |||||||||||
Credit contracts: | |||||||||||||||
Credit default swaps | 1,282 | 17 | — | — | |||||||||||
Other freestanding contracts: | |||||||||||||||
Foreign currency contracts | 2,097 | 27 | 14 | (51 | ) | ||||||||||
Margin | — | 7 | 5 | — | |||||||||||
Collateral | — | 3 | 1,564 | — | |||||||||||
Embedded Derivatives (2): | |||||||||||||||
GMIB reinsurance contracts | — | 1,991 | — | (842 | ) | ||||||||||
GMxB derivative features liability (3) | — | — | 5,431 | 485 | |||||||||||
SCS, SIO, MSO and IUL indexed features (4) | — | — | 687 | 21 | |||||||||||
Total | $ | 81,636 | $ | 4,936 | $ | 9,226 | $ | (817 | ) |
(1) | Reported in Other invested assets in the consolidated balance sheets. |
(2) | Reported in Net derivative gains (losses) in the consolidated statements of income (loss). |
(3) | Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. |
(4) | SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. |
Gross Amount Recognized | Gross Amount Offset in the Balance Sheets | Net Amount Presented in the Balance Sheets | |||||||||
(in millions) | |||||||||||
Assets | |||||||||||
Total derivatives | $ | 4,460 | $ | 4,399 | $ | 61 | |||||
Other financial instruments | 1,688 | — | 1,688 | ||||||||
Other invested assets | $ | 6,148 | $ | 4,399 | $ | 1,749 | |||||
Liabilities | |||||||||||
Total derivatives | $ | 4,399 | $ | 4,352 | $ | 47 | |||||
Other financial liabilities | 1,553 | — | 1,553 | ||||||||
Other liabilities | $ | 5,952 | $ | 4,352 | $ | 1,600 |
Net Amount Presented in the Balance Sheets | Collateral (Received)/Held | ||||||||||||||
Financial Instruments | Cash | Net Amount | |||||||||||||
(in millions) | |||||||||||||||
Assets | |||||||||||||||
Total derivatives | $ | 2,546 | $ | 367 | $ | 2,118 | $ | 61 | |||||||
Other financial instruments | 1,688 | — | — | 1,688 | |||||||||||
Other invested assets | $ | 4,234 | $ | 367 | $ | 2,118 | $ | 1,749 | |||||||
Liabilities | |||||||||||||||
Total derivatives | $ | 47 | $ | — | $ | — | $ | 47 | |||||||
Other financial liabilities | 1,553 | — | — | 1,553 | |||||||||||
Other liabilities | $ | 1,600 | $ | — | $ | — | $ | 1,600 |
Gross Amount Recognized | Gross Amount Offset in the Balance Sheets | Net Amount Presented in the Balance Sheets | |||||||||
(in millions) | |||||||||||
Assets | |||||||||||
Total derivatives | $ | 2,946 | $ | 2,912 | $ | 34 | |||||
Other financial instruments | 1,520 | — | 1,520 | ||||||||
Other invested assets | $ | 4,466 | $ | 2,912 | $ | 1,554 | |||||
Liabilities | |||||||||||
Total derivatives | $ | 3,109 | $ | 2,912 | $ | 197 | |||||
Other financial liabilities | 1,263 | — | 1,263 | ||||||||
Other liabilities | $ | 4,372 | $ | 2,912 | $ | 1,460 | |||||
Securities sold under agreement to repurchase (1) | $ | 571 | $ | — | $ | 571 |
(1) | Excludes expense of $2 million in Securities sold under agreement to repurchase. |
Net Amount Presented in the Balance Sheets | Collateral (Received)/Held | ||||||||||||||
Financial Instruments | Cash | Net Amount | |||||||||||||
(in millions) | |||||||||||||||
Assets | |||||||||||||||
Total derivatives | $ | 1,397 | $ | — | $ | (1,363 | ) | $ | 34 | ||||||
Other financial instruments | 1,520 | — | — | 1,520 | |||||||||||
Other invested assets | $ | 2,917 | $ | — | $ | (1,363 | ) | $ | 1,554 | ||||||
Liabilities | |||||||||||||||
Total derivatives | $ | 197 | $ | — | $ | — | $ | 197 | |||||||
Other financial liabilities | 1,263 | — | — | 1,263 | |||||||||||
Other liabilities | $ | 1,460 | $ | — | $ | — | $ | 1,460 | |||||||
Securities sold under agreement to repurchase (1) (2) (3) | $ | 571 | $ | (588 | ) | $ | — | $ | (17 | ) |
(1) | Excludes expense of $2 million in Securities sold under agreement to repurchase. |
(2) | U.S. Treasury and agency securities are in Fixed maturities available-for-sale on the consolidated balance sheets. |
(3) | Cash is included in Cash and cash equivalents on consolidated balance sheets. |
Remaining Contractual Maturity of the Agreements | |||||||||||||||||||
Overnight and Continuous | Up to 30 days | 30–90 days | Greater Than 90 days | Total | |||||||||||||||
(in millions) | |||||||||||||||||||
Securities sold under agreement to repurchase: (1) | |||||||||||||||||||
U.S. Treasury and agency securities | $ | — | $ | 571 | $ | — | $ | — | $ | 571 | |||||||||
Total | $ | — | $ | 571 | $ | — | $ | — | $ | 571 |
(1) | Excludes expense of $2 million in Securities sold under agreement to repurchase on the consolidated balance sheets. |
March 31, 2019 | December 31, 2018 | ||||||
(in millions) | |||||||
Closed Block Liabilities: | |||||||
Future policy benefits, policyholders’ account balances and other | $ | 6,670 | $ | 6,709 | |||
Other liabilities | 70 | 47 | |||||
Total Closed Block liabilities | 6,740 | 6,756 | |||||
Assets Designated to the Closed Block: | |||||||
Fixed maturities, available-for-sale, at fair value (amortized cost of $3,606 and $3,680) | 3,697 | 3,672 | |||||
Mortgage loans on real estate, net of valuation allowance of $0 and $0 | 1,822 | 1,824 | |||||
Policy loans | 727 | 736 | |||||
Cash and other invested assets | 142 | 76 | |||||
Other assets | 171 | 179 | |||||
Total assets designated to the Closed Block | 6,559 | 6,487 | |||||
Excess of Closed Block liabilities over assets designated to the Closed Block | 181 | 269 | |||||
Amounts included in accumulated other comprehensive income (loss): | |||||||
Net unrealized investment gains (losses), net of policyholders’ dividend obligation of $0 and $0 | 105 | 8 | |||||
Maximum future earnings to be recognized from Closed Block assets and liabilities | $ | 286 | $ | 277 |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
Revenues: | |||||||
Premiums and other income | $ | 48 | $ | 51 | |||
Net investment income (loss) | 67 | 73 | |||||
Investment gains (losses), net | (1 | ) | 1 | ||||
Total revenues | 114 | 125 | |||||
Benefits and Other Deductions: | |||||||
Policyholders’ benefits and dividends | 121 | 126 | |||||
Other operating costs and expenses | 1 | 1 | |||||
Total benefits and other deductions | 122 | 127 | |||||
Net income (loss) before income taxes | (8 | ) | (2 | ) | |||
Income tax (expense) benefit | (1 | ) | — | ||||
Net income (loss) | $ | (9 | ) | $ | (2 | ) |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
Balances, beginning of year | $ | — | $ | 19 | |||
Unrealized investment gains (losses), net of DAC | — | (19 | ) | ||||
Balances, end of period | $ | — | $ | — |
• | Return of Premium: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals); |
• | Ratchet: the benefit is the greatest of current account value, premiums paid (adjusted for withdrawals), or the highest account value on any anniversary up to contractually specified ages (adjusted for withdrawals); |
• | Roll-Up: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals) accumulated at contractually specified interest rates up to specified ages; |
• | Combo: the benefit is the greater of the ratchet benefit or the roll-up benefit, which may include either a five year or an annual reset; or |
• | Withdrawal: the withdrawal is guaranteed up to a maximum amount per year for life. |
GMDB | GMIB | ||||||||||||||
Direct | Ceded | Direct | Ceded | ||||||||||||
(in millions) | |||||||||||||||
Balance at January 1, 2019 | $ | 4,654 | $ | (107 | ) | $ | 3,741 | $ | (1,991 | ) | |||||
Paid guarantee benefits | (118 | ) | 4 | (56 | ) | 21 | |||||||||
Other changes in reserve | 129 | — | 55 | (39 | ) | ||||||||||
Balance at March 31, 2019 | $ | 4,665 | $ | (103 | ) | $ | 3,740 | $ | (2,009 | ) | |||||
Balance at January 1, 2018 | $ | 4,054 | $ | (2,030 | ) | $ | 4,754 | $ | (10,488 | ) | |||||
Paid guarantee benefits | (101 | ) | (54 | ) | (32 | ) | 27 | ||||||||
Other changes in reserve | 96 | 62 | (139 | ) | 788 | ||||||||||
Balance at March 31, 2018 | $ | 4,049 | $ | (2,022 | ) | $ | 4,583 | $ | (9,673 | ) |
Guarantee Type | |||||||||||||||||||
Return of Premium | Ratchet | Roll-Up | Combo | Total | |||||||||||||||
(in millions, except age and interest rate) | |||||||||||||||||||
Variable annuity contracts with GMDB features | |||||||||||||||||||
Account Values invested in: | |||||||||||||||||||
General Account | $ | 14,178 | $ | 98 | $ | 60 | $ | 181 | $ | 14,517 | |||||||||
Separate Accounts | 45,599 | 9,001 | 3,134 | 32,609 | 90,343 | ||||||||||||||
Total Account Values | $ | 59,777 | $ | 9,099 | $ | 3,194 | $ | 32,790 | $ | 104,860 | |||||||||
Net amount at risk, gross | $ | 143 | $ | 143 | $ | 2,025 | $ | 18,389 | $ | 20,700 | |||||||||
Net amount at risk, net of amounts reinsured | $ | 143 | $ | 138 | $ | 1,414 | $ | 18,389 | $ | 20,084 | |||||||||
Average attained age of policyholders (in years) | 51.4 | 67.1 | 73.8 | 69.2 | 55.3 | ||||||||||||||
Percentage of policyholders over age 70 | 10.2 | % | 43.5 | % | 66.1 | % | 50.7 | % | 19.0 | % | |||||||||
Range of contractually specified interest rates | N/A | N/A | 3% - 6% | 3% - 6.5% | 3% - 6.5% | ||||||||||||||
Variable annuity contracts with GMIB features | |||||||||||||||||||
Account Values invested in: | |||||||||||||||||||
General Account | $ | — | $ | — | $ | 19 | $ | 245 | $ | 264 | |||||||||
Separate Accounts | — | — | 21,923 | 35,745 | 57,668 | ||||||||||||||
Total Account Values | $ | — | $ | — | $ | 21,942 | $ | 35,990 | $ | 57,932 | |||||||||
Net amount at risk, gross | $ | — | $ | — | $ | 898 | $ | 8,287 | $ | 9,185 | |||||||||
Net amount at risk, net of amounts reinsured | $ | — | $ | — | $ | 281 | $ | 7,515 | $ | 7,796 | |||||||||
Average attained age of policyholders (in years) | N/A | N/A | 69.0 | 69.0 | 69.0 | ||||||||||||||
Weighted average years remaining until annuitization | N/A | N/A | 1.7 | 0.4 | 0.5 | ||||||||||||||
Range of contractually specified interest rates | N/A | N/A | 3% - 6% | 3% - 6.5% | 3% - 6.5% |
As of March 31, 2019 | As of December 31, 2018 | ||||||||||||||
GMDB | GMIB | GMDB | GMIB | ||||||||||||
(in millions) | |||||||||||||||
Equity | $ | 39,856 | $ | 17,692 | $ | 35,541 | $ | 15,759 | |||||||
Fixed income | 5,206 | 2,825 | 5,173 | 2,812 | |||||||||||
Balanced | 44,433 | 36,855 | 41,588 | 33,974 | |||||||||||
Other | 848 | 296 | 852 | 290 | |||||||||||
Total | $ | 90,343 | $ | 57,668 | $ | 83,154 | $ | 52,835 |
Direct Liability | Reinsurance Ceded | Net | |||||||||
(in millions) | |||||||||||
Balance at January 1, 2019 | $ | 787 | $ | (733 | ) | $ | 54 | ||||
Paid guaranteed benefits | (7 | ) | — | (7 | ) | ||||||
Other changes in reserves | 21 | (11 | ) | 10 | |||||||
Balance at March 31, 2019 | $ | 801 | $ | (744 | ) | $ | 57 | ||||
Balance at January 1, 2018 | $ | 692 | $ | (664 | ) | $ | 28 | ||||
Paid guaranteed benefits | (8 | ) | — | (8 | ) | ||||||
Other changes in reserves | 18 | (11 | ) | 7 | |||||||
Balance at March 31, 2018 | $ | 702 | $ | (675 | ) | $ | 27 |
Level 1 | Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
Level 2 | Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data. |
Level 3 | Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability. |
Level 1 | Level 2 | Level 3 | Total | ||||||||||||
(in millions) | |||||||||||||||
Assets | |||||||||||||||
Investments | |||||||||||||||
Fixed maturities, available-for-sale: | |||||||||||||||
Corporate (1) | $ | — | $ | 29,596 | $ | 1,169 | $ | 30,765 | |||||||
U.S. Treasury, government and agency | — | 12,968 | — | 12,968 | |||||||||||
States and political subdivisions | — | 424 | 39 | 463 | |||||||||||
Foreign governments | — | 498 | — | 498 | |||||||||||
Residential mortgage-backed (2) | — | 195 | — | 195 | |||||||||||
Asset-backed (3) | — | 71 | 534 | 605 | |||||||||||
Redeemable preferred stock | 157 | 278 | — | 435 | |||||||||||
Total fixed maturities, available-for-sale | 157 | 44,030 | 1,742 | 45,929 | |||||||||||
Other equity investments | 12 | — | — | 12 | |||||||||||
Trading account securities | 296 | 12,408 | — | 12,704 | |||||||||||
Other invested assets: | |||||||||||||||
Short-term investments | — | 198 | — | 198 | |||||||||||
Assets of consolidated VIEs/VOEs | — | — | 18 | 18 | |||||||||||
Swaps | — | 360 | — | 360 | |||||||||||
Credit default swaps | — | 22 | — | 22 | |||||||||||
Options | — | 2,164 | — | 2,164 | |||||||||||
Total other invested assets | — | 2,744 | 18 | 2,762 | |||||||||||
Cash equivalents | 2,518 | — | — | 2,518 | |||||||||||
GMIB reinsurance contract asset | — | — | 2,009 | 2,009 | |||||||||||
Separate Accounts assets | 114,780 | 2,750 | 383 | 117,913 | |||||||||||
Total Assets | $ | 117,763 | $ | 61,932 | $ | 4,152 | $ | 183,847 | |||||||
Liabilities | |||||||||||||||
GMxB derivative features’ liability | $ | — | $ | — | $ | 5,944 | $ | 5,944 | |||||||
SCS, SIO, MSO and IUL indexed features’ liability | — | 1,992 | — | 1,992 | |||||||||||
Total Liabilities | $ | — | $ | 1,992 | $ | 5,944 | $ | 7,936 |
(1) | Corporate fixed maturities includes both public and private issues. |
(2) | Includes publicly traded agency pass-through securities and collateralized obligations. |
(3) | Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. |
Level 1 | Level 2 | Level 3 | Total | ||||||||||||
(in millions) | |||||||||||||||
Assets | |||||||||||||||
Investments | |||||||||||||||
Fixed maturities, available-for-sale: | |||||||||||||||
Corporate (1) | $ | — | $ | 25,202 | $ | 1,174 | $ | 26,376 | |||||||
U.S. Treasury, government and agency | — | 13,335 | — | 13,335 | |||||||||||
States and political subdivisions | — | 416 | 38 | 454 | |||||||||||
Foreign governments | — | 519 | — | 519 | |||||||||||
Residential mortgage-backed (2) | — | 202 | — | 202 | |||||||||||
Asset-backed (3) | — | 71 | 519 | 590 | |||||||||||
Redeemable preferred stock | 163 | 276 | — | 439 | |||||||||||
Total fixed maturities, available-for-sale | 163 | 40,021 | 1,731 | 41,915 | |||||||||||
Other equity investments | 12 | — | — | 12 | |||||||||||
Trading account securities | 218 | 14,919 | 29 | 15,166 | |||||||||||
Other invested assets: | |||||||||||||||
Short-term investments | — | 412 | — | 412 | |||||||||||
Assets of consolidated VIEs/VOEs | — | — | 19 | 19 | |||||||||||
Swaps | — | 423 | — | 423 | |||||||||||
Credit default swaps | — | 17 | — | 17 | |||||||||||
Options | — | 956 | — | 956 | |||||||||||
Total other invested assets | — | 1,808 | 19 | 1,827 | |||||||||||
Cash equivalents | 2,160 | — | — | 2,160 | |||||||||||
GMIB reinsurance contracts asset | — | — | 1,991 | 1,991 | |||||||||||
Separate Accounts assets | 105,159 | 2,733 | 374 | 108,266 | |||||||||||
Total Assets | $ | 107,712 | $ | 59,481 | $ | 4,144 | $ | 171,337 | |||||||
Liabilities | |||||||||||||||
GMxB derivative features’ liability | $ | — | $ | — | $ | 5,431 | $ | 5,431 | |||||||
SCS, SIO, MSO and IUL indexed features’ liability | — | 687 | — | 687 | |||||||||||
Total Liabilities | $ | — | $ | 687 | $ | 5,431 | $ | 6,118 |
(1) | Corporate fixed maturities includes both public and private issues. |
(2) | Includes publicly traded agency pass-through securities and collateralized obligations. |
(3) | Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. |
Corporate | State and Political Subdivisions | Asset- backed | |||||||||
(in millions) | |||||||||||
Balance, January 1, 2019 | $ | 1,174 | $ | 38 | $ | 519 | |||||
Total gains (losses), realized and unrealized, included in: | |||||||||||
Income (loss) as: | |||||||||||
Net investment income (loss) | 1 | — | — | ||||||||
Other comprehensive income (loss) | 9 | 1 | 4 | ||||||||
Purchases | 70 | — | 11 | ||||||||
Sales | (33 | ) | — | — | |||||||
Transfers into Level 3 (1) | 17 | — | — | ||||||||
Transfers out of Level 3 (1) | (69 | ) | — | — | |||||||
Balance, March 31, 2019 | $ | 1,169 | $ | 39 | $ | 534 | |||||
Balance, January 1, 2018 | $ | 1,139 | $ | 40 | $ | 8 | |||||
Total gains (losses), realized and unrealized, included in: | |||||||||||
Income (loss) as: | |||||||||||
Net investment income (loss) | 2 | — | — | ||||||||
Other comprehensive income (loss) | (20 | ) | (1 | ) | — | ||||||
Purchases | 173 | — | — | ||||||||
Sales | (116 | ) | — | (1 | ) | ||||||
Transfers into Level 3 (1) | 67 | — | — | ||||||||
Transfers out of Level 3 (1) | (16 | ) | — | — | |||||||
Balance, March 31, 2018 | $ | 1,229 | $ | 39 | $ | 7 |
(1) | Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values. |
Other Equity Investments (2) | GMIB Reinsurance Contract Asset | Separate Accounts Assets | GMxB Derivative Features Liability | ||||||||||||
(in millions) | |||||||||||||||
Balance, January 1, 2019 | $ | 48 | $ | 1,991 | $ | 374 | $ | (5,431 | ) | ||||||
Total gains (losses), realized and unrealized, included in: | |||||||||||||||
Income (loss) as: | |||||||||||||||
Investment gains (losses), net | — | — | 7 | — | |||||||||||
Net derivative gains (losses), excluding non-performance risk | — | (13 | ) | — | 51 | ||||||||||
Non-performance risk (1) | — | 40 | — | (460 | ) | ||||||||||
Subtotal | — | 27 | 7 | (409 | ) | ||||||||||
Purchases (2) | — | 12 | 4 | (107 | ) | ||||||||||
Sales (3) | — | (21 | ) | — | 3 | ||||||||||
Settlements | — | — | (1 | ) | — | ||||||||||
Activity related to consolidated VIEs/VOEs | (1 | ) | — | — | — | ||||||||||
Transfers out of Level 3 (4) | (29 | ) | — | (1 | ) | — | |||||||||
Balance, March 31, 2019 | $ | 18 | $ | 2,009 | $ | 383 | $ | (5,944 | ) | ||||||
Balance, January 1, 2018 | $ | 25 | $ | 10,488 | $ | 349 | $ | (4,256 | ) | ||||||
Total gains (losses), realized and unrealized, included in: | |||||||||||||||
Income (loss) as: | |||||||||||||||
Investment gains (losses), net | — | — | 7 | — | |||||||||||
Net derivative gains (losses), excluding non-performance risk | — | (854 | ) | — | 436 | ||||||||||
Non-performance risk (1) | — | 13 | — | 49 | |||||||||||
Subtotal | — | (841 | ) | 7 | 485 | ||||||||||
Purchases (2) | — | 54 | 3 | (93 | ) | ||||||||||
Sales (3) | — | (27 | ) | (1 | ) | 2 | |||||||||
Settlements | — | — | (1 | ) | — | ||||||||||
Activity related to consolidated VIEs/VOEs | 1 | — | — | — | |||||||||||
Transfers into Level 3 (4) | 5 | — | — | — | |||||||||||
Balance, March 31, 2018 | $ | 31 | $ | 9,674 | $ | 357 | $ | (3,862 | ) |
(1) | The Company’s non-performance risk is recorded through Net derivative gains (losses). |
(2) | For the GMIB reinsurance contract asset, and the GMxB derivative features liability, represents attributed fee. |
(3) | For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid. |
(4) | Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values. |
Income (Loss) | |||||||||||
Investment Gains (Losses), Net | Net Derivative Gains (Losses) | OCI | |||||||||
(in millions) | |||||||||||
Held at March 31, 2019: | |||||||||||
Change in unrealized gains (losses): | |||||||||||
Fixed maturities, available-for-sale: | |||||||||||
Corporate | $ | — | $ | — | $ | 9 | |||||
State and political subdivisions | — | — | 1 | ||||||||
Asset-backed | — | — | 4 | ||||||||
Subtotal | — | — | 14 | ||||||||
GMIB reinsurance contracts | — | 27 | — | ||||||||
Separate Accounts assets (1) | 7 | — | — | ||||||||
GMxB derivative features liability | — | (409 | ) | — | |||||||
Total | $ | 7 | $ | (382 | ) | $ | 14 | ||||
Held at March 31, 2018: | |||||||||||
Change in unrealized gains (losses): | |||||||||||
Fixed maturities, available-for-sale: | |||||||||||
Corporate | $ | — | $ | — | $ | (19 | ) | ||||
State and political subdivisions | — | — | (1 | ) | |||||||
Subtotal | — | — | (20 | ) | |||||||
GMIB reinsurance contracts | — | (842 | ) | — | |||||||
Separate Accounts assets (1) | 7 | — | — | ||||||||
GMxB derivative features liability | — | 440 | — | ||||||||
Total | $ | 7 | $ | (402 | ) | $ | (20 | ) |
(1) | There is an investment expense that offsets this investment gain (loss). |
Fair Value | Valuation Technique | Significant Unobservable Input | Range | Weighted Average | ||||||||
(in millions) | ||||||||||||
Assets: | ||||||||||||
Investments: | ||||||||||||
Fixed maturities, available-for-sale: | ||||||||||||
Corporate | $ | 96 | Matrix pricing model | Spread over benchmark | 15 - 580 bps | 109 bps | ||||||
891 | Market comparable companies | EBITDA multiples Discount rate Cash flow multiples | 3.9x - 25.5x 6.1% - 16.5% 1.6x - 18.0x | 12.7x 10.6% 11.4x | ||||||||
Separate Accounts assets | 359 | Third party appraisal | Capitalization rate Exit capitalization rate Discount rate | 4.4% 5.5% 6.4% | ||||||||
1 | Discounted cash flow | Spread over U.S. Treasury curve Discount factor | 248 bps 4.8 % | |||||||||
GMIB reinsurance contract asset | 2,009 | Discounted cash flow | Lapse rates Withdrawal rates Utilization rates Non-performance risk Volatility rates - Equity Mortality rates (1): Ages 0 - 40 Ages 41 - 60 Ages 60 - 115 | 1.0% - 6.27% 0.0% - 8.0% 0.0% - 16.0% 52 - 129 bps 7.0% - 32.0% 0.01% - 0.18% 0.07% - 0.54% 0.42% - 42.0% | ||||||||
Liabilities: | ||||||||||||
GMIBNLG | 5,847 | Discounted cash flow | Non-performance risk Lapse rates Withdrawal rates Annuitization rates Mortality rates (1): Ages 0 - 40 Ages 41 - 60 Ages 60 - 115 | 149 bps 0.8% - 26.2% 0.0% - 12.144% 0.0% - 100.0% 0.01% - 0.19% 0.06% - 0.53% 0.41% - 41.2% | ||||||||
GWBL/GMWB | 137 | Discounted cash flow | Lapse rates Withdrawal rates Utilization rates Volatility rates - Equity | 0.5% - 5.7% 0.0% - 7.0% 100% after delay 7.0% - 32.0% | ||||||||
GIB | (44 | ) | Discounted cash flow | Lapse rates Withdrawal rates Utilization rates Volatility rates - Equity | 0.5% - 5.7% 0.0% - 8.0% 0.0% - 16.0% 7.0% - 32.0% | |||||||
GMAB | 4 | Discounted cash flow | Lapse rates Volatility rates - Equity | 0.5% - 11.0% 7.0% - 32.0% |
(1) | Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. |
Fair Value | Valuation Technique | Significant Unobservable Input | Range | Weighted Average | ||||||||
(in millions) | ||||||||||||
Assets: | ||||||||||||
Investments: | ||||||||||||
Fixed maturities, available-for-sale: | ||||||||||||
Corporate | $ | 93 | Matrix pricing model | Spread over benchmark | 15 - 580 bps | 104 bps | ||||||
881 | Market comparable companies | EBITDA multiples Discount rate Cash flow multiples | 4.1x - 37.8x 6.4% - 16.5% 1.8x - 18.0x | 12.1x 10.7% 11.4x | ||||||||
Separate Accounts assets | 352 | Third party appraisal | Capitalization rate Exit capitalization rate Discount rate | 4.4% 5.6% 6.5% | ||||||||
1 | Discounted cash flow | Spread over U.S. Treasury curve Discount factor | 248 bps 5.1% | |||||||||
GMIB reinsurance contract asset | 1,991 | Discounted cash flow | Lapse rates Withdrawal rates Utilization rates Non-performance risk Volatility rates - Equity Mortality rates (1): Ages 0 - 40 Ages 41 - 60 Ages 60 - 115 | 1.0% - 6.27% 0.0% - 8.0% 0.0% - 16.0% 74 - 159 bps 10.0% - 34.0% 0.01% - 0.18% 0.07% - 0.54% 0.42% - 42.0% | ||||||||
Liabilities: | ||||||||||||
GMIBNLG | 5,341 | Discounted cash flow | Non-performance risk Lapse rates Withdrawal rates Annuitization rates Mortality rates (1): Ages 0 - 40 Ages 41 - 60 Ages 60 - 115 | 189 bps 0.8% - 26.2% 0.0% - 12.1% 0.0% - 100.0% 0.01% - 0.19% 0.06% - 0.53% 0.41% - 41.2% | ||||||||
GWBL/GMWB | 130 | Discounted cash flow | Lapse rates Withdrawal rates Utilization rates Volatility rates - Equity | 0.5% - 5.7% 0.0% - 7.0% 100% after delay 10.0% - 34.0% | ||||||||
GIB | (48 | ) | Discounted cash flow | Lapse rates Withdrawal rates Utilization rates Volatility rates - Equity | 0.5% - 5.7% 0.0% - 8.0% 0.0% - 16.0% 10.0% - 34.0% | |||||||
GMAB | 7 | Discounted cash flow | Lapse rates Volatility rates - Equity | 1.0% - 5.7% 10.0% - 34.0% |
(1) | Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. |
Carrying Value | Fair Value | ||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||
(in millions) | |||||||||||||||||||
March 31, 2019: | |||||||||||||||||||
Mortgage loans on real estate | $ | 12,100 | $ | — | $ | — | $ | 12,002 | $ | 12,002 | |||||||||
FHLBNY Funding Agreements | $ | 4,001 | $ | — | $ | 4,011 | $ | — | $ | 4,011 | |||||||||
Policy loans | $ | 3,253 | $ | — | $ | — | $ | 4,064 | $ | 4,064 | |||||||||
Loans to affiliates | $ | 600 | $ | — | $ | 610 | $ | — | $ | 610 | |||||||||
Policyholders’ liabilities: Investment contracts | $ | 1,983 | $ | — | $ | — | $ | 2,094 | $ | 2,094 | |||||||||
Separate Accounts liabilities | $ | 8,173 | $ | — | $ | — | $ | 8,173 | $ | 8,173 | |||||||||
December 31, 2018: | |||||||||||||||||||
Mortgage loans on real estate | $ | 11,818 | $ | — | $ | — | $ | 11,478 | $ | 11,478 | |||||||||
FHLBNY Funding Agreements | $ | 4,002 | $ | — | $ | 3,956 | $ | — | $ | 3,956 | |||||||||
Policy loans | $ | 3,267 | $ | — | $ | — | $ | 3,944 | $ | 3,944 | |||||||||
Loans to affiliates | $ | 600 | $ | — | $ | 603 | $ | — | $ | 603 | |||||||||
Policyholders’ liabilities: Investment contracts | $ | 1,974 | $ | — | $ | — | $ | 2,015 | $ | 2,015 | |||||||||
Loans from affiliates | $ | 572 | $ | — | $ | 572 | $ | — | $ | 572 | |||||||||
Separate Accounts liabilities | $ | 7,406 | $ | — | $ | — | $ | 7,406 | $ | 7,406 |
Balance Sheet Line Item | March 31, 2019 | |||||
(in millions) | ||||||
Assets | ||||||
Operating lease asset | Other Assets | $ | 328 | |||
Liabilities | ||||||
Operating lease liability | Other Liabilities | $ | 422 |
Three Months Ended March 31, 2019 | ||||
(in millions) | ||||
Operating lease cost | $ | 53 | ||
Variable operating lease cost | $ | 3 | ||
Sublease income | $ | (4 | ) | |
Short-term lease expense | $ | 1 |
March 31, 2019 | ||||
Operating Leases (1) | (in millions) | |||
2019 | $ | 86 | ||
2020 | 89 | |||
2021 | 84 | |||
2022 | 81 | |||
2023 | 76 | |||
Thereafter | 84 | |||
Total lease payments | 500 | |||
Less: Interest | (78 | ) | ||
Present value of lease liabilities | $ | 422 |
(1) | As of March 31, 2019, the Company has additional operating real estate leases that have not yet commenced of approximately $10 million. These operating leases will commence in August 2019 with lease terms of five to ten years. |
March 31, 2019 | |||
Weighted-average remaining operating lease term (years) | 6 | ||
Weighted-average discount rate for operating leases | 3.15 | % |
Three Months Ended March 31, 2019 | ||||
(in millions) | ||||
Cash paid for amounts included in the measurement of lease liabilities: | ||||
Operating cash flows from operating leases | $ | 21 | ||
Non-cash transactions: | ||||
Leased assets obtained in exchange for new operating lease liabilities | $ | 1 |
December 31, 2018 | ||||
Calendar Year | (in millions) | |||
2019 | $ | 81 | ||
2020 | $ | 74 | ||
2021 | $ | 69 | ||
2022 | $ | 67 | ||
2023 | $ | 63 | ||
Thereafter | $ | 66 |
March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
Unrealized gains (losses) on investments | $ | 280 | $ | (129 | ) | ||
Defined benefit pension plans | (7 | ) | (5 | ) | |||
Total accumulated other comprehensive income (loss) from continuing operations | 273 | (134 | ) | ||||
Less: Accumulated other comprehensive (income) loss attributable to discontinued operations, net of noncontrolling interest | — | (24 | ) | ||||
Accumulated other comprehensive income (loss) attributable to AXA Equitable | $ | 273 | $ | (158 | ) |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
Change in net unrealized gains (losses) on investments: | |||||||
Net unrealized gains (losses) arising during the period | $ | 1,243 | $ | (984 | ) | ||
(Gains) losses reclassified to Net income (loss) during the period (1) | 6 | (71 | ) | ||||
Net unrealized gains (losses) on investments | 1,249 | (1,055 | ) | ||||
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other | (485 | ) | 313 | ||||
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $200 and $(197)) | 764 | (742 | ) | ||||
Change in defined benefit plans: | |||||||
Less: Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost | — | (4 | ) | ||||
Change in defined benefit plans (net of deferred income tax expense (benefit) of $0 and $0) | — | (4 | ) | ||||
Total other comprehensive income (loss), net of income taxes from continuing operations | 764 | (746 | ) | ||||
Other comprehensive income (loss) from discontinued operations, net of income taxes | — | (10 | ) | ||||
Other comprehensive income (loss) attributable to AXA Equitable | $ | 764 | $ | (756 | ) |
(1) | See “Reclassification adjustments” in Note 3. Reclassification amounts are presented net of income tax expense (benefit) of $1 million and $(19) million for the three months ended March 31, 2019 and 2018, respectively. |
Outstanding Balance at December 31, 2018 | Issued During the Period | Repaid During the Period | Outstanding Balance at March 31, 2019 | ||||||||||||
(in millions) | |||||||||||||||
Short-term funding agreements: | |||||||||||||||
Due in one year or less | $ | 1,640 | $ | 4,470 | $ | 4,470 | $ | 1,640 | |||||||
Long-term funding agreements: | |||||||||||||||
Due in years two through five | 1,569 | — | — | 1,569 | |||||||||||
Due in more than five years | 781 | — | — | 781 | |||||||||||
Total long-term funding agreements | 2,350 | — | — | 2,350 | |||||||||||
Total funding agreements (1) | $ | 3,990 | $ | 4,470 | $ | 4,470 | $ | 3,990 |
(1) | The $11 million and $12 million difference between the funding agreements carrying value shown in fair value table at March 31, 2019 and December 31, 2018, respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements’ borrowing rates. |
Three Months Ended March 31, 2018 | |||
(in millions) | |||
Investment management and service fees: | |||
Base fees | $ | 568 | |
Performance-based fees | 6 | ||
Research services | 114 | ||
Distribution services | 108 | ||
Shareholder services | 20 | ||
Other | 6 | ||
Total investment management and service fees | $ | 822 |
Three Months Ended March 31, 2018 | |||
(in millions) | |||
REVENUES | |||
Net derivative gains (losses) | $ | 2 | |
Net investment income (loss) | 39 | ||
Investment management and service fees | 803 | ||
Other income | 2 | ||
Total revenues | 846 | ||
BENEFITS AND OTHER DEDUCTIONS | |||
Compensation and benefits | 344 | ||
Distribution-related payments | 110 | ||
Interest expense | 2 | ||
Other operating costs and expenses | 189 | ||
Total benefits and other deductions | 645 | ||
Income from discontinued operations, before income taxes | 201 | ||
Income tax expense | (17 | ) | |
Net income from discontinued operations, net of taxes | 184 | ||
Less: Net income attributable to the noncontrolling interest | (155 | ) | |
Net income from discontinued operations, net of taxes and noncontrolling interest | $ | 29 |
As of March 31, 2018 | |||||||||||||||||||
As Previously Reported | Discontinued Operations Adjustment | As Adjusted | Impact of Revisions | As Revised | |||||||||||||||
(in millions) | |||||||||||||||||||
Consolidated Balance Sheet: | |||||||||||||||||||
Assets: | |||||||||||||||||||
DAC | $ | 4,826 | $ | — | $ | 4,826 | $ | (119 | ) | $ | 4,707 | ||||||||
Total Assets | $ | 222,424 | $ | — | $ | 222,424 | $ | (119 | ) | $ | 222,305 | ||||||||
Liabilities: | |||||||||||||||||||
Future policy benefits and other policyholders’ liabilities | $ | 28,374 | $ | — | $ | 28,374 | $ | (10 | ) | $ | 28,364 | ||||||||
Current and deferred income taxes | 1,728 | (432 | ) | 1,296 | (38 | ) | 1,258 | ||||||||||||
Other liabilities | 3,041 | (1,941 | ) | 1,100 | 70 | 1,170 | |||||||||||||
Total Liabilities | $ | 202,767 | $ | — | $ | 202,767 | $ | 22 | $ | 202,789 | |||||||||
Equity: | |||||||||||||||||||
Retained earnings | $ | 8,824 | $ | — | $ | 8,824 | $ | (141 | ) | $ | 8,683 | ||||||||
Total equity attributable to AXA Equitable | 15,545 | — | 15,545 | (141 | ) | 15,404 | |||||||||||||
Total Equity | 18,633 | — | 18,633 | (141 | ) | 18,492 | |||||||||||||
Total Liabilities, Redeemable Noncontrolling Interest and Equity | $ | 222,424 | $ | — | $ | 222,424 | $ | (119 | ) | $ | 222,305 |
Three Months Ended March 31, 2018 | |||||||||||||||||||||||
As Previously Reported | Gross DAC Adjustment | Discontinued Operations Adjustment | As Adjusted | Impact of Revisions | As Revised | ||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Consolidated Statement of Income (Loss): | |||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||
Policy charges and fee income | $ | 869 | $ | — | $ | — | $ | 869 | $ | (8 | ) | $ | 861 | ||||||||||
Net derivative gains (losses) | (777 | ) | — | (2 | ) | (779 | ) | (38 | ) | (817 | ) | ||||||||||||
Total revenues | 2,031 | — | (846 | ) | 1,185 | (46 | ) | 1,139 | |||||||||||||||
Benefits and other deductions: | |||||||||||||||||||||||
Policyholders’ benefits | 489 | — | — | 489 | (9 | ) | 480 | ||||||||||||||||
Interest credited to policyholders’ account balances | 338 | — | — | 338 | (83 | ) | 255 | ||||||||||||||||
Compensation and benefits | 456 | (33 | ) | (344 | ) | 79 | 70 | 149 | |||||||||||||||
Commissions | 371 | (101 | ) | (110 | ) | 160 | — | 160 | |||||||||||||||
Amortization of DAC | 10 | 135 | — | 145 | 64 | 209 | |||||||||||||||||
Other operating costs and expenses | 440 | (1 | ) | (189 | ) | 250 | — | 250 | |||||||||||||||
Total benefits and other deductions | 2,115 | — | (645 | ) | 1,470 | 42 | 1,512 | ||||||||||||||||
Income (loss) from continuing operations, before income taxes | (84 | ) | — | (201 | ) | (285 | ) | (88 | ) | (373 | ) | ||||||||||||
Income tax (expense) benefit from continuing operations | 44 | — | 17 | 61 | 19 | 80 | |||||||||||||||||
Net income (loss) from continuing operations | (40 | ) | — | (184 | ) | (224 | ) | (69 | ) | (293 | ) | ||||||||||||
Net income (loss) | (40 | ) | — | (155 | ) | (195 | ) | (69 | ) | (264 | ) | ||||||||||||
Net income (loss) attributable to AXA Equitable | $ | (194 | ) | $ | — | $ | — | $ | (194 | ) | $ | (69 | ) | $ | (263 | ) |
Three Months Ended March 31, 2018 | |||||||||||||||||||
As Previously Reported | Discontinued Operations Adjustment | As Adjusted | Impact of Revisions | As Revised | |||||||||||||||
(in millions) | |||||||||||||||||||
Statement of Comprehensive Income (Loss): | |||||||||||||||||||
Net income (loss) | $ | (40 | ) | $ | (155 | ) | $ | (195 | ) | $ | (69 | ) | $ | (264 | ) | ||||
Comprehensive income (loss) | $ | (789 | ) | $ | (162 | ) | $ | (951 | ) | $ | (69 | ) | $ | (1,020 | ) | ||||
Comprehensive income (loss) attributable to AXA Equitable | $ | (950 | ) | $ | (1 | ) | $ | (951 | ) | $ | (69 | ) | $ | (1,020 | ) |
Three Months Ended March 31, 2018 | |||||||||||||||||||
As Previously Reported | Discontinued Operations Adjustment | As Adjusted | Impact of Revisions | As Revised | |||||||||||||||
(in millions) | |||||||||||||||||||
Consolidated Statement of Equity: | |||||||||||||||||||
Retained earnings, beginning of year | $ | 9,010 | $ | — | $ | 9,010 | $ | (72 | ) | $ | 8,938 | ||||||||
Net income (loss) | (194 | ) | — | (194 | ) | (69 | ) | (263 | ) | ||||||||||
Retained earnings, end of period | 8,824 | — | 8,824 | (141 | ) | 8,683 | |||||||||||||
Total AXA Equitable’s equity, end of period | 15,545 | — | 15,545 | (141 | ) | 15,404 | |||||||||||||
Total Equity, End of Period | $ | 18,633 | $ | — | $ | 18,633 | $ | (141 | ) | $ | 18,492 |
Three Months Ended March 31, 2018 | |||||||||||||||
As Previously Reported | Presentation Reclassifi- cations | Impact of Revisions | As Revised | ||||||||||||
(in millions) | |||||||||||||||
Consolidated Statement of Cash Flows: | |||||||||||||||
Cash flows from operating activities: | |||||||||||||||
Net income (loss) (1) | $ | (40 | ) | $ | — | $ | (69 | ) | $ | (109 | ) | ||||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||||||||||||
Interest credited to policyholders’ account balances | 338 | — | (83 | ) | 255 | ||||||||||
Policy charges and fee income | (869 | ) | — | 8 | (861 | ) | |||||||||
Net derivative (gains) losses | 777 | — | 38 | 815 | |||||||||||
Amortization and depreciation | — | 137 | 64 | 201 | |||||||||||
Amortization of deferred sales commission | 7 | (7 | ) | — | — | ||||||||||
Other depreciation and amortization | (23 | ) | 23 | — | — | ||||||||||
Amortization of other intangibles | 8 | (8 | ) | — | — | ||||||||||
Equity (income) loss from limited partnerships | — | (39 | ) | — | (39 | ) | |||||||||
Distributions from joint ventures and limited partnerships | 25 | (25 | ) | — | — | ||||||||||
Changes in: | |||||||||||||||
Reinsurance recoverable | 2 | — | (149 | ) | (147 | ) | |||||||||
DAC | 10 | (10 | ) | — | — | ||||||||||
Capitalization of DAC | — | (135 | ) | — | (135 | ) | |||||||||
Future policy benefits | (191 | ) | — | (7 | ) | (198 | ) | ||||||||
Current and deferred income taxes | (52 | ) | — | 132 | 80 | ||||||||||
Other, net | (122 | ) | 64 | 70 | 12 | ||||||||||
Net cash provided by (used in) operating activities | $ | (21 | ) | $ | — | $ | 4 | $ | (17 | ) | |||||
Cash flows from investing activities: | |||||||||||||||
Proceeds from the sale/maturity/prepayment of: | |||||||||||||||
Trading account securities | $ | 1,606 | $ | — | $ | 77 | $ | 1,683 | |||||||
Real estate joint ventures | — | 140 | — | 140 | |||||||||||
Short-term investments | — | 688 | — | 688 | |||||||||||
Other | 54 | (140 | ) | — | (86 | ) | |||||||||
Payment for the purchase/origination of: | |||||||||||||||
Short-term investments | — | (377 | ) | — | (377 | ) | |||||||||
Cash settlements related to derivative instruments | (14 | ) | — | (489 | ) | (503 | ) | ||||||||
Change in short-term investments | 396 | (311 | ) | (85 | ) | — | |||||||||
Other, net | (560 | ) | — | 153 | (407 | ) | |||||||||
Net cash provided by (used in) investing activities | $ | (639 | ) | $ | — | $ | (344 | ) | $ | (983 | ) | ||||
Cash flows from financing activities: | |||||||||||||||
Policyholders’ account balances: | |||||||||||||||
Deposits | $ | 2,366 | $ | — | $ | (468 | ) | $ | 1,898 | ||||||
Withdrawals | (1,322 | ) | — | 241 | (1,081 | ) | |||||||||
Transfers (to) from Separate Accounts | (115 | ) | — | 567 | 452 | ||||||||||
Net cash provided by (used in) financing activities | $ | 1,040 | $ | — | $ | 340 | $ | 1,380 | |||||||
Non-cash transactions during the period: | |||||||||||||||
(Settlement) issuance of long-term debt | $ | — | $ | — | $ | (202 | ) | $ | (202 | ) | |||||
Transfer of assets to reinsurer | $ | — | $ | — | $ | (604 | ) | $ | (604 | ) |
(1) | Net income (loss) includes $155 million in the three months ended March 31, 2018 of the discontinued operations that are not included in Net income (loss) in the Consolidated Statements of Income (Loss). |
• | fee income and premiums from our life insurance and annuity products; and |
• | investment income from our General Account investment portfolio. |
• | policyholders’ benefits and interest credited to policyholders’ account balances; |
• | sales commissions and compensation paid to intermediaries and advisors that distribute our products and services; and |
• | compensation and benefits provided to our employees and other operating expenses. |
• | Variable annuity hedging programs. We use a dynamic hedging program (within this program, generally, we reevaluate our economic exposure at least daily and rebalance our hedge positions accordingly) to mitigate certain risks associated with the GMxB features that are embedded in our liabilities for our variable annuity products. This program utilizes various derivative instruments that are managed in an effort to reduce the economic impact of unfavorable changes in GMxB features’ exposures attributable to movements in the equity markets and interest rates. Although this program is designed to provide a measure of economic protection against the impact of adverse market conditions, it does not qualify for hedge accounting treatment. Accordingly, changes in value of the derivatives will be recognized in the period in which they occur with offsetting changes in reserves partially recognized in the current period, resulting in net income volatility. In addition to our dynamic hedging program, |
• | GMIB reinsurance contracts. Historically, GMIB reinsurance contracts were used to cede to non-affiliated reinsurers a portion of our exposure to variable annuity products that offer a GMIB feature. We account for the GMIB reinsurance contracts as derivatives and report them at fair value. Gross reserves for GMIB reserves are calculated on the basis of assumptions related to projected benefits and related contract charges over the lives of the contracts. Accordingly, our gross reserves will not immediately reflect the offsetting impact on future claims exposure resulting from the same capital market or interest rate fluctuations that cause gains or losses on the fair value of the GMIB reinsurance contracts. Because changes in the fair value of the GMIB reinsurance contracts are recorded in the period in which they occur and a majority of the changes in gross reserves for GMIB are recognized over time, net income will be more volatile. |
• | Certain of our variable annuity and life insurance products pay guaranteed minimum interest crediting rates. We are required to pay these guaranteed minimum rates even if earnings on our investment portfolio decline, with the resulting investment margin compression negatively impacting earnings. In addition, we expect more policyholders to hold policies with comparatively high guaranteed rates longer (lower lapse rates) in a low interest rate environment. Conversely, a rise in average yield on our investment portfolio should positively impact earnings. Similarly, we expect policyholders would be less likely to hold policies with existing guaranteed rates (higher lapse rates) as interest rates rise. |
• | A prolonged low interest rate environment also may subject us to increased hedging costs or an increase in the amount of statutory reserves that our insurance subsidiaries are required to hold for GMxB features, lowering their statutory surplus, which would adversely affect their ability to pay dividends to us. In addition, it may also increase the perceived value of GMxB features to our policyholders, which in turn may lead to a higher rate of annuitization and higher persistency of those products over time. Finally, low interest rates may continue to cause an acceleration of DAC amortization or reserve increase due to loss recognition for interest-sensitive products. |
• | National Association of Insurance Commissioners (“NAIC”). In 2015, the NAIC Financial Condition (E) Committee established a working group to study and address, as appropriate, regulatory issues resulting from variable annuity captive reinsurance transactions, including reforms that would improve the current statutory reserve and risk-based capital (“RBC”) framework for insurance companies that sell variable annuity products. In August 2018, the NAIC adopted the new framework developed and proposed by this working group, expected to take effect January 2020, and which has now been referred to various other NAIC committees to develop the expected full implementation details. Among other changes, the new framework includes new prescriptions for reflecting hedge effectiveness, investment returns, interest rates, mortality and policyholder behavior in calculating statutory reserves and RBC. Once effective, it could materially change the level of variable annuity reserves and RBC requirements as well as their sensitivity to capital markets including interest rate, equity markets, volatility and credit spreads. Overall, we believe the NAIC reform is moving variable annuity capital standards towards an economic framework and is consistent with how we manage our business. However, we cannot predict whether the NYDFS or other state insurance regulators will adopt standards different from the NAIC framework. |
• | Fiduciary Rules/“Best Interest” Standards of Conduct. In the wake of the March 2018 federal appeals court decision to vacate the Department of Labor’s 2016 fiduciary rulemaking (the “DOL Rule”), the SEC and NAIC as well as state regulators are currently considering whether to apply an impartial conduct standard similar to the DOL Rule to recommendations made in connection with certain annuities and, in one case, to life insurance |
• | In April 2018, the SEC released a set of proposed rules that would, among other things, enhance the existing standard of conduct for broker-dealers to require them to act in the best interest of their clients; clarify the nature of the fiduciary obligations owed by registered investment advisers to their clients; impose new disclosure requirements aimed at ensuring investors understand the nature of their relationship with their investment professionals; and restrict certain broker-dealers and their financial professionals from using the terms “adviser” or “advisor”. Public comments were due by August 7, 2018. Although the full impact of the proposed rules can only be measured when the implementing regulations are adopted, the intent of this provision is to authorize the SEC to impose on broker-dealers’ fiduciary duties to their customers similar to those that apply to investment advisers under existing law. We are currently assessing these proposed rules to determine the impact they may have on our business. |
Three Months Ended March 31, 2018 | |||
(in millions) | |||
Reductions to expense line items: | |||
Compensation and benefits | $ | 33 | |
Commissions | 101 | ||
Other operating costs and expenses | 1 | ||
Total reductions | $ | 135 | |
Increase to expense line item: | |||
Amortization of DAC | $ | 135 |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(in millions) | |||||||
REVENUES | |||||||
Policy charges and fee income | $ | 859 | $ | 861 | |||
Premiums | 232 | 223 | |||||
Net derivative gains (losses) | (1,555 | ) | (817 | ) | |||
Net investment income (loss) | 904 | 509 | |||||
Investment gains (losses), net | (8 | ) | 87 | ||||
Investment management and service fees | 248 | 254 | |||||
Other income | 10 | 22 | |||||
Total revenues | 690 | 1,139 | |||||
BENEFITS AND OTHER DEDUCTIONS | |||||||
Policyholders’ benefits | 819 | 480 | |||||
Interest credited to policyholders’ account balances | 269 | 255 | |||||
Compensation and benefits | 82 | 149 | |||||
Commissions | 157 | 160 | |||||
Interest expense | 4 | 9 | |||||
Amortization of deferred policy acquisition costs | 165 | 209 | |||||
Other operating costs and expenses | 184 | 250 | |||||
Total benefits and other deductions | 1,680 | 1,512 | |||||
Income (loss) from continuing operations, before income taxes | (990 | ) | (373 | ) | |||
Income tax (expense) benefit from continuing operations | 162 | 80 | |||||
Net income (loss) from continuing operations | (828 | ) | (293 | ) | |||
Net income (loss) from discontinued operations, net of taxes and noncontrolling interest | — | 29 | |||||
Net income (loss) | (828 | ) | (264 | ) | |||
Less: Net (income) loss attributable to the noncontrolling interest | (2 | ) | 1 | ||||
Net income (loss) attributable to AXA Equitable | $ | (830 | ) | $ | (263 | ) |
• | Net derivative gains (losses) decreased by $738 million mainly due to the higher freestanding derivative losses and increase in the fair value of the GMIBNLG liability. |
• | Policyholders’ benefits increased by $339 million mainly due to the favorable impact of higher interest rates on our GMxB liabilities in the first quarter of 2018. The GMxB assumption updates in the third quarter of 2018 reduced the impact of interest rates on GMxB policyholders' benefits in the first quarter of 2019. Policyholders' benefits also increased due to higher mortality experience on our life products. |
• | Investment gains (losses), net increased by $95 million primarily due to realized losses on the sale of fixed maturities in the first three months of 2019 compared to realized gains on the sale of fixed maturities in the first three months of 2018. |
• | Investment management, service fees and other income decreased by $18 million mainly due to lower average Separate Accounts AV in 2019 compared to 2018 as a result of a decline in equity markets in the fourth quarter of 2018. |
• | Interest credited to policyholders’ account balances increased by $14 million primarily driven by higher SCS AV. |
• | Net investment income (loss) increased by $395 million mainly due to a change in the market value of trading account securities supporting our variable annuity products due to lower interest rates. |
• | Compensation and benefits decreased by $67 million mainly due to a non-recurring loss resulting from the annuity purchase transaction and partial settlement of the employee pension plan in the first three months of 2018. |
• | Other operating costs and expenses decreased by $66 million mainly due to lower amortization of deferred cost of reinsurance and lower separation costs. |
• | Amortization of deferred policy acquisition costs decreased by $44 million mainly due to lower amortization on our variable and interest sensitive life products resulting from no longer being in loss recognition, partially offset by higher amortization on our SCS products due to the impact of a non-repeating favorable DAC amortization in our SCS product in the first three months of 2018. |
• | Policy charges, fee income and premiums increased by $7 million primarily due to higher cost of insurance charges and lower ceded fee income and premiums as a result of the unwind of our GMxB reinsurance with an affiliate in April 2018. |
• | Interest expense decreased by $5 million due to lower repurchase agreement costs. |
• | Income tax benefit increased by $82 million primarily driven by higher pre-tax losses. |
• | liabilities for future policy benefits; |
• | accounting for reinsurance; |
• | capitalization and amortization of DAC and policyholder bonus interest credits; |
• | estimated fair values of investments in the absence of quoted market values and investment impairments; |
• | estimated fair values of freestanding derivatives and the recognition and estimated fair value of embedded derivatives requiring bifurcation; |
• | measurement of income taxes and the valuation of deferred tax assets; and |
• | liabilities for litigation and regulatory matters. |
(i) | maintain effective controls to timely validate that actuarial models are properly configured to capture all relevant product features and provide reasonable assurance timely reviews of assumptions and data have occurred, and, as a result, errors were identified in future policyholders’ benefits and DAC balances; and |
(ii) | maintain sufficient experienced personnel to prepare the Company’s consolidated financial statements and to verify consolidating and adjusting journal entries are completely and accurately recorded to the appropriate accounts and, as a result, errors were identified in the consolidated financial statements, including in the presentation and disclosure between sections of the statements of cash flows. |
(i) | the revision of the interim financial statements for the nine, six, and three months ended September 30, June 30, and March 31, 2018 and 2017, respectively, and the annual financial statements for the year ended December 31, 2017; |
(ii) | the revision for the three and six months ended March 31, 2018, and June 30, 2018, respectively, as well as the three, six and nine months ended March 31, 2017, June 30, 2017 and September 30, 2017, respectively and for the years ended December 31, 2017 and 2016 |
(iii) | the revision of the interim financial statements for the three months ended March 31, 2018, the nine months ended September 30, 2017, the six months ended June 30, 2017 and the annual financial statements for the years ended December 31, 2017 and 2016 and |
• | We have designed and implemented an enhanced model validation control framework, including a rotational schedule to periodically re-validate all U.S. GAAP models. |
• | We have designed and implemented enhanced controls and governance processes for new model implementations. |
• | We have designed and implemented enhanced controls for model changes. |
• | We have designed and implemented enhanced controls over the annual assumption setting process, including a comprehensive master assumption inventory and risk framework. |
• | We have completed a current state assessment of significant data flows feeding actuarial models and assumptions. We have initiated a validation review and a control design assessment of these data flows. |
• | We are in the process of completing a comprehensive plan for enhancing the process and controls over the reliability of data feeding significant actuarial models. |
• | With respect to insufficient personnel, we have strengthened our finance team by adding approximately 25 employees to the Accounting and Financial Reporting areas. Of these additional resources, eleven have a CPA license, eight have worked at a “Big 4” public accounting firm and the remainder have worked in a finance area within a public company. We have conducted both specific job-related training and general training on SOX controls and U.S. GAAP related technical topics to new and existing staff. |
• | To improve controls over journal entries, a less controlled secondary process that was used for consolidating certain entities, reflecting adjustments to prior periods and generating the business segment disclosures, has been eliminated. Beginning with third quarter 2018, all journal entries are recorded in the Company’s general ledger and the secondary process is no longer necessary. |
• | We have enhanced the controls over journal entries through the implementation of new standards designed to ensure effective review and approval of journal entries with sufficient supporting documentation. |
• | We have designed and implemented new management review controls within the period end financial reporting process that will operate at a level of precision sufficient to detect errors that could result in a material misstatement. |
Number | Description and Method of Filing |
31.1# | Certification of the Registrant’s Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
31.2# | Certification of the Registrant’s Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
32.1# | Certification of the Registrant’s Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
32.2# | Certification of the Registrant’s Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
101.INS | XBRL Instance Document |
101.SCH | XBRL Taxonomy Extension Schema Document |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
# | Filed herewith. |
Date: May 14, 2019 | AXA EQUITABLE LIFE INSURANCE COMPANY | ||
By: | /s/ Anders Malmström | ||
Name: | Anders Malmström | ||
Title: | Senior Executive Director and Chief Financial Officer | ||
Date: May 14, 2019 | /s/ Andrea Nitzan | ||
Name: | Andrea Nitzan | ||
Title: | Managing Director, Chief Accounting Officer and Controller | ||
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
/s/ Mark Pearson |
Mark Pearson |
Chief Executive Officer |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
/s/ Anders Malmstrom |
Anders Malmstrom |
Senior Executive Director and |
Chief Financial Officer |
/s/ Mark Pearson |
Mark Pearson |
Chief Executive Officer |
/s/ Anders Malmstrom |
Anders Malmstrom |
Senior Executive Director and |
Chief Financial Officer |
DOCUMENT AND ENTITY INFORMATION - shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
May 13, 2019 |
|
Document and Entity Information [Abstract] | ||
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2019 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2019 | |
Amendment Flag | false | |
Entity Registrant Name | AXA EQUITABLE LIFE INSURANCE CO | |
Entity Central Index Key | 0000727920 | |
Entity Current Reporting Status | Yes | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Emerging Growth Company | false | |
Entity Small Business | false | |
Entity Common Stock Shares Outstanding | 2,000,000 |
CONSOLIDATED BALANCE SHEET (UNAUDITED) (Parenthetical) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Fixed maturities available-for-sale, amortized cost | $ 44,926 | $ 42,492 |
Mortgage loans on real estate, valuation allowances | $ 0 | $ 7 |
Common stock par value (in dollars per share) | $ 1.25 | $ 1.25 |
Common stock authorized (in shares) | 2,000,000 | 2,000,000 |
Common stock issued (in shares) | 2,000,000 | 2,000,000 |
Common stock outstanding (in shares) | 2,000,000 | 2,000,000 |
CONSOLIDATED STATEMENTS OF INCOME (LOSS) (UNAUDITED) - USD ($) $ in Millions |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|||
REVENUES | ||||
Policy charges and fee income | $ 859 | $ 861 | ||
Premiums | 232 | 223 | ||
Net derivative gains (losses) | (1,555) | (817) | ||
Net investment income (loss) | 904 | 509 | ||
Investment gains (losses), net | (8) | 87 | ||
Investment management and service fees | 248 | 254 | ||
Other income | 10 | 22 | ||
Total revenues | 690 | 1,139 | ||
BENEFITS AND OTHER DEDUCTIONS | ||||
Policyholders’ benefits | 819 | 480 | ||
Interest credited to policyholders’ account balances | 269 | 255 | ||
Compensation and benefits | 82 | 149 | ||
Commissions | 157 | 160 | ||
Interest expense | 4 | 9 | ||
Amortization of deferred policy acquisition costs | 165 | 209 | ||
Other operating costs and expenses | 184 | 250 | ||
Total benefits and other deductions | 1,680 | 1,512 | ||
Income (loss) from continuing operations, before income taxes | (990) | (373) | ||
Income tax (expense) benefit from continuing operations | 162 | 80 | ||
Net income (loss) from continuing operations | (293) | |||
Net income (loss) from discontinued operations, net of taxes and noncontrolling interest | 0 | 29 | ||
Net income (loss) | (828) | (264) | ||
Net income (loss) | [1] | (828) | (109) | |
Less: Net (income) loss attributable to the noncontrolling interest | (2) | 1 | ||
Net income (loss) attributable to AXA Equitable | $ (830) | $ (263) | ||
|
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Statement of Comprehensive Income [Abstract] | ||
Net income (loss) | $ (828) | $ (264) |
Other comprehensive income (loss) net of income taxes: | ||
Change in unrealized gains (losses), net of reclassification adjustment | 764 | (742) |
Changes in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment | 0 | (4) |
Other comprehensive income (loss) from discontinued operations | 0 | (10) |
Total other comprehensive income (loss), net of income taxes | 764 | (756) |
Comprehensive income (loss) attributable to AXA Equitable | $ (64) | $ (1,020) |
CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED) - USD ($) $ in Millions |
Total |
AXA Equitable Equity |
Common Stock |
Additional Paid-in Capital |
Retained Earnings |
Accumulated Other Comprehensive Income (Loss) |
Noncontrolling Interest |
Continuing Operations
Noncontrolling Interest
|
Discontinued Operations
Noncontrolling Interest
|
---|---|---|---|---|---|---|---|---|---|
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Cumulative effect of adoption of revenue recognition standard ASC 606 | Accounting Standards Update 2014-09 | $ 33 | $ 8 | $ 8 | $ 25 | $ 25 | ||||
Beginning of year at Dec. 31, 2017 | 19,492 | 16,397 | $ 2 | $ 6,859 | 8,938 | $ 598 | 3,095 | $ 19 | 3,076 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Deconsolidation of real estate joint ventures | (8) | (8) | (8) | ||||||
Repurchase of AB Holding units | (2) | (2) | (2) | ||||||
Dividends paid to noncontrolling interest | (176) | (176) | (176) | ||||||
Net income (loss) | (129) | (263) | (263) | 134 | 1 | 133 | |||
Other comprehensive income (loss) | (749) | (756) | (756) | 7 | 7 | ||||
Other | 31 | 18 | 18 | 13 | 13 | ||||
End of year at Mar. 31, 2018 | 18,492 | 15,404 | 2 | 6,877 | 8,683 | (158) | 3,088 | 12 | 3,076 |
Beginning of year at Dec. 31, 2018 | 12,428 | 12,416 | 2 | 7,807 | 5,098 | (491) | 12 | 12 | 0 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net income (loss) | (830) | (830) | (830) | ||||||
Other comprehensive income (loss) | 764 | 764 | 764 | ||||||
Other | 8 | 8 | 8 | ||||||
End of year at Mar. 31, 2019 | $ 12,370 | $ 12,358 | $ 2 | $ 7,815 | $ 4,268 | $ 273 | $ 12 | $ 12 | $ 0 |
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions |
3 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
||||||
Cash flows from operating activities: | |||||||
Net income (loss) | [1] | $ (828) | $ (109) | ||||
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: | |||||||
Interest credited to policyholders’ account balances | 269 | 255 | |||||
Policy charges and fee income | (859) | (861) | |||||
Net derivative (gains) losses | 1,555 | 815 | |||||
Investment (gains) losses, net | 8 | (87) | |||||
Realized and unrealized (gains) losses on trading securities | (250) | 63 | |||||
Non-cash long-term incentive compensation expense | 8 | 12 | |||||
Amortization and depreciation | [2] | 143 | 201 | ||||
Amortization of deferred cost of reinsurance asset | 0 | 46 | |||||
Equity (income) loss from limited partnerships | [2] | (11) | (39) | ||||
Changes in: | |||||||
Net broker-dealer and customer related receivables/payables | 0 | 283 | |||||
Reinsurance recoverable | (97) | (147) | |||||
Segregated cash and securities, net | 0 | (208) | |||||
Capitalization of deferred policy acquisition costs | [2] | (145) | (135) | ||||
Future policy benefits | 41 | (198) | |||||
Current and deferred income taxes | 54 | 80 | |||||
Other, net | (36) | 12 | |||||
Net cash provided by (used in) operating activities | (148) | (17) | |||||
Proceeds from the sale/maturity/prepayment of: | |||||||
Fixed maturities, available-for-sale | 2,662 | 3,238 | |||||
Mortgage loans on real estate | 216 | 68 | |||||
Trading account securities | 3,376 | 1,683 | |||||
Real estate joint ventures | 1 | 140 | |||||
Short-term investments | [2] | 747 | 688 | ||||
Other | 41 | (86) | |||||
Payment for the purchase/origination of: | |||||||
Fixed maturities, available-for-sale | (5,065) | (2,313) | |||||
Mortgage loans on real estate | (517) | (447) | |||||
Trading account securities | (518) | (2,595) | |||||
Short-term investments | [2] | (681) | (377) | ||||
Other | (62) | (48) | |||||
Cash settlements related to derivative instruments | (978) | (503) | |||||
Investment in capitalized software, leasehold improvements and EDP equipment | (13) | (24) | |||||
Other, net | 97 | (407) | |||||
Net cash provided by (used in) investing activities | (694) | (983) | |||||
Policyholders’ account balances: | |||||||
Deposits | 2,271 | 1,898 | |||||
Withdrawals | (1,048) | (1,081) | |||||
Transfers (to) from Separate Accounts | 445 | 452 | |||||
Change in short-term financings | 0 | (76) | |||||
Change in collateralized pledged assets | (6) | (5) | |||||
Change in collateralized pledged liabilities | 625 | (31) | |||||
Increase (decrease) in overdrafts payable | 0 | 7 | |||||
Repurchase of AB Holding Units | 0 | (2) | |||||
Purchase (redemption) of noncontrolling interests of consolidated company-sponsored investment funds | 0 | 373 | |||||
Distribution to noncontrolling interests in consolidated subsidiaries | 0 | (176) | |||||
Repayment of loans from affiliates | (572) | 0 | |||||
Increase (decrease) in securities sold under agreement to repurchase | (573) | 17 | |||||
Other, net | 0 | 4 | |||||
Net cash provided by (used in) financing activities | 1,142 | 1,380 | |||||
Effect of exchange rate changes on cash and cash equivalents | 0 | 8 | |||||
Change in cash and cash equivalents | 300 | 388 | |||||
Cash and cash equivalents, beginning of year | 2,622 | ||||||
Cash and cash equivalents, end of period | 2,922 | 3,797 | |||||
Cash and cash equivalents of disposed subsidiary: | |||||||
Beginning of year | 1,009 | ||||||
End of period | 1,235 | ||||||
Cash and cash equivalents of continuing operations | |||||||
Beginning of year | 2,622 | 3,409 | |||||
End of period | 2,922 | 3,797 | |||||
Cash flows of disposed subsidiary: | |||||||
operating activities | 274 | ||||||
investing activities | (182) | ||||||
financing activities | 126 | ||||||
Effect of exchange rate changes on cash and cash equivalents | 8 | ||||||
Non-cash transactions during the period | |||||||
(Settlement) issuance of long-term debt | [1] | (202) | |||||
Transfer of assets to reinsurer | [1] | $ (604) | |||||
|
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (Parenthetical) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Net (income) loss attributable to the noncontrolling interest | $ 2 | $ (1) |
Alliance Bernstein | Discontinued Operations | ||
Net (income) loss attributable to the noncontrolling interest | $ 155 |
ORGANIZATION |
3 Months Ended |
---|---|
Mar. 31, 2019 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization | ORGANIZATION Consolidation AXA Equitable Life Insurance Company’s (“AXA Equitable” and, collectively with its consolidated subsidiaries, the “Company”) primary business is providing life insurance and employee benefit products to both individuals and businesses. The Company is an indirect, wholly-owned subsidiary of AXA Equitable Holdings, Inc. (“Holdings”). As of March 31, 2019 and December 31, 2018, AXA S.A. (“AXA”), a French holding company for the AXA Group, owned approximately 48% and 59%, respectively, of the outstanding common stock of Holdings. The accompanying consolidated financial statements represent the consolidated results and financial position of AXA Equitable and not the consolidated results and financial position of Holdings. Discontinued Operations In the fourth quarter of 2018, the Company transferred its economic interest in the business of AllianceBernstein Holding L.P. (“AB Holding”), AllianceBernstein L.P. (“ABLP”) and their subsidiaries (collectively, “AB”) to a newly created wholly-owned subsidiary of Holdings (the “AB Business Transfer”). See Note 13 for additional information. |
SIGNIFICANT ACCOUNTING POLICIES |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Significant Accounting Policies | SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Intercompany balances and transactions have been eliminated. In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The terms “first quarter 2019” or “first three months of 2019” and “first quarter 2018” or “first three months of 2018” refer to the three months ended March 31, 2019 and 2018, respectively. Adoption of New Accounting Pronouncements
Future Adoption of New Accounting Pronouncements
Accounting and Consolidation of Variable Interest Entities (“VIEs”) At March 31, 2019, the Company held $1.1 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including hedge funds, private equity funds and real estate-related funds. As an equity investor, the Company is considered to have a variable interest in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests or other financial arrangements, if any, the Company was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheets as Other equity investments and to apply the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are $168.6 billion at March 31, 2019. The Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $1.1 billion and $866 million of unfunded commitments at March 31, 2019. The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations. At March 31, 2019, the Company consolidated one real estate joint venture for which it was identified as primary beneficiary under the VIE model. The consolidated entity is jointly owned by AXA Equitable Life Insurance Company (“AXA Equitable Life”) and AXA France and holds an investment in a real estate venture. Included in the Company’s consolidated balance sheet at March 31, 2019 related to this VIE is $35 million of Real estate held for production of income. In addition, Real estate held for production of income reflects $16 million as related to two non-consolidated joint ventures at March 31, 2019. Assumption Updates and Model Changes In 2018, the Company began conducting its annual review of the Company’s assumptions and models during the third quarter, consistent with industry practice. The annual review encompasses assumptions underlying the valuation of unearned revenue liabilities, embedded derivatives for the Company’s insurance business, liabilities for future policyholder benefits, deferred policy acquisition cost (“DAC”) and deferred sales inducement (“DSI”) assets. Accordingly, there were no material assumption changes in the first quarters of 2019 or 2018. Reclassification of DAC Capitalization During the fourth quarter of 2018, the Company changed the presentation of the capitalization of DAC in the consolidated statements of income for all prior periods presented herein by netting the capitalized amounts within the applicable expense line items, such as Compensation and benefits, Commissions and Other operating costs and expenses. Previously, the Company had netted the capitalized amounts within the Amortization of DAC. There was no impact on Net income (loss) or Comprehensive income (loss) from this reclassification. The reclassification adjustments for the three months ended March 31, 2018 are presented in the table below. Capitalization of DAC reclassified to Compensation and benefits, Commissions and Other operating costs and expenses reduced the amounts previously reported in those expense line items, while the capitalization of DAC reclassified from the Amortization of deferred policy acquisition costs line item increases that expense line item.
Revenue Recognition The table below presents the revenues recognized during the three months ended March 31, 2019 and 2018, disaggregated by category:
Revision of Prior Period Financial Statements During the second and third quarter of 2018, the Company revised its financial statements to reflect the correction of errors identified by the Company in its previously issued financial statements. The impact of these errors was not considered to be material. However, in order to improve the consistency and comparability of the financial statements, management revised the Company’s consolidated financial statements as of and for the three and six months ended March 31, 2018 and June 30, 2018, respectively. In addition, during the fourth quarter of 2018, the Company identified certain cash flows that were incorrectly classified in the Company’s consolidated statements of cash flows. The Company has determined that these misclassifications were not material to its financial statements of any period. The impact of the misclassifications detailed in the revision tables included in Note 14 on the consolidated statement of cash flows for the three months ended March 31, 2018 were corrected in the comparative consolidated statements of cash flows for the three months ended March 31, 2019 and 2018 contained elsewhere in the financial statements. The misclassifications for the six and nine months ended June 30, 2018 and September 30, 2018 will be corrected in the Company’s comparative consolidated statements of cash flows to be included in the Form 10-Q filings as of and for the three and six months ended June 30, 2019 and as of and for the three and nine months ended September 30, 2019, respectively. See Note 14 for further information. |
INVESTMENTS |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments | INVESTMENTS Fixed Maturities The following tables provide information relating to fixed maturities classified as available-for-sale (“AFS”). Available-for-Sale Securities by Classification
The contractual maturities of AFS fixed maturities at March 31, 2019 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Contractual Maturities of Available-for-Sale Fixed Maturities
The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities during the three months ended March 31, 2019 and 2018:
The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts: Fixed Maturities - Credit Loss Impairments
______________
Net unrealized investment gains (losses) on fixed maturities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated: Net Unrealized Gains (Losses) on Fixed Maturities Classified as AFS
Changes in net unrealized investment gains (losses) recognized in AOCI include reclassification adjustments to reflect amounts realized in Net income (loss) for the current period that had been part of OCI in earlier periods. The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturities on which an OTTI loss has been recognized and all other: Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses
All Other Net Unrealized Investment Gains (Losses) in AOCI
The following tables disclose the fair values and gross unrealized losses of the 674 issues at March 31, 2019 and the 1,471 issues at December 31, 2018 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated:
The Company’s investments in fixed maturities do not include concentrations of credit risk of any single issuer greater than 10% of the consolidated equity of the Company, other than securities of the U.S. government, U.S. government agencies, and certain securities guaranteed by the U.S. government. The Company maintains a diversified portfolio of corporate securities across industries and issuers and does not have exposure to any single issuer in excess of 0.7% of total investments. The largest exposures to a single issuer of corporate securities held at March 31, 2019 and December 31, 2018 were $218 million and $210 million, respectively, representing 1.8% and 1.7% of the consolidated equity of the Company Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the National Association of Insurance Commissioners (“NAIC”) designation of 3 (medium investment grade), 4 or 5 (below investment grade) or 6 (in or near default). At March 31, 2019 and December 31, 2018, respectively, approximately $1,250 million and $1,228 million, or 2.8% and 2.9%, of the $44,926 million and $42,492 million aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had net unrealized losses of $5 million and $30 million at March 31, 2019 and December 31, 2018, respectively. At March 31, 2019 and December 31, 2018, respectively, the $427 million and $795 million of gross unrealized losses of twelve months or more were concentrated in corporate and U.S. Treasury, government and agency securities. In accordance with the policy described in Note 2, the Company concluded that an adjustment to income for OTTI for the three months ended March 31, 2019 or 2018 for these securities was not warranted. At March 31, 2019 and December 31, 2018, the Company did not intend to sell the securities nor will it likely be required to dispose of the securities before the anticipated recovery of their remaining amortized cost basis. At March 31, 2019 and December 31, 2018, the fair value of the Company’s trading account securities was $12,704 million and $15,166 million, respectively. At March 31, 2019 and December 31, 2018, trading account securities included the General Account’s investment in Separate Accounts which had carrying values of $50 million and $48 million, respectively. Net unrealized and realized gains (losses) on trading account equity securities are included in Net investment income (loss) in the Consolidated Statements of Income (Loss). The table below shows a breakdown of Net investment income (loss) from trading account securities during the three months ended March 31, 2019 and 2018: Net Investment Income (Loss) from Trading Account Securities
Mortgage Loans The payment terms of mortgage loans may from time to time be restructured or modified. At March 31, 2019 and December 31, 2018, the carrying values of problem commercial mortgage loans on real estate that had been classified as non-accrual loans were $0 and $19 million, respectively. Valuation Allowances for Mortgage Loans: The change in the valuation allowance for credit losses for commercial mortgage loans during the three months ended March 31, 2019 and 2018 are as follows:
There were no allowances for credit losses for agricultural mortgage loans for the three months ended March 31, 2019 and 2018. The following tables provide information relating to the loan-to-value and debt service coverage ratios for commercial and agricultural mortgage loans at March 31, 2019 and December 31, 2018. The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios
______________
The following table provides information relating to the aging analysis of past due mortgage loans at March 31, 2019 and December 31, 2018. Age Analysis of Past Due Mortgage Loans
The following table provides information relating to impaired mortgage loans at March 31, 2019 and December 31, 2018. Impaired Mortgage Loans
|
DERIVATIVES |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DERIVATIVES | DERIVATIVES The Company uses derivatives as part of its overall asset/liability risk management primarily to reduce exposures to equity market and interest rate risks. Derivative hedging strategies are designed to reduce these risks from an economic perspective and are all executed within the framework of a “Derivative Use Plan” approved by applicable states’ insurance law. Derivatives are generally not accounted for using hedge accounting, with the exception of Treasury Inflation-Protected Securities (“TIPS”), which is discussed further below. Operation of these hedging programs is based on models involving numerous estimates and assumptions, including, among others, mortality, lapse, surrender and withdrawal rates, election rates, fund performance, market volatility and interest rates. A wide range of derivative contracts are used in these hedging programs, including exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, bond and bond-index total return swaps, swaptions, variance swaps and equity options, credit and foreign exchange derivatives, as well as bond and repo transactions to support the hedging. The derivative contracts are collectively managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in capital markets. In addition, as part of its hedging strategy, the Company targets an asset level for all variable annuity products at or above a CTE98 level under most economic scenarios (CTE is a statistical measure of tail risk which quantifies the total asset requirement to sustain a loss if an event outside a given probability level has occurred. CTE98 denotes the financial resources a company would need to cover the average of the worst 2% of scenarios.) Derivatives utilized to hedge exposure to Variable Annuities with Guarantee Features The Company has issued and continues to offer variable annuity products with GMxB features. The risk associated with the GMDB feature is that under-performance of the financial markets could result in GMDB benefits, in the event of death, being higher than what accumulated policyholders’ account balances would support. The risk associated with the GMIB feature is that under-performance of the financial markets could result in the present value of GMIB, in the event of annuitization, being higher than what accumulated policyholders’ account balances would support, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. The risk associated with products that have a GMxB derivative features liability is that under-performance of the financial markets could result in the GMxB derivative features’ benefits being higher than what accumulated policyholders’ account balances would support. For GMxB features, the Company retains certain risks including basis, credit spread and some volatility risk and risk associated with actual versus expected actuarial assumptions for mortality, lapse and surrender, withdrawal and policyholder election rates, among other things. The derivative contracts are managed to correlate with changes in the value of the GMxB features that result from financial markets movements. A portion of exposure to realized equity volatility is hedged using equity options and variance swaps and a portion of exposure to credit risk is hedged using total return swaps on fixed income indices. Additionally, the Company is party to total return swaps for which the reference U.S. Treasury securities are contemporaneously purchased from the market and sold to the swap counterparty. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. The Company has also purchased reinsurance contracts to mitigate the risks associated with GMDB features and the impact of potential market fluctuations on future policyholder elections of GMIB features contained in certain annuity contracts issued by the Company. Derivatives utilized to hedge crediting rate exposure on SCS, SIO, MSO and IUL products/investment options The Company hedges crediting rates in the Structured Capital Strategies (“SCS”) variable annuity, Structured Investment Option in the EQUI-VEST variable annuity series (“SIO”), Market Stabilizer Option (“MSO”) in the variable life insurance products and Indexed Universal Life (“IUL”) insurance products. These products permit the contract owner to participate in the performance of an index, ETF or commodity price movement up to a cap for a set period of time. They also contain a protection feature, in which the Company will absorb, up to a certain percentage, the loss of value in an index, ETF or commodity price, which varies by product segment. In order to support the returns associated with these features, the Company enters into derivative contracts whose payouts, in combination with fixed income investments, emulate those of the index, ETF or commodity price, subject to caps and buffers, thereby substantially reducing any exposure to market-related earnings volatility. Derivatives used for General Account Investment Portfolio The Company maintains a strategy in its General Account investment portfolio to replicate the credit exposure of fixed maturity securities otherwise permissible for investment under its investment guidelines through the sale of credit default swaps (“CDSs”). Under the terms of these swaps, the Company receives quarterly fixed premiums that, together with any initial amount paid or received at trade inception, replicate the credit spread otherwise currently obtainable by purchasing the referenced entity’s bonds of similar maturity. These credit derivatives generally have remaining terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net investment income (loss). The Company manages its credit exposure taking into consideration both cash and derivatives based positions and selects the reference entities in its replicated credit exposures in a manner consistent with its selection of fixed maturities. In addition, the Company generally transacts the sale of CDSs in single name reference entities of investment grade credit quality and with counterparties subject to collateral posting requirements. If there is an event of default by the reference entity or other such credit event as defined under the terms of the swap contract, the Company is obligated to perform under the credit derivative and, at the counterparty’s option, either pay the referenced amount of the contract less an auction-determined recovery amount or pay the referenced amount of the contract and receive in return the defaulted or similar security of the reference entity for recovery by sale at the contract settlement auction. To date, there have been no events of default or circumstances indicative of a deterioration in the credit quality of the named referenced entities to require or suggest that the Company will have to perform under these CDSs. The maximum potential amount of future payments the Company could be required to make under these credit derivatives is limited to the par value of the referenced securities which is the U.S. dollar or euro-equivalent of the derivative’s notional amount. The Standard North American CDS Contract (“SNAC”) or Standard European Corporate Contract (“STEC”) under which the Company executes these CDS sales transactions does not contain recourse provisions for recovery of amounts paid under the credit derivative. The Company purchased 30-year TIPS and other sovereign bonds, both inflation linked and non-inflation linked, as General Account investments and enters into asset or cross-currency basis swaps, to result in payment of the given bond’s coupons and principal at maturity in the bond’s specified currency to the swap counterparty in return for fixed dollar amounts. These swaps, when considered in combination with the bonds, together result in a net position that is intended to replicate a dollar-denominated fixed-coupon cash bond with a yield higher than a term-equivalent U.S. Treasury bond. In 2016, the Company implemented a program to mitigate its duration gap using total return swaps for which the reference U.S. Treasury securities are sold to the swap counterparty under arrangements economically similar to repurchase agreements. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. Under this program, the Company derecognized $3,905 million of U.S. Treasury securities for which the Company received proceeds of $3,905 million at inception of the total return swap contract. Under the terms of these swaps, the Company retains ongoing exposure to the total returns of the underlying U.S. Treasury securities in exchange for a financing cost. At March 31, 2019, the aggregate fair value of U.S. Treasury securities derecognized under this program was $3,788 million. Reported in Other invested assets in the Company’s balance sheet at March 31, 2019 is $87 million, representing the fair value of the total return swap contracts. The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments. Derivative Instruments by Category
______________
Equity-Based and Treasury Futures Contracts Margin All outstanding equity-based and treasury futures contracts at March 31, 2019 are exchange-traded and net settled daily in cash. At March 31, 2019, the Company had open exchange-traded futures positions on: (i) the S&P 500, Russell 2000, and Emerging Market indices, having initial margin requirements of $256 million, (ii) the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, having initial margin requirements of $34 million and (iii) the Euro Stoxx, FTSE 100, Topix, ASX 200, and European, Australasia, and Far East (“EAFE”) indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, Australian dollar/U.S. dollar, and Yen/U.S. dollar, having initial margin requirements of $25 million. Collateral Arrangements The Company generally has executed a Credit Support Annex (“CSA”) under the International Swaps and Derivatives Association Master Agreement (“ISDA Master Agreement”) it maintains with each of its over-the-counter (“OTC”) derivative counterparties that requires both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities, U.S. government and government agency securities and investment grade corporate bonds. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed. At March 31, 2019 and December 31, 2018, respectively, the Company held $2,556 million and $1,564 million in cash and securities collateral delivered by trade counterparties, representing the fair value of the related derivative agreements. The unrestricted cash collateral is reported in Other invested assets. The Company posted collateral of $9 million and $3 million at March 31, 2019 and December 31, 2018, respectively, in the normal operation of its collateral arrangements. Securities Repurchase and Reverse Repurchase Transactions Securities repurchase and reverse repurchase transactions are conducted by the Company under a standardized securities industry master agreement, amended to suit the requirements of each respective counterparty. The Company’s securities repurchase and reverse repurchase agreements are accounted for as secured borrowing or lending arrangements, respectively and are reported in the consolidated balance sheets on a gross basis. At March 31, 2019 and December 31, 2018, the balance outstanding under securities repurchase transactions was $0 and $573 million, respectively. The Company utilized these repurchase and reverse repurchase agreements for asset liability and cash management purposes. For other instruments used for asset and liability management purposes, see Note 12. The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at March 31, 2019. Offsetting of Financial Assets and Liabilities and Derivative Instruments At March 31, 2019
The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at March 31, 2019. Collateral Amounts Not Offset in the Consolidated Balance Sheets At March 31, 2019
The Company had no securities sold under agreements to repurchase at March 31, 2019. The following table presents information about the Company’s offsetting financial assets and liabilities and derivative instruments at December 31, 2018. Offsetting of Financial Assets and Liabilities and Derivative Instruments At December 31, 2018
______________
The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2018. Collateral Amounts Not Offset in the Consolidated Balance Sheets At December 31, 2018
The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2018. Repurchase Agreement Accounted for as Secured Borrowings At December 31, 2018
|
CLOSED BLOCK |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block | CLOSED BLOCK Summarized financial information for the Company’s Closed Block is as follows:
The Company’s Closed Block revenues and expenses are as follows:
A reconciliation of the Company’s policyholder dividend obligation follows:
|
INSURANCE LIABILITIES |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance Liabilities | INSURANCE LIABILITIES Variable Annuity Contracts – GMDB, GMIB, GIB and GWBL and Other Features The Company has certain variable annuity contracts with GMDB, GMIB, GIB and GWBL and other features in-force that guarantee one of the following:
Liabilities for Variable Annuity Contracts with GMDB and GMIB Features without No-Lapse Guarantee Rider (“NLG”) Feature The change in the liabilities for variable annuity contracts with GMDB and GMIB features and no NLG feature are summarized in the tables below. The amounts for the direct contracts (before reinsurance ceded) are reflected in the consolidated balance sheets in Future policy benefits and other policyholders’ liabilities. The amounts for the ceded contracts are reflected in the consolidated balance sheets in Amounts due from reinsurers. Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No NLG Feature For the Three Months Ended March 31, 2019 and 2018
Liabilities for Embedded and Freestanding Insurance Related Derivatives The liability for the GMxB derivative features liability, the liability for SCS, SIO, MSO and IUL indexed features and the asset and liability for the GMIB reinsurance contracts are considered embedded or freestanding insurance derivatives and are reported at fair value. For the fair value of the assets and liabilities associated with these embedded or freestanding insurance derivatives, see Note 7. Account Values and Net Amount at Risk Account Values and Net Amount at Risk (“NAR”) for direct variable annuity contracts in-force with GMDB and GMIB features as of March 31, 2019 are presented in the following tables by guarantee type. For contracts with the GMDB feature, the NAR in the event of death is the amount by which the GMDB feature exceeds the related Account Values. For contracts with the GMIB feature, the NAR in the event of annuitization is the amount by which the present value of the GMIB benefits exceed the related Account Values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB features may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive: Direct Variable Annuity Contracts with GMDB and GMIB Features At March 31, 2019
For more information about the reinsurance programs of the Company’s GMDB and GMIB exposure, see “Reinsurance Agreements” in Note 10 of the Notes to the Consolidated Financial Statements included in the Annual Report on Form 10-K for the year ended December 31, 2018. Separate Accounts Investments by Investment Category Underlying Variable Annuity Contracts with GMDB and GMIB Features The total account values of variable annuity contracts with GMDB and GMIB features include amounts allocated to the guaranteed interest option, which is part of the General Account and variable investment options that invest through Separate Accounts in variable insurance trusts. The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB features. The investment performance of the assets impacts the related account values and, consequently, the NAR associated with the GMDB and GMIB benefits and guarantees. Because the Company’s variable annuity contracts offer both GMDB and GMIB features, GMDB and GMIB amounts are not mutually exclusive. Investment in Variable Insurance Trust Mutual Funds
Hedging Programs for GMDB, GMIB, GIB and Other Features The Company has a program intended to hedge certain risks associated first with the GMDB feature and with the GMIB feature of the Accumulator series of variable annuity products. The program has also been extended to cover other guaranteed benefits as they have been made available. This program utilizes derivative contracts, such as exchange-traded equity, currency and interest rate futures contracts, total return and/or equity swaps, interest rate swap and floor contracts, swaptions, variance swaps as well as equity options, that collectively are managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in the capital markets. At the present time, this program hedges certain economic risks on products sold from 2001 forward, to the extent such risks are not externally reinsured. These programs do not qualify for hedge accounting treatment. Therefore, gains (losses) on the derivatives contracts used in these programs, including current period changes in fair value, are recognized in Net derivative gains (losses) in the period in which they occur, and may contribute to income (loss) volatility. Variable and Interest-Sensitive Life Insurance Policies - NLG The NLG feature contained in variable and interest-sensitive life insurance policies keeps them in force in situations where the policy value is not sufficient to cover monthly charges then due. The NLG remains in effect so long as the policy meets a contractually specified premium funding test and certain other requirements. The change in the NLG feature reflected in the General Account in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets is summarized in the table below.
|
FAIR VALUE DISCLOSURES |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures | FAIR VALUE DISCLOSURES The accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value:
The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument. Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness. Assets and liabilities measured at fair value on a recurring basis are summarized below. At March 31, 2019 and December 31, 2018, no assets were required to be measured at fair value on a non-recurring basis. Fair value measurements are required on a non-recurring basis for certain assets, including goodwill and mortgage loans on real estate, only when an OTTI or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. The Company recognizes transfers between valuation levels at the beginning of the reporting period. Fair Value Measurements at March 31, 2019
______________
Fair Value Measurements at December 31, 2018
______________
The fair values of the Company’s public fixed maturities are generally based on prices obtained from independent valuation service providers and for which the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Although each security generally is priced by multiple independent valuation service providers, the Company ultimately uses the price received from the independent valuation service provider highest in the vendor hierarchy based on the respective asset type, with limited exception. To validate reasonableness, prices also are internally reviewed by those with relevant expertise through comparison with directly observed recent market trades. Consistent with the fair value hierarchy, public fixed maturities validated in this manner generally are reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If as a result it is determined that the independent valuation service provider is able to reprice the security in a manner agreed as more consistent with current market observations, the security remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company’s own assumptions about market-participant inputs would be used in pricing the security. The fair values of the Company’s private fixed maturities are determined from prices obtained from independent valuation service providers. Prices not obtained from an independent valuation service provider are determined by using a discounted cash flow model or a market comparable company valuation technique. In certain cases, these models use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model or a market comparable company valuation technique may also incorporate unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the fair value measurement of a security, a Level 3 classification generally is made. The net fair value of the Company’s freestanding derivative positions as disclosed in Note 4 are generally based on prices obtained either from independent valuation service providers or derived by applying market inputs from recognized vendors into industry standard pricing models. The majority of these derivative contracts are traded in the OTC derivative market and are classified in Level 2. The fair values of derivative assets and liabilities traded in the OTC market are determined using quantitative models that require use of the contractual terms of the derivative instruments and multiple market inputs, including interest rates, prices, and indices to generate continuous yield or pricing curves, including overnight index swap (“OIS”) curves, and volatility factors, which then are applied to value the positions. The predominance of market inputs is actively quoted and can be validated through external sources or reliably interpolated if less observable. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If as a result it is determined that the independent valuation service provider is able to reprice the derivative instrument in a manner agreed as more consistent with current market observations, the position remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company’s own assumptions about market-participant inputs would be used in pricing the security. Investments classified as Level 1 primarily include redeemable preferred stock, trading account securities, cash equivalents and Separate Accounts assets. Fair value measurements classified as Level 1 include exchange-traded prices of fixed maturities, equity securities and derivative contracts, and net asset values for transacting subscriptions and redemptions of mutual fund shares held by Separate Accounts. Cash equivalents classified as Level 1 include money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less, and are carried at cost as a proxy for fair value measurement due to their short-term nature. Investments classified as Level 2 are measured at fair value on a recurring basis and primarily include U.S. government and agency securities and certain corporate debt securities, such as public and private fixed maturities. As market quotes generally are not readily available or accessible for these securities, their fair value measures are determined utilizing relevant information generated by market transactions involving comparable securities and often are based on model pricing techniques that effectively discount prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Observable inputs generally used to measure the fair value of securities classified as Level 2 include benchmark yields, reported secondary trades, issuer spreads, benchmark securities and other reference data. Additional observable inputs are used when available, and as may be appropriate, for certain security types, such as prepayment, default, and collateral information for the purpose of measuring the fair value of mortgage- and asset-backed securities. The Company’s AAA-rated mortgage- and asset-backed securities are classified as Level 2 for which the observability of market inputs to their pricing models is supported by sufficient, albeit more recently contracted, market activity in these sectors. Certain Company products such as the SCS and EQUI-VEST variable annuity products, and in the MSO fund available in some life contracts offer investment options which permit the contract owner to participate in the performance of an index, ETF or commodity price. These investment options, which depending on the product and on the index selected can currently have 1, 3, 5, or 6 year terms, provide for participation in the performance of specified indices, ETF or commodity price movement up to a segment-specific declared maximum rate. Under certain conditions that vary by product, e.g. holding these segments for the full term, these segments also shield policyholders from some or all negative investment performance associated with these indices, ETF or commodity prices. These investment options have defined formulaic liability amounts, and the current values of the option component of these segment reserves are accounted for as Level 2 embedded derivatives. The fair values of these embedded derivatives are based on data obtained from independent valuation service providers. The Company’s investments classified as Level 3 primarily include corporate debt securities, such as private fixed maturities. Determinations to classify fair value measures within Level 3 of the valuation hierarchy generally are based upon the significance of the unobservable factors to the overall fair value measurement. Included in the Level 3 classification are fixed maturities with indicative pricing obtained from brokers that otherwise could not be corroborated to market observable data. The Company applies various due diligence procedures, as considered appropriate, to validate these non-binding broker quotes for reasonableness, based on its understanding of the markets, including use of internally-developed assumptions about inputs a market participant would use to price the security. In addition, asset-backed securities are classified as Level 3. The Company also issues certain benefits on its variable annuity products that are accounted for as derivatives and are also considered Level 3. The GMIBNLG feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates applied to the contract’s benefit base if and when the contract account value is depleted and the NLG feature is activated. The GMWB feature allows the policyholder to withdraw at minimum, over the life of the contract, an amount based on the contract’s benefit base. The GWBL feature allows the policyholder to withdraw, each year for the life of the contract, a specified annual percentage of an amount based on the contract’s benefit base. The GMAB feature increases the contract account value at the end of a specified period to a GMAB base. The GIB feature provides a lifetime annuity based on predetermined annuity purchase rates if and when the contract account value is depleted. This lifetime annuity is based on predetermined annuity purchase rates applied to a GIB base. Level 3 also includes the GMIB reinsurance contract assets which are accounted for as derivative contracts. The GMIB reinsurance contract asset and liabilities’ fair value reflects the present value of reinsurance premiums and recoveries and risk margins over a range of market consistent economic scenarios while GMxB derivative features liability reflects the present value of expected future payments (benefits) less fees, adjusted for risk margins and nonperformance risk, attributable to GMxB derivative features’ liability over a range of market-consistent economic scenarios. The valuations of the GMIB reinsurance contract asset and GMxB derivative features liability incorporate significant non-observable assumptions related to policyholder behavior, risk margins and projections of equity Separate Accounts funds. The credit risks of the counterparty and of the Company are considered in determining the fair values of its GMIB reinsurance contract asset and GMxB derivative features liability positions, respectively, after taking into account the effects of collateral arrangements. Incremental adjustment to the swap curve for non-performance risk is made to the fair values of the GMIB reinsurance contract asset and liabilities and GMIBNLG feature to reflect the claims-paying ratings of counterparties and the Company. Equity and fixed income volatilities were modeled to reflect current market volatilities. Due to the unique, long duration of the GMIBNLG feature, adjustments were made to the equity volatilities to remove the illiquidity bias associated with the longer tenors and risk margins were applied to the non-capital markets inputs to the GMIBNLG valuations. After giving consideration to collateral arrangements, the Company reduced the fair value of its GMIB reinsurance contract asset by $148 million and $184 million at March 31, 2019 and December 31, 2018, respectively, to recognize incremental counterparty non-performance risk. Lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, which include other factors such as considering surrender charges. Generally, lapse rates are assumed to be lower in periods when a surrender charge applies. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. For valuing the embedded derivative, lapse rates vary throughout the period over which cash flows are projected. The Company’s consolidated VIEs/VOEs hold investments that are classified as Level 3, and primarily consist of corporate bonds that are vendor priced with no ratings available, bank loans, non-agency collateralized mortgage obligations and asset-backed securities. During the three months ended March 31, 2019, AFS fixed maturities with fair values of $69 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $17 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.7% of total equity at March 31, 2019. During the three months ended March 31, 2018, AFS fixed maturities with fair values of $16 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $67 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.4% of total equity at March 31, 2018. The tables below present reconciliations for all Level 3 assets and liabilities for the three months ended March 31, 2019 and 2018. Level 3 Instruments - Fair Value Measurements
______________
______________
The table below details changes in unrealized gains (losses) for the three months ended March 31, 2019 and 2018 by category for Level 3 assets and liabilities still held at March 31, 2019 and 2018. Level 3 Instruments
______________
The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities at March 31, 2019 and December 31, 2018. Quantitative Information about Level 3 Fair Value Measurements at March 31, 2019
______________
Quantitative Information about Level 3 Fair Value Measurements at December 31, 2018
______________
Excluded from the tables above at March 31, 2019 and December 31, 2018, respectively, are approximately $796 million and $826 million of Level 3 fair value measurements of investments for which the underlying quantitative inputs are not developed by the Company and are not readily available. These investments primarily consist of certain privately placed debt securities with limited trading activity, including residential mortgage- and asset-backed instruments, and their fair values generally reflect unadjusted prices obtained from independent valuation service providers and indicative, non-binding quotes obtained from third-party broker-dealers recognized as market participants. Significant increases or decreases in the fair value amounts received from these pricing sources may result in the Company’s reporting significantly higher or lower fair value measurements for these Level 3 investments. The fair value of private placement securities is determined by application of a matrix pricing model or a market comparable company value technique. The significant unobservable input to the matrix pricing model valuation technique is the spread over the industry-specific benchmark yield curve. Generally, an increase or decrease in spreads would lead to directionally inverse movement in the fair value measurements of these securities. The significant unobservable input to the market comparable company valuation technique is the discount rate. Generally, a significant increase (decrease) in the discount rate would result in significantly lower (higher) fair value measurements of these securities. Residential mortgage-backed securities classified as Level 3 primarily consist of non-agency paper with low trading activity. Included in the tables above at March 31, 2019 and December 31, 2018, there were no Level 3 securities that were determined by application of a matrix pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Generally, a change in spreads would lead to directionally inverse movement in the fair value measurements of these securities. Asset-backed securities classified as Level 3 primarily consist of non-agency mortgage loan trust certificates, including subprime and Alt-A paper, credit tenant loans, and equipment financings. Included in the tables above at March 31, 2019 and December 31, 2018, there were no securities that were determined by the application of matrix-pricing for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Significant increases (decreases) in spreads would result in significantly lower (higher) fair value measurements. Separate Accounts assets classified as Level 3 in the table at March 31, 2019 and December 31, 2018, primarily consist of a private real estate fund and mortgage loans. A third-party appraisal valuation technique is used to measure the fair value of the private real estate investment fund, including consideration of observable replacement cost and sales comparisons for the underlying commercial properties, as well as the results from applying a discounted cash flow approach. Significant increase (decrease) in isolation in the capitalization rate and exit capitalization rate assumptions used in the discounted cash flow approach to the appraisal value would result in a higher (lower) measure of fair value. With respect to the fair value measurement of mortgage loans a discounted cash flow approach is applied, a significant increase (decrease) in the assumed spread over U.S. Treasury securities would produce a lower (higher) fair value measurement. Changes in the discount rate or factor used in the valuation techniques to determine the fair values of these private equity investments and mortgage loans generally are not correlated to changes in the other significant unobservable inputs. Significant increase (decrease) in isolation in the discount rate or factor would result in significantly lower (higher) fair value measurements. These fair value measurements are determined using substantially the same valuation techniques as earlier described above for the Company’s General Account investments in these securities. Significant unobservable inputs with respect to the fair value measurement of the Level 3 GMIB reinsurance contract asset and the Level 3 liabilities identified in the table above are developed using the Company data. Validations of unobservable inputs are performed to the extent the Company has experience. When an input is changed the model is updated and the results of each step of the model are analyzed for reasonableness. The significant unobservable inputs used in the fair value measurement of the Company’s GMIB reinsurance contract asset are lapse rates, withdrawal rates and GMIB utilization rates. Significant increases in GMIB utilization rates or decreases in lapse or withdrawal rates in isolation would tend to increase the GMIB reinsurance contract asset. Fair value measurement of the GMIB reinsurance contract asset and liabilities includes dynamic lapse and GMIB utilization assumptions whereby projected contractual lapses and GMIB utilization reflect the projected net amount of risks of the contract. As the net amount of risk of a contract increases, the assumed lapse rate decreases and the GMIB utilization increases. Increases in volatility would increase the asset and liabilities. The significant unobservable inputs used in the fair value measurement of the Company’s GMIBNLG liability are lapse rates, withdrawal rates, GMIB utilization rates, adjustment for Non-performance risk and NLG forfeiture rates. NLG forfeiture rates are caused by excess withdrawals above the annual GMIB accrual rate that cause the NLG to expire. Significant decreases in lapse rates, NLG forfeiture rates, adjustment for non-performance risk and GMIB utilization rates would tend to increase the GMIBNLG liability, while decreases in withdrawal rates and volatility rates would tend to decrease the GMIBNLG liability. The significant unobservable inputs used in the fair value measurement of the Company’s GMWB and GWBL liability are lapse rates and withdrawal rates. Significant increases in withdrawal rates or decreases in lapse rates in isolation would tend to increase these liabilities. Increases in volatility would increase these liabilities. Certain financial instruments are exempt from the requirements for fair value disclosure, such as insurance liabilities other than financial guarantees and investment contracts, limited partnerships accounted for under the equity method and pension and other postretirement obligations. The carrying values and fair values at March 31, 2019 and December 31, 2018 for financial instruments not otherwise disclosed in Notes 3 and 4 are presented in the table below.
As our COLI policies are recorded at their cash surrender value, they are not required to be included in the table above. Fair values for commercial and agricultural mortgage loans on real estate are measured by discounting future contractual cash flows to be received on the mortgage loan using interest rates at which loans with similar characteristics and credit quality would be made. The discount rate is derived based on the appropriate U.S. Treasury rate with a like term to the remaining term of the loan to which a spread reflective of the risk premium associated with the specific loan is added. Fair values for mortgage loans anticipated to be foreclosed and problem mortgage loans are limited to the fair value of the underlying collateral, if lower. The fair value of policy loans is calculated by discounting expected cash flows based upon the U.S. treasury yield curve and historical loan repayment patterns. The fair values of the Company's funding agreements are determined by discounted cash flow analysis based on the indicative funding agreement rates published by the FHLB. The fair values for the Company’s association plans contracts, supplementary contracts not involving life contingencies (“SCNILC”), deferred annuities and certain annuities, which are included in Policyholders’ account balances and liabilities for investment contracts with fund investments in Separate Accounts are estimated using projected cash flows discounted at rates reflecting current market rates. Significant unobservable inputs reflected in the cash flows include lapse rates and withdrawal rates. Incremental adjustments may be made to the fair value to reflect non-performance risk. Certain other products such as Access Accounts and Escrow Shield Plus product reserves are held at book value. |
LEASES |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LEASES | LEASES Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For those leases with a term greater than one year, the Company recognizes on the balance sheet at the time of lease commencement or modification a right of use (“RoU”) operating lease asset and a lease liability, initially measured at the present value of the lease payments. Lease costs are recognized in the income statement over the lease term on a straight-line basis. RoU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. The Company's lease population primarily consists of real estate leases for office space. The Company also has operating leases for various types of furniture and office equipment. For certain equipment leases, the Company applies a portfolio approach to effectively account for the operating lease RoU assets and liabilities. For certain lease agreements entered into or reassessed after the adoption of ASC 842, the Company elected to combine the lease and related non-lease components for its operating leases; however, the non-lease components associated with the Company’s operating leases are primarily variable in nature and as such are not included in the determination of the RoU asset and lease liability but are recognized in the period in which the obligation for those payments is incurred. The Company’s operating leases may include options to extend or terminate the lease, which are not included in the determination of the RoU asset or lease liability unless they are reasonably certain to be exercised. The Company's operating leases have remaining lease terms of one year to 12 years, some of which include options to extend the leases. The Company typically does not include its renewal options in its lease terms for calculating its RoU operating lease asset and lease liability as the renewal options allow the Company to maintain operational flexibility and the Company is not reasonably certain it will exercise these renewal options until close to the initial end date of the lease. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. As the Company's leases do not provide an implicit rate, we used an incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company primarily subleases floor space within our New Jersey and New York lease properties to various third parties. The lease term for the subleases typically corresponds to the head lease term. Balance Sheet Classification of Operating Lease Assets and Liabilities
The table below summarizes the components of lease costs for the three months ended March 31, 2019. Lease Costs
Maturities of lease liabilities as of March 31, 2019 are as follows: Maturities of Lease Liabilities
Weighted Average of Lease Term and Discount Rate
Supplemental cash flow information related to leases was as follows: Lease Liabilities Information
The following table presents the Company’s future minimum lease obligation under ASC 840 as of December 31, 2018:
|
INCOME TAXES |
3 Months Ended |
---|---|
Mar. 31, 2019 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | INCOME TAXES Income tax expense for the three months ended March 31, 2019 and 2018 was computed using an estimated annual effective tax rate (“ETR”), with discrete items recognized in the period in which they occur. The estimated ETR is revised, as necessary, at the end of successive interim reporting periods. |
EQUITY |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity | EQUITY Accumulated Other Comprehensive Income (Loss) AOCI represents cumulative gains (losses) on items that are not reflected in Net income (loss). The balances as of March 31, 2019 and 2018 follow:
The components of OCI, net of taxes for the three months ended March 31, 2019 and 2018 follow:
______________
Investment gains and losses reclassified from AOCI to Net income (loss) primarily consist of realized gains (losses) on sales and OTTI of AFS securities and are included in Total investment gains (losses), net on the consolidated statements of income (loss). Amounts reclassified from AOCI to Net income (loss) as related to defined benefit plans primarily consist of amortizations of net (gains) losses and net prior service cost (credit) recognized as a component of net periodic cost and reported in Compensation and benefit expenses in the consolidated statements of income (loss). Amounts presented in the table above are net of tax. |
RELATED PARTY TRANSACTIONS |
3 Months Ended |
---|---|
Mar. 31, 2019 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | RELATED PARTY TRANSACTIONS The Company’s significant transactions during the three months ended March 31, 2019 with related parties are summarized below. Loans from Affiliates Senior Surplus Notes On December 28, 2018, AXA Equitable issued a $572 million senior surplus note due December 28, 2019 to Holdings, which bears interest at a fixed rate of 3.75%, payable semi-annually. The surplus note is intended to have priority in right of payments and in all other respects to any and all other surplus notes issued by AXA Equitable at any time. AXA Equitable repaid this note on March 5, 2019 and incurred $4 million of interest expense during three months ended March 31, 2019. Investment management fees The Company recorded investment management fee expense of $24 million and $21 million, respectively, from AllianceBernstein for the three months ended March 31, 2019 and 2018. |
COMMITMENT AND CONTINGENT LIABILITIES |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities | COMMITMENTS AND CONTINGENT LIABILITIES Litigation Litigation, regulatory and other loss contingencies arise in the ordinary course of the Company’s activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters arising from the conduct of its business. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages and other relief. Claimants are not always required to specify the monetary damages they seek, or they may be required only to state an amount sufficient to meet a court’s jurisdictional requirements. Moreover, some jurisdictions allow claimants to allege monetary damages that far exceed any reasonably possible verdict. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. Litigation against the Company includes a variety of claims including, among other things, insurers’ sales practices, alleged agent misconduct, alleged failure to properly supervise agents, contract administration, product design, features and accompanying disclosure, cost of insurance increases, the use of captive reinsurers, payments of death benefits and the reporting and escheatment of unclaimed property, alleged breach of fiduciary duties, alleged mismanagement of client funds and other matters. As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters. The outcome of a litigation or regulatory matter is difficult to predict, and the amount or range of potential losses associated with these or other loss contingencies requires significant management judgment. It is not possible to predict the ultimate outcome or to provide reasonably possible losses or ranges of losses for all pending regulatory matters, litigation and other loss contingencies. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters, nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company’s litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company’s results of operations or cash flows in a particular quarterly or annual period. For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company, however, believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of March 31, 2019, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $95 million. For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company’s accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews. In August 2015, a lawsuit was filed in Connecticut Superior Court, Judicial Division of New Haven entitled Richard T. O’Donnell, on behalf of himself and all others similarly situated v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action on behalf of all persons who purchased variable annuities from AXA Equitable, which were subsequently subjected to the volatility management strategy and who suffered injury as a result thereof. Plaintiff asserts a claim for breach of contract alleging that AXA Equitable implemented the volatility management strategy in violation of applicable law. In November 2015, the Connecticut Federal District Court transferred this action to the United States District Court for the Southern District of New York. In March 2017, the Southern District of New York granted AXA Equitable’s motion to dismiss the complaint. In April 2017, the plaintiff filed a notice of appeal. In April 2018, the United States Court of Appeals for the Second Circuit reversed the trial court’s decision with instructions to remand the case to Connecticut state court. In September 2018, the Second Circuit issued its mandate, following AXA Equitable’s notification to the court that it would not file a petition for writ of certiorari. The case was transferred in December 2018 and is pending in Connecticut Superior Court, Judicial District of Stamford. We are vigorously defending this matter. In February 2016, a lawsuit was filed in the United States District Court for the Southern District of New York entitled Brach Family Foundation, Inc. v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action brought on behalf of all owners of universal life (“UL”) policies subject to AXA Equitable’s COI rate increase. In early 2016, AXA Equitable raised COI rates for certain UL policies issued between 2004 and 2007, which had both issue ages 70 and above and a current face value amount of $1 million and above. A second putative class action was filed in Arizona in 2017 and consolidated with the Brach matter. The current consolidated amended class action complaint alleges the following claims: breach of contract; misrepresentations by AXA Equitable in violation of Section 4226 of the New York Insurance Law; violations of New York General Business Law Section 349; and violations of the California Unfair Competition Law, and the California Elder Abuse Statute. Plaintiffs seek; (a) compensatory damages, costs, and, pre- and post-judgment interest; (b) with respect to their claim concerning Section 4226, a penalty in the amount of premiums paid by the plaintiffs and the putative class; and (c) injunctive relief and attorneys’ fees in connection with their statutory claims. Five other federal actions challenging the COI rate increase are also pending against AXA Equitable and have been coordinated with the Brach action for the purposes of pre-trial activities. They contain allegations similar to those in the Brach action as well as additional allegations for violations of various states’ consumer protection statutes and common law fraud. Two actions are also pending against AXA Equitable in New York state court. AXA Equitable is vigorously defending each of these matters. Obligation under funding agreements As a member of the FHLBNY, AXA Equitable has access to collateralized borrowings. It also may issue funding agreements to the FHLBNY. Both the collateralized borrowings and funding agreements would require AXA Equitable to pledge qualified mortgage-backed assets and/or government securities as collateral. AXA Equitable issues short-term funding agreements to the FHLBNY and uses the funds for asset liability and cash management purposes. AXA Equitable issues long-term funding agreements to the FHLBNY and uses the funds for spread lending purposes. For other instruments used for asset liability management purposes see Note 4. Funding agreements are reported in Policyholders’ account balances in the consolidated balance sheets. Change in FHLBNY Funding Agreements during the Three Months Ended March 31, 2019
______________
Guarantees and Other Commitments At March 31, 2019, the Company had $877 million of commitments under equity financing arrangements to certain limited partnerships, including $258 million of commitments to funds managed by affiliates. In addition, at March 31, 2019, the Company had $325 million of commitments under equity financing arrangements to existing mortgage loan agreements. The Company had $19 million of undrawn letters of credit related to reinsurance at March 31, 2019. Pursuant to certain assumption agreements (the “Assumption Agreements”), Holdings legally assumed primary liability from AXA Equitable for all current and future liabilities of AXA Equitable under certain employee benefit plans that provide participants with medical, life insurance and deferred compensation benefits as well as under the AXA Equitable Retirement plan, a frozen qualified pension plan. AXA Equitable remains secondarily liable for its obligations under these plans and would recognize such liabilities in the event Holdings does not perform under the terms of the Assumption Agreements. |
DISCONTINUED OPERATIONS |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations and Disposal Groups [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations | DISCONTINUED OPERATIONS The results of AB are reflected in the Company’s consolidated financial statements as discontinued operations and are presented in Net income (loss) from discontinued operations, net of taxes. Intercompany transactions between the Company and AB prior to the AB Business Transfer have been eliminated. Ongoing service transactions with AB are reported as related party transactions as further described in Note 12. The table below presents AB’s revenues recognized in three months ended March 31, 2018, disaggregated by category:
The following table presents the amounts related to the Net income of AB that has been reflected in Discontinued Operations:
|
REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Changes and Error Corrections [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revision of Prior Period Financial Statements | REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS Reclassification of DAC Capitalization During the fourth quarter of 2018, the Company changed the presentation of the capitalization of DAC in the consolidated statements of income for all prior periods presented herein by netting the capitalized amounts within the applicable expense line items, such as Compensation and benefits, Commissions and Other operating costs and expenses. Previously, the Company had netted the capitalized amounts within the Amortization of DAC. There was no impact on Net income (loss) or Comprehensive income (loss) from this reclassification. See Note 2 for further details of this reclassification. Revisions of Prior Period Financial Statements During the second and third quarter of 2018, the Company revised its financial statements to reflect the correction of errors identified by the Company in its previously issued financial statements. The impact of these errors was not considered to be material. However, in order to improve the consistency and comparability of the financial statements, management revised the Company’s consolidated financial statements as of and for the three and six months ended March 31, 2018 and June 30, 2018, respectively. In addition, during the fourth quarter of 2018, the Company identified certain cash flows that were incorrectly classified in the Company’s consolidated statements of cash flows. The Company has determined that these misclassifications were not material to its financial statements of any period. The impact of the misclassifications detailed in the revision tables included on the consolidated statement of cash flows for the three months ended March 31, 2018 were corrected in the comparative consolidated statements of cash flows for the three months ended March 31, 2019 and 2018 contained elsewhere in the financial statements. The misclassifications for the six and nine months ended June 30, 2018 and September 30, 2018 will be corrected in the Company’s comparative consolidated statements of cash flows to be included in the Form 10-Q filings as of and for the three and six months ended June 30, 2019 and as of and for the three and nine months ended September 30, 2019, respectively. Discontinued Operations As further described in Note 13, as a result of the AB Business Transfer in the fourth quarter of 2018, AB’s operations are now reflected as discontinued operations in the Company’s consolidated financial statements. The financial information for prior periods presented in the consolidated financial statements have been adjusted to reflect AB as discontinued operations. Revision of Consolidated Financial Statements as of and for the Three Months Ended March 31, 2018 The following tables present line items of the consolidated financial statements as of and for the three months ended March 31, 2018 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s March 31, 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, adjustment for the discontinued operations, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables.
______________
|
SUBSEQUENT EVENTS |
3 Months Ended |
---|---|
Mar. 31, 2019 | |
Subsequent Events [Abstract] | |
Subsequent Events | SUBSEQUENT EVENTS None. |
SIGNIFICANT ACCOUNTING POLICIES (Policies) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adoption of New Accounting Pronouncements and Future Adoption of New Accounting Pronouncements | Adoption of New Accounting Pronouncements
Future Adoption of New Accounting Pronouncements
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting and Consolidation of VIEs | Accounting and Consolidation of Variable Interest Entities (“VIEs”) At March 31, 2019, the Company held $1.1 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including hedge funds, private equity funds and real estate-related funds. As an equity investor, the Company is considered to have a variable interest in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests or other financial arrangements, if any, the Company was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheets as Other equity investments and to apply the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are $168.6 billion at March 31, 2019. The Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $1.1 billion and $866 million of unfunded commitments at March 31, 2019. The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations. At March 31, 2019, the Company consolidated one real estate joint venture for which it was identified as primary beneficiary under the VIE model. The consolidated entity is jointly owned by AXA Equitable Life Insurance Company (“AXA Equitable Life”) and AXA France and holds an investment in a real estate venture. Included in the Company’s consolidated balance sheet at March 31, 2019 related to this VIE is $35 million of Real estate held for production of income. In addition, Real estate held for production of income reflects $16 million as related to two non-consolidated joint ventures at March 31, 2019. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revision of Prior Period Financial Statements | Revision of Prior Period Financial Statements During the second and third quarter of 2018, the Company revised its financial statements to reflect the correction of errors identified by the Company in its previously issued financial statements. The impact of these errors was not considered to be material. However, in order to improve the consistency and comparability of the financial statements, management revised the Company’s consolidated financial statements as of and for the three and six months ended March 31, 2018 and June 30, 2018, respectively. In addition, during the fourth quarter of 2018, the Company identified certain cash flows that were incorrectly classified in the Company’s consolidated statements of cash flows. The Company has determined that these misclassifications were not material to its financial statements of any period. The impact of the misclassifications detailed in the revision tables included in Note 14 on the consolidated statement of cash flows for the three months ended March 31, 2018 were corrected in the comparative consolidated statements of cash flows for the three months ended March 31, 2019 and 2018 contained elsewhere in the financial statements. The misclassifications for the six and nine months ended June 30, 2018 and September 30, 2018 will be corrected in the Company’s comparative consolidated statements of cash flows to be included in the Form 10-Q filings as of and for the three and six months ended June 30, 2019 and as of and for the three and nine months ended September 30, 2019, respectively. See Note 14 for further information. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements | The accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value:
The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument. Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness. |
SIGNIFICANT ACCOUNTING POLICIES (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of New Accounting Pronouncements and Changes in Accounting Principles |
Future Adoption of New Accounting Pronouncements
The reclassification adjustments for the three months ended March 31, 2018 are presented in the table below. Capitalization of DAC reclassified to Compensation and benefits, Commissions and Other operating costs and expenses reduced the amounts previously reported in those expense line items, while the capitalization of DAC reclassified from the Amortization of deferred policy acquisition costs line item increases that expense line item.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues Disaggregated by Category | The table below presents the revenues recognized during the three months ended March 31, 2019 and 2018, disaggregated by category:
|
INVESTMENTS (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Available-for-sale Securities by Classification | The following tables provide information relating to fixed maturities classified as available-for-sale (“AFS”). Available-for-Sale Securities by Classification
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Available-for-sale Securities Fixed Maturities Contractual Maturities | The contractual maturities of AFS fixed maturities at March 31, 2019 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Contractual Maturities of Available-for-Sale Fixed Maturities
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Sales, Gross Gains (Losses) and OTTI for AFS Fixed Maturities | The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities during the three months ended March 31, 2019 and 2018:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed Maturities - Credit Loss Impairments | The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts: Fixed Maturities - Credit Loss Impairments
______________
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Unrealized Gain (Loss) on Fixed Maturities and Equity Securities Included in AOCI | Net unrealized investment gains (losses) on fixed maturities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated: Net Unrealized Gains (Losses) on Fixed Maturities Classified as AFS
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Unrealized Gain (Losses) on Fixed Maturities with OTTI Losses | The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturities on which an OTTI loss has been recognized and all other: Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
All Other Net Unrealized Investment Gains (Losses) in AOCI | All Other Net Unrealized Investment Gains (Losses) in AOCI
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Gross Unrealized Loss on Investments | The following tables disclose the fair values and gross unrealized losses of the 674 issues at March 31, 2019 and the 1,471 issues at December 31, 2018 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Investment Income (Loss) from Trading Securities | The table below shows a breakdown of Net investment income (loss) from trading account securities during the three months ended March 31, 2019 and 2018: Net Investment Income (Loss) from Trading Account Securities
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Valuation Allowance for Mortgage Loans | The change in the valuation allowance for credit losses for commercial mortgage loans during the three months ended March 31, 2019 and 2018 are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage Loans by Loan-To-Value and Debt Service Coverage Ratios | The following tables provide information relating to the loan-to-value and debt service coverage ratios for commercial and agricultural mortgage loans at March 31, 2019 and December 31, 2018. The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios
______________
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Age Analysis of Past Due Mortgage Loans | The following table provides information relating to the aging analysis of past due mortgage loans at March 31, 2019 and December 31, 2018. Age Analysis of Past Due Mortgage Loans
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Impaired Mortgage Loans | The following table provides information relating to impaired mortgage loans at March 31, 2019 and December 31, 2018. Impaired Mortgage Loans
|
DERIVATIVES (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments by Category | The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments. Derivative Instruments by Category
______________
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offsetting Financial Assets and Liabilities and Derivative Instruments | The following table presents information about the Company’s offsetting financial assets and liabilities and derivative instruments at December 31, 2018. Offsetting of Financial Assets and Liabilities and Derivative Instruments At December 31, 2018
______________
The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at March 31, 2019. Offsetting of Financial Assets and Liabilities and Derivative Instruments At March 31, 2019
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gross Collateral Amounts Not Offset in Consolidated Balance Sheets | The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at March 31, 2019. Collateral Amounts Not Offset in the Consolidated Balance Sheets At March 31, 2019
The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2018. Collateral Amounts Not Offset in the Consolidated Balance Sheets At December 31, 2018
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase Agreements Accounted for as Secured Borrowings | The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2018. Repurchase Agreement Accounted for as Secured Borrowings At December 31, 2018
|
CLOSED BLOCK (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summarized Financial Information for Closed Blocks | Summarized financial information for the Company’s Closed Block is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block Revenues and Expenses | The Company’s Closed Block revenues and expenses are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Policy Holder Dividend Obligation | A reconciliation of the Company’s policyholder dividend obligation follows:
|
INSURANCE LIABILITIES (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GMDB and GMIB Liabilities and Other Policyholder's Liabilities | Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No NLG Feature For the Three Months Ended March 31, 2019 and 2018
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variable Annuity Contracts with GMDB and GMIB Features | Direct Variable Annuity Contracts with GMDB and GMIB Features At March 31, 2019
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment in Variable Insurance Trust Mutual Funds | The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB features. The investment performance of the assets impacts the related account values and, consequently, the NAR associated with the GMDB and GMIB benefits and guarantees. Because the Company’s variable annuity contracts offer both GMDB and GMIB features, GMDB and GMIB amounts are not mutually exclusive. Investment in Variable Insurance Trust Mutual Funds
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of No-Lapse Guarantee Liabilities and Other Policyholder's Liabilities | The change in the NLG feature reflected in the General Account in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets is summarized in the table below.
|
FAIR VALUE DISCLOSURES (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets and Liabilities Measured at Fair Value on Recurring Basis | Assets and liabilities measured at fair value on a recurring basis are summarized below. At March 31, 2019 and December 31, 2018, no assets were required to be measured at fair value on a non-recurring basis. Fair value measurements are required on a non-recurring basis for certain assets, including goodwill and mortgage loans on real estate, only when an OTTI or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. The Company recognizes transfers between valuation levels at the beginning of the reporting period. Fair Value Measurements at March 31, 2019
______________
Fair Value Measurements at December 31, 2018
______________
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | The tables below present reconciliations for all Level 3 assets and liabilities for the three months ended March 31, 2019 and 2018. Level 3 Instruments - Fair Value Measurements
______________
______________
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Assets Unrealized Gains Losses By Category For Level 3 Assets And Liabilities Still Held | The table below details changes in unrealized gains (losses) for the three months ended March 31, 2019 and 2018 by category for Level 3 assets and liabilities still held at March 31, 2019 and 2018. Level 3 Instruments
______________
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Inputs Quantitative Information | The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities at March 31, 2019 and December 31, 2018. Quantitative Information about Level 3 Fair Value Measurements at March 31, 2019
______________
Quantitative Information about Level 3 Fair Value Measurements at December 31, 2018
______________
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosure Financial Instruments Not Carried At Fair Value | The carrying values and fair values at March 31, 2019 and December 31, 2018 for financial instruments not otherwise disclosed in Notes 3 and 4 are presented in the table below.
|
LEASES (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets and Liabilities, Leases | Balance Sheet Classification of Operating Lease Assets and Liabilities
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lease, Cost | The table below summarizes the components of lease costs for the three months ended March 31, 2019. Lease Costs
Weighted Average of Lease Term and Discount Rate
Supplemental cash flow information related to leases was as follows: Lease Liabilities Information
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lessee, Operating Lease, Liability, Maturity | Maturities of lease liabilities as of March 31, 2019 are as follows: Maturities of Lease Liabilities
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Future Minimum Rental Payments for Operating Leases | The following table presents the Company’s future minimum lease obligation under ASC 840 as of December 31, 2018:
|
EQUITY (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accumulated Other Comprehensive Income (Loss) | AOCI represents cumulative gains (losses) on items that are not reflected in Net income (loss). The balances as of March 31, 2019 and 2018 follow:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of Accumulated Other Comprehensive Income (Loss), Net of Taxes | The components of OCI, net of taxes for the three months ended March 31, 2019 and 2018 follow:
______________
|
COMMITMENT AND CONTINGENT LIABILITIES (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Federal Home Loan Bank, Advances |
______________
|
DISCONTINUED OPERATIONS (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations and Disposal Groups [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disposal Groups, Including Discontinued Operations | The table below presents AB’s revenues recognized in three months ended March 31, 2018, disaggregated by category:
The following table presents the amounts related to the Net income of AB that has been reflected in Discontinued Operations:
|
REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Tables) |
3 Months Ended |
---|---|
Mar. 31, 2019 | |
Accounting Changes and Error Corrections [Abstract] | |
Financial Information Affected by Revisions and Change in Accounting Principle | . |
ORGANIZATION - Narrative (Details) |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2019 |
Dec. 31, 2018 |
|
AXA Equity Holdings [Member] | ||
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] | ||
Ownership percentage | 48.00% | 59.00% |
SIGNIFICANT ACCOUNTING POLICIES - Impact of New Accounting Pronouncements (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Jan. 01, 2019 |
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Accounting Policies [Abstract] | |||
Operating lease asset | $ 347 | $ 328 | |
Operating lease liability | 439 | 422 | |
Amortization of deferred policy acquisition costs | $ 165 | $ 209 | |
Deferred Rent Credit | 58 | ||
Operating Lease, Impairment Loss | $ 34 |
SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Variable Interest Entity [Line Items] | ||
Amortization of deferred policy acquisition costs | $ 165 | $ 209 |
Variable Interest Entity, Not Primary Beneficiary | ||
Variable Interest Entity [Line Items] | ||
Variable Interest Entity, nonconsolidated net assets | 168,600 | |
Variable interest, maximum loss exposure | 1,100 | |
Variable interest entity, unused commitments | 866 | |
Variable interest entity, consolidated, assets | 1,100 | |
Variable Interest Entity, Primary Beneficiary | ||
Variable Interest Entity [Line Items] | ||
Variable interest entity, consolidated, assets | 35 | |
Operating income (loss) | $ 16 |
SIGNIFICANT ACCOUNTING POLICIES - Reclassification of DAC (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Amortization of deferred policy acquisition costs | $ 165 | $ 209 |
Reclassification Of DAC | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Total reductions | 135 | |
Amortization of deferred policy acquisition costs | 135 | |
Reclassification Of DAC | Compensation and benefits | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Total reductions | 33 | |
Reclassification Of DAC | Commissions | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Total reductions | 101 | |
Reclassification Of DAC | Other operating costs and expenses | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Total reductions | $ 1 |
SIGNIFICANT ACCOUNTING POLICIES - Disaggregation of Revenue (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Total investment management and service fees | ||
Disaggregation of Revenue [Line Items] | ||
Revenues disaggregated by category | $ 248 | $ 254 |
Base fees | ||
Disaggregation of Revenue [Line Items] | ||
Revenues disaggregated by category | 178 | 182 |
Distribution services | ||
Disaggregation of Revenue [Line Items] | ||
Revenues disaggregated by category | 70 | 72 |
Other income | ||
Disaggregation of Revenue [Line Items] | ||
Revenues disaggregated by category | $ 5 | $ 7 |
INVESTMENTS - Available-for-sale Securities (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
---|---|---|
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 44,926 | $ 42,492 |
Gross Unrealized Gains | 1,438 | 618 |
Gross Unrealized Losses | 435 | 1,195 |
Fair Value | 45,929 | 41,915 |
OTTI in AOCI | 2 | 2 |
Amortized Cost | ||
Subtotal | 43,711 | |
Fair Value | ||
Subtotal | 44,694 | |
March 31, 2019 | 45,929 | |
Corporate | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 30,106 | 26,690 |
Gross Unrealized Gains | 867 | 385 |
Gross Unrealized Losses | 208 | 699 |
Fair Value | 30,765 | 26,376 |
OTTI in AOCI | 0 | 0 |
U.S. Treasury, government and agency | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 12,719 | 13,646 |
Gross Unrealized Gains | 462 | 143 |
Gross Unrealized Losses | 213 | 454 |
Fair Value | 12,968 | 13,335 |
OTTI in AOCI | 0 | 0 |
State and Political Sub-divisions | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 408 | 408 |
Gross Unrealized Gains | 55 | 47 |
Gross Unrealized Losses | 0 | 1 |
Fair Value | 463 | 454 |
OTTI in AOCI | 0 | 0 |
Foreign governments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 478 | 515 |
Gross Unrealized Gains | 27 | 17 |
Gross Unrealized Losses | 7 | 13 |
Fair Value | 498 | 519 |
OTTI in AOCI | 0 | 0 |
Residential mortgage-backed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 185 | 193 |
Gross Unrealized Gains | 10 | 9 |
Gross Unrealized Losses | 0 | 0 |
Fair Value | 195 | 202 |
OTTI in AOCI | 0 | 0 |
Amortized Cost | ||
Without single maturity date | 185 | |
Fair Value | ||
Without single maturity date | 195 | |
Asset- backed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 608 | 600 |
Gross Unrealized Gains | 1 | 1 |
Gross Unrealized Losses | 4 | 11 |
Fair Value | 605 | 590 |
OTTI in AOCI | 2 | 2 |
Amortized Cost | ||
Without single maturity date | 608 | |
Fair Value | ||
Without single maturity date | 605 | |
Redeemable preferred stock | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 422 | 440 |
Gross Unrealized Gains | 16 | 16 |
Gross Unrealized Losses | 3 | 17 |
Fair Value | 435 | 439 |
OTTI in AOCI | 0 | $ 0 |
Amortized Cost | ||
Without single maturity date | 422 | |
Fair Value | ||
Without single maturity date | 435 | |
Total Fixed Maturities | ||
Amortized Cost | ||
Due in one year or less | 1,817 | |
Due in years two through five | 10,322 | |
Due in years six through ten | 14,953 | |
Due after ten years | 16,619 | |
Fair Value | ||
Due in one year or less | 1,829 | |
Due in years two through five | 10,519 | |
Due in years six through ten | 15,367 | |
Due after ten years | $ 16,979 |
INVESTMENTS - Credit Loss Impairments (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Investments, Debt and Equity Securities [Abstract] | ||
Proceeds from sales | $ 1,361 | $ 3,428 |
Gross gains on sales | 8 | 127 |
Gross losses on sales | (15) | (41) |
Total OTTI | 0 | 0 |
Non-credit losses recognized in OCI | 0 | 0 |
Credit losses recognized in Net income (loss) | 0 | 0 |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning of year | 12,428 | 19,492 |
End of year | 12,370 | 18,492 |
Accumulated Other-than-Temporary Impairment Attributable to Parent [Member] | Fixed Maturities | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning of year | (46) | (10) |
Previously recognized impairments on securities that matured, paid, prepaid or sold | 28 | 0 |
Recognized impairments on securities impaired to fair value this period | 0 | 0 |
Impairments recognized this period on securities not previously impaired | 0 | 0 |
Additional impairments this period on securities previously impaired | 0 | 0 |
Increases due to passage of time on previously recorded credit losses | 0 | 0 |
Accretion of previously recognized impairments due to increases in expected cash flows | 0 | 0 |
End of year | $ (18) | $ (10) |
INVESTMENTS - Net Unrealized Investment Gains (Losses) (Details) - Net Unrealized Gains (Losses) on Investments - Fixed Maturities - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
---|---|---|
Unrealized Net Investment Gain and Losses [Line Items] | ||
Net unrealized gains (losses) | $ 1,003 | $ (577) |
With OTTI loss | ||
Unrealized Net Investment Gain and Losses [Line Items] | ||
Net unrealized gains (losses) | 0 | 0 |
All other | ||
Unrealized Net Investment Gain and Losses [Line Items] | ||
Net unrealized gains (losses) | $ 1,003 | $ (577) |
INVESTMENTS - Rollforward of Net Unrealized Investment Gains (Losses) (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning of year | $ 12,428 | $ 19,492 |
Deferred income taxes | (200) | 197 |
End of year | 12,370 | 18,492 |
Accumulated Net Investment Gain (Loss) Attributable to Parent | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning of year | (468) | 679 |
Net investment gains (losses) arising during the period | 1,583 | (1,245) |
Included in Net income (loss) | (3) | (88) |
DAC | (655) | 288 |
Deferred income taxes | (211) | 197 |
Policyholders’ liabilities | 77 | 108 |
End of year | 323 | (61) |
Accumulated Net Investment Gain (Loss) Attributable to Parent | All other | Net Unrealized Gains (Losses) on Investments | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning of year | (577) | 1,526 |
Net investment gains (losses) arising during the period | 1,583 | (1,245) |
Included in Net income (loss) | (3) | (88) |
End of year | 1,003 | 193 |
Accumulated Net Investment Gain (Loss) Attributable to Parent | All other | DAC | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning of year | 39 | (315) |
DAC | (655) | 288 |
End of year | (616) | (27) |
Accumulated Net Investment Gain (Loss) Attributable to Parent | All other | Policyholders’ Liabilities | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning of year | (55) | (232) |
Policyholders’ liabilities | 77 | 108 |
End of year | 22 | (124) |
Accumulated Net Investment Gain (Loss) Attributable to Parent | All other | Deferred Income Tax Asset (Liability) | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning of year | 125 | (300) |
Deferred income taxes | (211) | 197 |
End of year | (86) | (103) |
Accumulated Net Investment Gain (Loss) Attributable to Parent | Fixed Maturities | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning of year | 0 | (4) |
Net investment gains (losses) arising during the period | (10) | 0 |
Included in Net income (loss) | 10 | (2) |
DAC | 0 | (1) |
Deferred income taxes | 0 | 0 |
Policyholders’ liabilities | 0 | 1 |
End of year | 0 | (6) |
Accumulated Net Investment Gain (Loss) Attributable to Parent | Fixed Maturities | With OTTI loss | Net Unrealized Gains (Losses) on Investments | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning of year | 0 | 1 |
Net investment gains (losses) arising during the period | (10) | 0 |
End of year | 0 | (1) |
Accumulated Net Investment Gain (Loss) Attributable to Parent | Fixed Maturities | With OTTI loss | DAC | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning of year | 0 | 1 |
DAC | 0 | (1) |
End of year | 0 | 0 |
Accumulated Net Investment Gain (Loss) Attributable to Parent | Fixed Maturities | With OTTI loss | Policyholders’ Liabilities | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning of year | 0 | (1) |
Policyholders’ liabilities | 0 | 1 |
End of year | 0 | 0 |
Accumulated Net Investment Gain (Loss) Attributable to Parent | Fixed Maturities | With OTTI loss | Deferred Income Tax Asset (Liability) | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning of year | 0 | (5) |
Deferred income taxes | 0 | 0 |
End of year | $ 0 | $ (5) |
INVESTMENTS - Gross Unrealized Losses (Details) $ in Millions |
Mar. 31, 2019
USD ($)
security
|
Dec. 31, 2018
USD ($)
security
|
---|---|---|
Investments, Debt and Equity Securities [Abstract] | ||
Number of fixed maturities in an unrealized loss position greater than 12 months | security | 674 | 1,471 |
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less Than 12 Months, Fair Value | $ 976 | $ 11,832 |
Less Than 12 Months, Gross Unrealized Losses | 8 | 400 |
Greater than 12 Months, Fair Value | 8,901 | 9,460 |
Greater Than 12 Months, Gross Unrealized Losses | 427 | 795 |
Total, Fair Value | 9,877 | 21,292 |
Total, Gross Unrealized Losses | 435 | 1,195 |
Corporate | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less Than 12 Months, Fair Value | 653 | 8,369 |
Less Than 12 Months, Gross Unrealized Losses | 6 | 306 |
Greater than 12 Months, Fair Value | 5,387 | 6,161 |
Greater Than 12 Months, Gross Unrealized Losses | 202 | 393 |
Total, Fair Value | 6,040 | 14,530 |
Total, Gross Unrealized Losses | 208 | 699 |
U.S. Treasury, government and agency | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less Than 12 Months, Fair Value | 0 | 2,636 |
Less Than 12 Months, Gross Unrealized Losses | 0 | 68 |
Greater than 12 Months, Fair Value | 3,163 | 3,154 |
Greater Than 12 Months, Gross Unrealized Losses | 213 | 386 |
Total, Fair Value | 3,163 | 5,790 |
Total, Gross Unrealized Losses | 213 | 454 |
State and Political Sub-divisions | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less Than 12 Months, Fair Value | 0 | |
Less Than 12 Months, Gross Unrealized Losses | 0 | |
Greater than 12 Months, Fair Value | 19 | |
Greater Than 12 Months, Gross Unrealized Losses | 1 | |
Total, Fair Value | 19 | |
Total, Gross Unrealized Losses | 1 | |
Foreign governments | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less Than 12 Months, Fair Value | 0 | 109 |
Less Than 12 Months, Gross Unrealized Losses | 0 | 3 |
Greater than 12 Months, Fair Value | 67 | 76 |
Greater Than 12 Months, Gross Unrealized Losses | 7 | 10 |
Total, Fair Value | 67 | 185 |
Total, Gross Unrealized Losses | 7 | 13 |
Residential mortgage-backed | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less Than 12 Months, Fair Value | 0 | |
Less Than 12 Months, Gross Unrealized Losses | 0 | |
Greater than 12 Months, Fair Value | 13 | |
Greater Than 12 Months, Gross Unrealized Losses | 0 | |
Total, Fair Value | 13 | |
Total, Gross Unrealized Losses | 0 | |
Asset- backed | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less Than 12 Months, Fair Value | 279 | 558 |
Less Than 12 Months, Gross Unrealized Losses | 1 | 11 |
Greater than 12 Months, Fair Value | 249 | 6 |
Greater Than 12 Months, Gross Unrealized Losses | 3 | 0 |
Total, Fair Value | 528 | 564 |
Total, Gross Unrealized Losses | 4 | 11 |
Redeemable preferred stock | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less Than 12 Months, Fair Value | 44 | 160 |
Less Than 12 Months, Gross Unrealized Losses | 1 | 12 |
Greater than 12 Months, Fair Value | 35 | 31 |
Greater Than 12 Months, Gross Unrealized Losses | 2 | 5 |
Total, Fair Value | 79 | 191 |
Total, Gross Unrealized Losses | $ 3 | $ 17 |
INVESTMENTS - Narrative (Details) $ in Millions |
Mar. 31, 2019
USD ($)
security
|
Dec. 31, 2018
USD ($)
security
|
---|---|---|
Debt Securities, Available-for-sale [Line Items] | ||
Number of fixed maturities in an unrealized loss position greater than 12 months | security | 674 | 1,471 |
Securities sold under agreements to repurchase | $ 0 | $ 573 |
Debt securities exposure in single issuer greater than stated percentage of total investments | 0.70% | |
AOCI Unrealized gain (loss) on AFS securities | $ (5) | (30) |
Gross unrealized losses of twelve months or more | 427 | 795 |
Trading securities, at fair value | 12,704 | 15,166 |
Separate account equity investment carrying value | 50 | 48 |
Corporate | ||
Debt Securities, Available-for-sale [Line Items] | ||
Debt securities exposure in single issuer of total investments | $ 218 | $ 210 |
Debt securities exposure in single issuer of total investments, percent | 1.80% | 1.70% |
Fixed Maturities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale securities, amortized cost basis | $ 44,926 | $ 42,492 |
External Credit Rating, Non Investment Grade [Member] | Fixed Maturities | Other Than Investment Grade | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale securities, amortized cost | $ 1,250 | $ 1,228 |
Percentage of available for sale securities | 2.80% | 2.90% |
Total Commercial Mortgage Loans | ||
Debt Securities, Available-for-sale [Line Items] | ||
Mortgage loans classified as nonaccrual | $ 0 | $ 19 |
INVESTMENTS - Trading Securities (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Debt Securities, Trading, Gain (Loss) [Abstract] | ||
Net investment gains (losses) recognized during the period on securities held at the end of the period | $ 274 | $ (96) |
Net investment gains (losses) recognized on securities sold during the period | (24) | (1) |
Unrealized and realized gains (losses) on trading securities arising during the period | 250 | (97) |
Interest and dividend income from trading securities | 90 | 66 |
Net investment income (loss) from trading securities | $ 340 | $ (31) |
INVESTMENTS - Valuation Allowance for Mortgage Loans (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
Dec. 31, 2018 |
|
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract] | |||
Individually evaluated for impairment | $ 0 | $ 7 | |
Total Commercial Mortgage Loans | |||
Financing Receivable, Allowance for Credit Losses [Roll Forward] | |||
Beginning balance, January 1 | 7 | $ 8 | |
Charge-offs | (7) | 0 | |
Recoveries | 0 | (1) | |
Provision | 0 | 0 | |
Ending balance, March 31, | 0 | 7 | |
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract] | |||
Individually evaluated for impairment | $ 0 | $ 7 |
INVESTMENTS - Mortgage Loans (Details) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2019 |
Dec. 31, 2018 |
|
With no related allowance recorded | ||
Impaired Mortgage Loans [Abstract] | ||
Recorded Investment | $ 2 | $ 2 |
Unpaid Principal Balance | 2 | 2 |
Related Allowance | 0 | 0 |
Average Recorded Investment | 2 | 0 |
Interest Income Recognized | 0 | 0 |
With related allowance recorded | ||
Impaired Mortgage Loans [Abstract] | ||
Recorded Investment | 0 | 27 |
Unpaid Principal Balance | 0 | 31 |
Related Allowance | 0 | (7) |
Average Recorded Investment | 13 | 27 |
Interest Income Recognized | 0 | 0 |
Total Commercial Mortgage Loans | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 9,370 | 9,130 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Financing receivables, recorded investment, past due | 0 | 27 |
Financing receivables, recorded investment, current | 9,370 | 9,103 |
Total Financing Receivables | 9,370 | 9,130 |
Financing receivable, recorded investment, 90 days or more past due and accruing | 0 | 0 |
Total Commercial Mortgage Loans | With related allowance recorded | ||
Impaired Mortgage Loans [Abstract] | ||
Recorded Investment | 0 | 27 |
Unpaid Principal Balance | 0 | 31 |
Related Allowance | 0 | (7) |
Average Recorded Investment | 13 | 27 |
Interest Income Recognized | 0 | 0 |
Total Commercial Mortgage Loans | 30-59 Days | ||
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Financing receivables, recorded investment, past due | 0 | 0 |
Total Commercial Mortgage Loans | 60-89 Days | ||
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Financing receivables, recorded investment, past due | 0 | 0 |
Total Commercial Mortgage Loans | 90 Days or More | ||
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Financing receivables, recorded investment, past due | 0 | 27 |
Total Commercial Mortgage Loans | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 5,963 | 5,948 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 5,963 | 5,948 |
Total Commercial Mortgage Loans | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 827 | 677 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 827 | 677 |
Total Commercial Mortgage Loans | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 1,616 | 1,510 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 1,616 | 1,510 |
Total Commercial Mortgage Loans | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 832 | 746 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 832 | 746 |
Total Commercial Mortgage Loans | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 132 | 249 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 132 | 249 |
Total Commercial Mortgage Loans | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Commercial Mortgage Loans | 0% - 50% | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 1,024 | 1,072 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 1,024 | 1,072 |
Total Commercial Mortgage Loans | 0% - 50% | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 764 | 780 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 764 | 780 |
Total Commercial Mortgage Loans | 0% - 50% | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 21 | 21 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 21 | 21 |
Total Commercial Mortgage Loans | 0% - 50% | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 215 | 247 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 215 | 247 |
Total Commercial Mortgage Loans | 0% - 50% | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 24 | 24 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 24 | 24 |
Total Commercial Mortgage Loans | 0% - 50% | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Commercial Mortgage Loans | 0% - 50% | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Commercial Mortgage Loans | 50% - 70% | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 7,497 | 7,186 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 7,497 | 7,186 |
Total Commercial Mortgage Loans | 50% - 70% | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 4,933 | 4,908 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 4,933 | 4,908 |
Total Commercial Mortgage Loans | 50% - 70% | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 806 | 656 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 806 | 656 |
Total Commercial Mortgage Loans | 50% - 70% | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 1,284 | 1,146 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 1,284 | 1,146 |
Total Commercial Mortgage Loans | 50% - 70% | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 474 | 325 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 474 | 325 |
Total Commercial Mortgage Loans | 50% - 70% | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 151 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 151 |
Total Commercial Mortgage Loans | 50% - 70% | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Commercial Mortgage Loans | 70% - 90% | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 849 | 845 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 849 | 845 |
Total Commercial Mortgage Loans | 70% - 90% | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 266 | 260 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 266 | 260 |
Total Commercial Mortgage Loans | 70% - 90% | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Commercial Mortgage Loans | 70% - 90% | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 117 | 117 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 117 | 117 |
Total Commercial Mortgage Loans | 70% - 90% | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 334 | 370 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 334 | 370 |
Total Commercial Mortgage Loans | 70% - 90% | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 132 | 98 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 132 | 98 |
Total Commercial Mortgage Loans | 70% - 90% | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Commercial Mortgage Loans | 90% plus | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 27 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 27 |
Total Commercial Mortgage Loans | 90% plus | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Commercial Mortgage Loans | 90% plus | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Commercial Mortgage Loans | 90% plus | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Commercial Mortgage Loans | 90% plus | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 27 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 27 |
Total Commercial Mortgage Loans | 90% plus | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Commercial Mortgage Loans | 90% plus | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Agricultural Mortgage Loans | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 2,730 | 2,695 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Financing receivables, recorded investment, past due | 90 | 68 |
Financing receivables, recorded investment, current | 2,640 | 2,627 |
Total Financing Receivables | 2,730 | 2,695 |
Financing receivable, recorded investment, 90 days or more past due and accruing | 54 | 40 |
Total Agricultural Mortgage Loans | With no related allowance recorded | ||
Impaired Mortgage Loans [Abstract] | ||
Recorded Investment | 2 | 2 |
Unpaid Principal Balance | 2 | 2 |
Related Allowance | 0 | 0 |
Average Recorded Investment | 2 | 0 |
Interest Income Recognized | 0 | 0 |
Total Agricultural Mortgage Loans | 30-59 Days | ||
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Financing receivables, recorded investment, past due | 9 | 18 |
Total Agricultural Mortgage Loans | 60-89 Days | ||
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Financing receivables, recorded investment, past due | 26 | 8 |
Total Agricultural Mortgage Loans | 90 Days or More | ||
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Financing receivables, recorded investment, past due | 55 | 42 |
Total Agricultural Mortgage Loans | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 397 | 394 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 397 | 394 |
Total Agricultural Mortgage Loans | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 200 | 193 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 200 | 193 |
Total Agricultural Mortgage Loans | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 524 | 513 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 524 | 513 |
Total Agricultural Mortgage Loans | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 939 | 941 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 939 | 941 |
Total Agricultural Mortgage Loans | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 587 | 572 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 587 | 572 |
Total Agricultural Mortgage Loans | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 83 | 82 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 83 | 82 |
Total Agricultural Mortgage Loans | 0% - 50% | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 1,646 | 1,611 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 1,646 | 1,611 |
Total Agricultural Mortgage Loans | 0% - 50% | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 278 | 282 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 278 | 282 |
Total Agricultural Mortgage Loans | 0% - 50% | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 130 | 147 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 130 | 147 |
Total Agricultural Mortgage Loans | 0% - 50% | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 276 | 267 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 276 | 267 |
Total Agricultural Mortgage Loans | 0% - 50% | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 563 | 543 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 563 | 543 |
Total Agricultural Mortgage Loans | 0% - 50% | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 350 | 321 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 350 | 321 |
Total Agricultural Mortgage Loans | 0% - 50% | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 49 | 51 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 49 | 51 |
Total Agricultural Mortgage Loans | 50% - 70% | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 1,065 | 1,038 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 1,065 | 1,038 |
Total Agricultural Mortgage Loans | 50% - 70% | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 119 | 112 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 119 | 112 |
Total Agricultural Mortgage Loans | 50% - 70% | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 70 | 46 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 70 | 46 |
Total Agricultural Mortgage Loans | 50% - 70% | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 248 | 246 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 248 | 246 |
Total Agricultural Mortgage Loans | 50% - 70% | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 357 | 379 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 357 | 379 |
Total Agricultural Mortgage Loans | 50% - 70% | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 237 | 224 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 237 | 224 |
Total Agricultural Mortgage Loans | 50% - 70% | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 34 | 31 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 34 | 31 |
Total Agricultural Mortgage Loans | 70% - 90% | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 19 | 46 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 19 | 46 |
Total Agricultural Mortgage Loans | 70% - 90% | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Agricultural Mortgage Loans | 70% - 90% | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Agricultural Mortgage Loans | 70% - 90% | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Agricultural Mortgage Loans | 70% - 90% | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 19 | 19 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 19 | 19 |
Total Agricultural Mortgage Loans | 70% - 90% | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 27 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 27 |
Total Agricultural Mortgage Loans | 70% - 90% | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Agricultural Mortgage Loans | 90% plus | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Agricultural Mortgage Loans | 90% plus | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Agricultural Mortgage Loans | 90% plus | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Agricultural Mortgage Loans | 90% plus | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Agricultural Mortgage Loans | 90% plus | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Agricultural Mortgage Loans | 90% plus | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Agricultural Mortgage Loans | 90% plus | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Mortgage Loans | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 12,100 | 11,825 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Financing receivables, recorded investment, past due | 90 | 95 |
Financing receivables, recorded investment, current | 12,010 | 11,730 |
Total Financing Receivables | 12,100 | 11,825 |
Financing receivable, recorded investment, 90 days or more past due and accruing | 54 | 40 |
Total Mortgage Loans | 30-59 Days | ||
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Financing receivables, recorded investment, past due | 9 | 18 |
Total Mortgage Loans | 60-89 Days | ||
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Financing receivables, recorded investment, past due | 26 | 8 |
Total Mortgage Loans | 90 Days or More | ||
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Financing receivables, recorded investment, past due | 55 | 69 |
Total Mortgage Loans | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 6,360 | 6,342 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 6,360 | 6,342 |
Total Mortgage Loans | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 1,027 | 870 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 1,027 | 870 |
Total Mortgage Loans | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 2,140 | 2,023 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 2,140 | 2,023 |
Total Mortgage Loans | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 1,771 | 1,687 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 1,771 | 1,687 |
Total Mortgage Loans | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 719 | 821 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 719 | 821 |
Total Mortgage Loans | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 83 | 82 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 83 | 82 |
Total Mortgage Loans | 0% - 50% | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 2,670 | 2,683 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 2,670 | 2,683 |
Total Mortgage Loans | 0% - 50% | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 1,042 | 1,062 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 1,042 | 1,062 |
Total Mortgage Loans | 0% - 50% | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 151 | 168 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 151 | 168 |
Total Mortgage Loans | 0% - 50% | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 491 | 514 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 491 | 514 |
Total Mortgage Loans | 0% - 50% | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 587 | 567 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 587 | 567 |
Total Mortgage Loans | 0% - 50% | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 350 | 321 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 350 | 321 |
Total Mortgage Loans | 0% - 50% | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 49 | 51 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 49 | 51 |
Total Mortgage Loans | 50% - 70% | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 8,562 | 8,224 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 8,562 | 8,224 |
Total Mortgage Loans | 50% - 70% | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 5,052 | 5,020 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 5,052 | 5,020 |
Total Mortgage Loans | 50% - 70% | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 876 | 702 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 876 | 702 |
Total Mortgage Loans | 50% - 70% | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 1,532 | 1,392 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 1,532 | 1,392 |
Total Mortgage Loans | 50% - 70% | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 831 | 704 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 831 | 704 |
Total Mortgage Loans | 50% - 70% | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 237 | 375 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 237 | 375 |
Total Mortgage Loans | 50% - 70% | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 34 | 31 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 34 | 31 |
Total Mortgage Loans | 70% - 90% | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 868 | 891 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 868 | 891 |
Total Mortgage Loans | 70% - 90% | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 266 | 260 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 266 | 260 |
Total Mortgage Loans | 70% - 90% | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Mortgage Loans | 70% - 90% | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 117 | 117 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 117 | 117 |
Total Mortgage Loans | 70% - 90% | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 353 | 389 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 353 | 389 |
Total Mortgage Loans | 70% - 90% | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 132 | 125 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 132 | 125 |
Total Mortgage Loans | 70% - 90% | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Mortgage Loans | 90% plus | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 27 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 27 |
Total Mortgage Loans | 90% plus | Greater than 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Mortgage Loans | 90% plus | 1.8x to 2.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Mortgage Loans | 90% plus | 1.5x to 1.8x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Mortgage Loans | 90% plus | 1.2x to 1.5x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 27 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 27 |
Total Mortgage Loans | 90% plus | 1.0x to 1.2x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | 0 | 0 |
Total Mortgage Loans | 90% plus | Less than 1.0x | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Total Mortgage Loans | 0 | 0 |
Financing Receivable, Recorded Investment, Aging [Abstract] | ||
Total Financing Receivables | $ 0 | $ 0 |
DERIVATIVES - Derivatives by Category (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
Dec. 31, 2018 |
|
Derivatives, Fair Value [Line Items] | |||
Notional Amount | $ 99,602 | $ 81,636 | |
Fair Value, Assets Derivatives | 6,470 | 4,936 | |
Net Amount Presented in the Balance Sheets | 12,383 | 9,226 | |
Gains (Losses) Reported In Net Income (Loss) | (1,555) | $ (817) | |
Equity Futures | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 6,544 | 10,411 | |
Fair Value, Assets Derivatives | 0 | 0 | |
Net Amount Presented in the Balance Sheets | 0 | 0 | |
Gains (Losses) Reported In Net Income (Loss) | (738) | (29) | |
Equity Swaps | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 8,065 | 7,697 | |
Fair Value, Assets Derivatives | 6 | 140 | |
Net Amount Presented in the Balance Sheets | 371 | 168 | |
Gains (Losses) Reported In Net Income (Loss) | (973) | 64 | |
Equity Option | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 37,417 | 21,698 | |
Fair Value, Assets Derivatives | 3,474 | 2,119 | |
Net Amount Presented in the Balance Sheets | 1,310 | 1,163 | |
Gains (Losses) Reported In Net Income (Loss) | 1,101 | (15) | |
Interest Rate Swaps | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 28,153 | 27,003 | |
Fair Value, Assets Derivatives | 910 | 632 | |
Net Amount Presented in the Balance Sheets | 209 | 194 | |
Gains (Losses) Reported In Net Income (Loss) | 648 | (490) | |
Interest Rate Futures | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 16,385 | 11,448 | |
Fair Value, Assets Derivatives | 0 | 0 | |
Net Amount Presented in the Balance Sheets | 0 | 0 | |
Gains (Losses) Reported In Net Income (Loss) | 55 | 40 | |
Credit default swaps | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 1,242 | 1,282 | |
Fair Value, Assets Derivatives | 22 | 17 | |
Net Amount Presented in the Balance Sheets | 0 | 0 | |
Gains (Losses) Reported In Net Income (Loss) | 10 | 0 | |
Foreign Currency Contracts | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 1,796 | 2,097 | |
Fair Value, Assets Derivatives | 24 | 27 | |
Net Amount Presented in the Balance Sheets | 1 | 14 | |
Gains (Losses) Reported In Net Income (Loss) | 10 | (51) | |
Collateral | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 0 | 0 | |
Fair Value, Assets Derivatives | 16 | 7 | |
Net Amount Presented in the Balance Sheets | 0 | 5 | |
Gains (Losses) Reported In Net Income (Loss) | 0 | 0 | |
Margin | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 0 | 0 | |
Fair Value, Assets Derivatives | 9 | 3 | |
Net Amount Presented in the Balance Sheets | 2,556 | 1,564 | |
Gains (Losses) Reported In Net Income (Loss) | 0 | 0 | |
GMIB Reinsurance Contracts | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 0 | 0 | |
Fair Value, Assets Derivatives | 2,009 | 1,991 | |
Net Amount Presented in the Balance Sheets | 0 | 0 | |
Gains (Losses) Reported In Net Income (Loss) | 27 | (842) | |
GMxB Derivative Features’ Liability | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 0 | 0 | |
Fair Value, Assets Derivatives | 0 | 0 | |
Net Amount Presented in the Balance Sheets | 5,944 | 5,431 | |
Gains (Losses) Reported In Net Income (Loss) | (409) | 485 | |
SCS, SIO, MSO and IUL Indexed Features | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 0 | 0 | |
Fair Value, Assets Derivatives | 0 | 0 | |
Net Amount Presented in the Balance Sheets | 1,992 | $ 687 | |
Gains (Losses) Reported In Net Income (Loss) | $ (1,286) | $ 21 |
DERIVATIVES - Offsetting of Financial Assets and Liabilities and Derivative Instruments (Details) - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Dec. 31, 2018 |
Mar. 31, 2019 |
|
Securities Sold under Agreements to Repurchase | ||
Net Amount Presented in the Balance Sheets | $ 573 | $ 0 |
Interest expense, securities sold under agreements to repurchase | 2 | |
Total derivatives | ||
Assets | ||
Gross Amount Recognized | 2,946 | 4,460 |
Gross Amount Offset in the Balance Sheets | 2,912 | 4,399 |
Net Amount Presented in the Balance Sheets | 34 | 61 |
Liabilities | ||
Gross Amount Recognized | 3,109 | 4,399 |
Gross Amount Offset in the Balance Sheets | 2,912 | 4,352 |
Net Amount Presented in the Balance Sheets | 197 | 47 |
Other financial instruments | ||
Assets | ||
Gross Amount Recognized | 1,520 | 1,688 |
Gross Amount Offset in the Balance Sheets | 0 | 0 |
Net Amount Presented in the Balance Sheets | 1,520 | 1,688 |
Other invested assets | ||
Assets | ||
Gross Amount Recognized | 4,466 | 6,148 |
Gross Amount Offset in the Balance Sheets | 2,912 | 4,399 |
Net Amount Presented in the Balance Sheets | 1,554 | 1,749 |
Other financial liabilities | ||
Liabilities | ||
Gross Amount Recognized | 1,263 | 1,553 |
Gross Amount Offset in the Balance Sheets | 0 | 0 |
Net Amount Presented in the Balance Sheets | 1,263 | 1,553 |
Other liabilities | ||
Liabilities | ||
Gross Amount Recognized | 4,372 | 5,952 |
Gross Amount Offset in the Balance Sheets | 2,912 | 4,352 |
Net Amount Presented in the Balance Sheets | 1,460 | $ 1,600 |
Securities sold under agreement to repurchase | ||
Securities Sold under Agreements to Repurchase | ||
Gross Amount Recognized | 571 | |
Gross Amount Offset in Balance Sheets | 0 | |
Net Amount Presented in the Balance Sheets | $ 571 |
DERIVATIVES - Collateral Amounts Not Offset in the Consolidated Balance Sheets (Details) - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Dec. 31, 2018 |
Mar. 31, 2019 |
|
Assets | ||
Net Amount Presented in the Balance Sheets | $ 4,936 | $ 6,470 |
Liabilities | ||
Net Amount Presented in the Balance Sheets | 9,226 | 12,383 |
Securities Sold under Agreements to Repurchase | ||
Net Amount Presented in the Balance Sheets | 573 | 0 |
Interest expense, securities sold under agreements to repurchase | 2 | |
Total derivatives | ||
Assets | ||
Net Amount Presented in the Balance Sheets | 1,397 | 2,546 |
Collateral Held, Financial Instruments | 0 | 367 |
Collateral (Received) Held, Cash | 1,363 | 2,118 |
Net Amount | 34 | 61 |
Liabilities | ||
Net Amount Presented in the Balance Sheets | 197 | 47 |
Collateral Held, Financial Instruments | 0 | 0 |
Collateral Held, Cash | 0 | 0 |
Net Amount | 197 | 47 |
Other financial instruments | ||
Assets | ||
Net Amount Presented in the Balance Sheets | 1,520 | 1,688 |
Collateral Held, Financial Instruments | 0 | 0 |
Collateral (Received) Held, Cash | 0 | 0 |
Net Amount | 1,520 | 1,688 |
Other invested assets | ||
Assets | ||
Net Amount Presented in the Balance Sheets | 2,917 | 4,234 |
Collateral Held, Financial Instruments | 0 | 367 |
Collateral (Received) Held, Cash | 1,363 | 2,118 |
Net Amount | 1,554 | 1,749 |
Other financial liabilities | ||
Liabilities | ||
Net Amount Presented in the Balance Sheets | 1,263 | 1,553 |
Collateral Held, Financial Instruments | 0 | 0 |
Collateral Held, Cash | 0 | 0 |
Net Amount | 1,263 | 1,553 |
Other liabilities | ||
Liabilities | ||
Net Amount Presented in the Balance Sheets | 1,460 | 1,600 |
Collateral Held, Financial Instruments | 0 | 0 |
Collateral Held, Cash | 0 | 0 |
Net Amount | 1,460 | $ 1,600 |
Securities sold under agreement to repurchase | ||
Securities Sold under Agreements to Repurchase | ||
Net Amount Presented in the Balance Sheets | 571 | |
Collateral Held, Financial Instruments | (588) | |
Collateral Held, Cash | 0 | |
Net Amount | $ (17) |
DERIVATIVES - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Dec. 31, 2018 |
|
Derivative [Line Items] | ||
Proceeds from sale of treasury stock | $ 3,905 | |
Net Amount Presented in the Balance Sheets | 12,383 | $ 9,226 |
Derivative, Net Liability Position, Aggregate Fair Value | 9 | 3 |
Securities Sold under Agreements to Repurchase | 0 | 573 |
US Treasury Securities | ||
Derivative [Line Items] | ||
Marketable securities | 3,788 | |
Total Return Swap | ||
Derivative [Line Items] | ||
Marketable securities | 87 | |
Collateral Contracts [Member] | ||
Derivative [Line Items] | ||
Net Amount Presented in the Balance Sheets | 2,556 | $ 1,564 |
S&P 500, Russell 1000, NASDAQ 100 and Emerging Market Indices | ||
Derivative [Line Items] | ||
Initial margin requirements | 256 | |
Us Treasury Notes Ultra Long Bonds And Euro Dollar | ||
Derivative [Line Items] | ||
Initial margin requirements | 34 | |
Euro Stoxx, FTSE100, EAFE And Topix Indices | ||
Derivative [Line Items] | ||
Initial margin requirements | $ 25 |
DERIVATIVES - Repurchase Agreements (Details) $ in Millions |
12 Months Ended |
---|---|
Dec. 31, 2018
USD ($)
| |
Assets Sold under Agreements to Repurchase [Line Items] | |
Remaining Contractual Maturity of the Agreements | $ 571 |
Interest expense, securities sold under agreements to repurchase | 2 |
Overnight and Continuous | |
Assets Sold under Agreements to Repurchase [Line Items] | |
Remaining Contractual Maturity of the Agreements | 0 |
Up to 30 days | |
Assets Sold under Agreements to Repurchase [Line Items] | |
Remaining Contractual Maturity of the Agreements | 571 |
30–90 days | |
Assets Sold under Agreements to Repurchase [Line Items] | |
Remaining Contractual Maturity of the Agreements | 0 |
Greater Than 90 days | |
Assets Sold under Agreements to Repurchase [Line Items] | |
Remaining Contractual Maturity of the Agreements | 0 |
U.S. Treasury, government and agency | |
Assets Sold under Agreements to Repurchase [Line Items] | |
Remaining Contractual Maturity of the Agreements | 571 |
U.S. Treasury, government and agency | Overnight and Continuous | |
Assets Sold under Agreements to Repurchase [Line Items] | |
Remaining Contractual Maturity of the Agreements | 0 |
U.S. Treasury, government and agency | Up to 30 days | |
Assets Sold under Agreements to Repurchase [Line Items] | |
Remaining Contractual Maturity of the Agreements | 571 |
U.S. Treasury, government and agency | 30–90 days | |
Assets Sold under Agreements to Repurchase [Line Items] | |
Remaining Contractual Maturity of the Agreements | 0 |
U.S. Treasury, government and agency | Greater Than 90 days | |
Assets Sold under Agreements to Repurchase [Line Items] | |
Remaining Contractual Maturity of the Agreements | $ 0 |
CLOSED BLOCK - Summarized Financial Information for Closed Block (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
Mar. 31, 2018 |
Dec. 31, 2017 |
---|---|---|---|---|
Closed Block Liabilities: | ||||
Future policy benefits, policyholders’ account balances and other | $ 6,670 | $ 6,709 | ||
Policyholder dividend obligation | 0 | 0 | $ 0 | $ 19 |
Other liabilities | 70 | 47 | ||
Total Closed Block liabilities | 6,740 | 6,756 | ||
Assets Designated to the Closed Block: | ||||
Fixed maturities, available-for-sale, at fair value (amortized cost of $3,606 and $3,680) | 3,697 | 3,672 | ||
Fixed maturities, available for sale, amortized cost | 3,606 | 3,680 | ||
Mortgage loans on real estate, net of valuation allowance of $0 and $0 | 1,822 | 1,824 | ||
Mortgage loan valuation allowance | 0 | 0 | ||
Policy loans | 727 | 736 | ||
Cash and other invested assets | 142 | 76 | ||
Other assets | 171 | 179 | ||
Total assets designated to the Closed Block | 6,559 | 6,487 | ||
Excess of Closed Block liabilities over assets designated to the Closed Block | 181 | 269 | ||
Amounts included in accumulated other comprehensive income (loss): | ||||
Net unrealized investment gains (losses), net of policyholders’ dividend obligation of $0 and $0 | 105 | 8 | ||
Maximum future earnings to be recognized from Closed Block assets and liabilities | $ 286 | $ 277 |
CLOSED BLOCK - Revenues and Expenses (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Revenues: | ||
Premiums and other income | $ 48 | $ 51 |
Net investment income (loss) | 67 | 73 |
Investment gains (losses), net | (1) | 1 |
Total revenues | 114 | 125 |
Benefits and Other Deductions: | ||
Policyholders’ benefits and dividends | 121 | 126 |
Other operating costs and expenses | 1 | 1 |
Total benefits and other deductions | 122 | 127 |
Net income (loss) before income taxes | (8) | (2) |
Income tax (expense) benefit | (1) | 0 |
Net income (loss) | $ (9) | $ (2) |
CLOSED BLOCK - Reconciliation of Policyholder Dividend Obligation (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Movement in Closed Block Dividend Obligation [Roll Forward] | ||
Balances, beginning of year | $ 0 | $ 19 |
Unrealized investment gains (losses), net of DAC | 0 | (19) |
Balances, end of period | $ 0 | $ 0 |
INSURANCE LIABILITIES - GMDB and GMIB Liabilities and Other Policyholder's Liabilities (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
GMDB Direct [Member] | ||
Direct Liability | ||
Balance, beginning of period | $ 4,654 | $ 4,054 |
Paid guarantee benefits | (118) | (101) |
Other changes in reserves | 129 | 96 |
Balance, end of period | 4,665 | 4,049 |
GMDB | ||
Direct Liability | ||
Balance, beginning of period | (107) | (2,030) |
Paid guarantee benefits | 4 | (54) |
Other changes in reserves | 0 | 62 |
Balance, end of period | (103) | (2,022) |
GMIB Direct [Member] | ||
Direct Liability | ||
Balance, beginning of period | 3,741 | 4,754 |
Paid guarantee benefits | (56) | (32) |
Other changes in reserves | 55 | (139) |
Balance, end of period | 3,740 | 4,583 |
GMIB Ceded [Member] | ||
Direct Liability | ||
Balance, beginning of period | (1,991) | (10,488) |
Paid guarantee benefits | 21 | 27 |
Other changes in reserves | (39) | 788 |
Balance, end of period | $ (2,009) | $ (9,673) |
INSURANCE LIABILITIES - GMDB Reinsurance Ceded (Details) - GMDB - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Guaranteed Minimum Death Benefit Reinsurance Ceded [Roll Forward] | ||
Balance, beginning of year | $ 107 | $ 2,030 |
Paid guarantee benefits | 4 | (54) |
Other changes in reserve | 0 | (62) |
Balance, end of period | $ 103 | $ 2,022 |
INSURANCE LIABILITIES - Variable Annuity Contracts with GMDB and GMIB Features (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Dec. 31, 2018 |
|
GMDB | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account Value Invested In General Account | $ 14,517 | |
Account Value Invested In Separate Accounts | 90,343 | $ 83,154 |
Net Amount At Risk By Product And Guarantee, Account Value | 104,860 | |
Net amount at risk, gross | 20,700 | |
Net amount at risk, net of amounts reinsured | $ 20,084 | |
Average attained age of policyholders (in years) | 55 years 3 months 19 days | |
Percentage of policyholders over age 70 | 19.00% | |
GMDB | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates | 3.00% | |
GMDB | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates | 6.50% | |
GMDB | Return of Premium | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account Value Invested In General Account | $ 14,178 | |
Account Value Invested In Separate Accounts | 45,599 | |
Net Amount At Risk By Product And Guarantee, Account Value | 59,777 | |
Net amount at risk, gross | 143 | |
Net amount at risk, net of amounts reinsured | $ 143 | |
Average attained age of policyholders (in years) | 51 years 4 months 24 days | |
Percentage of policyholders over age 70 | 10.20% | |
GMDB | Ratchet | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account Value Invested In General Account | $ 98 | |
Account Value Invested In Separate Accounts | 9,001 | |
Net Amount At Risk By Product And Guarantee, Account Value | 9,099 | |
Net amount at risk, gross | 143 | |
Net amount at risk, net of amounts reinsured | $ 138 | |
Average attained age of policyholders (in years) | 67 years 1 month 6 days | |
Percentage of policyholders over age 70 | 43.50% | |
GMDB | Roll-Up | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account Value Invested In General Account | $ 60 | |
Account Value Invested In Separate Accounts | 3,134 | |
Net Amount At Risk By Product And Guarantee, Account Value | 3,194 | |
Net amount at risk, gross | 2,025 | |
Net amount at risk, net of amounts reinsured | $ 1,414 | |
Average attained age of policyholders (in years) | 73 years 9 months 18 days | |
Percentage of policyholders over age 70 | 66.10% | |
GMDB | Roll-Up | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates | 3.00% | |
GMDB | Roll-Up | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates | 6.00% | |
GMDB | Combo | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account Value Invested In General Account | $ 181 | |
Account Value Invested In Separate Accounts | 32,609 | |
Net Amount At Risk By Product And Guarantee, Account Value | 32,790 | |
Net amount at risk, gross | 18,389 | |
Net amount at risk, net of amounts reinsured | $ 18,389 | |
Average attained age of policyholders (in years) | 69 years 2 months 12 days | |
Percentage of policyholders over age 70 | 50.70% | |
GMDB | Combo | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates | 3.00% | |
GMDB | Combo | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates | 6.50% | |
GMIB | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account Value Invested In General Account | $ 264 | |
Account Value Invested In Separate Accounts | 57,668 | $ 52,835 |
Net Amount At Risk By Product And Guarantee, Account Value | 57,932 | |
Net amount at risk, gross | 9,185 | |
Net amount at risk, net of amounts reinsured | $ 7,796 | |
Average attained age of policyholders (in years) | 69 years | |
Weighted average years remaining until annuitization | 6 months | |
GMIB | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates | 3.00% | |
GMIB | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates | 6.50% | |
GMIB | Return of Premium | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account Value Invested In General Account | $ 0 | |
Account Value Invested In Separate Accounts | 0 | |
Net Amount At Risk By Product And Guarantee, Account Value | 0 | |
Net amount at risk, gross | 0 | |
Net amount at risk, net of amounts reinsured | 0 | |
GMIB | Ratchet | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account Value Invested In General Account | 0 | |
Account Value Invested In Separate Accounts | 0 | |
Net Amount At Risk By Product And Guarantee, Account Value | 0 | |
Net amount at risk, gross | 0 | |
Net amount at risk, net of amounts reinsured | 0 | |
GMIB | Roll-Up | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account Value Invested In General Account | 19 | |
Account Value Invested In Separate Accounts | 21,923 | |
Net Amount At Risk By Product And Guarantee, Account Value | 21,942 | |
Net amount at risk, gross | 898 | |
Net amount at risk, net of amounts reinsured | $ 281 | |
Average attained age of policyholders (in years) | 69 years | |
Weighted average years remaining until annuitization | 1 year 8 months 12 days | |
GMIB | Roll-Up | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates | 3.00% | |
GMIB | Roll-Up | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates | 6.00% | |
GMIB | Combo | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account Value Invested In General Account | $ 245 | |
Account Value Invested In Separate Accounts | 35,745 | |
Net Amount At Risk By Product And Guarantee, Account Value | 35,990 | |
Net amount at risk, gross | 8,287 | |
Net amount at risk, net of amounts reinsured | $ 7,515 | |
Average attained age of policyholders (in years) | 69 years | |
Weighted average years remaining until annuitization | 4 months 24 days | |
GMIB | Combo | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates | 3.00% | |
GMIB | Combo | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates | 6.50% |
INSURANCE LIABILITIES - Investment in Variable Insurance Trust Mutual Funds (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
---|---|---|
GMDB | ||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | ||
Investment in Variable Insurance Trust Mutual Funds | $ 90,343 | $ 83,154 |
GMDB | Equity | ||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | ||
Investment in Variable Insurance Trust Mutual Funds | 39,856 | 35,541 |
GMDB | Fixed income | ||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | ||
Investment in Variable Insurance Trust Mutual Funds | 5,206 | 5,173 |
GMDB | Balanced | ||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | ||
Investment in Variable Insurance Trust Mutual Funds | 44,433 | 41,588 |
GMDB | Other | ||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | ||
Investment in Variable Insurance Trust Mutual Funds | 848 | 852 |
GMIB | ||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | ||
Investment in Variable Insurance Trust Mutual Funds | 57,668 | 52,835 |
GMIB | Equity | ||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | ||
Investment in Variable Insurance Trust Mutual Funds | 17,692 | 15,759 |
GMIB | Fixed income | ||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | ||
Investment in Variable Insurance Trust Mutual Funds | 2,825 | 2,812 |
GMIB | Balanced | ||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | ||
Investment in Variable Insurance Trust Mutual Funds | 36,855 | 33,974 |
GMIB | Other | ||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | ||
Investment in Variable Insurance Trust Mutual Funds | $ 296 | $ 290 |
INSURANCE LIABILITIES - Summary of No-Lapse Guarantee Liabilities and Other Policyholder's Liabilities (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Direct Liability | ||
Direct Liability | ||
Balance, beginning of period | $ 787 | $ 692 |
Paid guaranteed benefits | (7) | (8) |
Other changes in reserves | 21 | 18 |
Balance, end of period | 801 | 702 |
Reinsurance Ceded | ||
Direct Liability | ||
Balance, beginning of period | (733) | (664) |
Paid guaranteed benefits | 0 | 0 |
Other changes in reserves | (11) | (11) |
Balance, end of period | (744) | (675) |
Net | ||
Direct Liability | ||
Balance, beginning of period | 54 | 28 |
Paid guaranteed benefits | (7) | (8) |
Other changes in reserves | 10 | 7 |
Balance, end of period | $ 57 | $ 27 |
FAIR VALUE DISCLOSURES - Assets and Liabilities Measure at Fair Value on Recurring Basis (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
---|---|---|
Assets | ||
Fair Value | $ 45,929 | $ 41,915 |
Trading account securities | 12,704 | 15,166 |
Fair Value, Measurements, Recurring | ||
Assets | ||
Fair Value | 45,929 | 41,915 |
Other equity investments | 12 | 12 |
Trading account securities | 12,704 | 15,166 |
Other invested assets | 2,762 | 1,827 |
Cash equivalents | 2,518 | 2,160 |
GMIB reinsurance contract asset | 2,009 | 1,991 |
Separate Accounts assets | 117,913 | 108,266 |
Total Assets | 183,847 | 171,337 |
Liabilities | ||
Total Liabilities | 7,936 | 6,118 |
Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Fair Value | 157 | 163 |
Other equity investments | 12 | 12 |
Trading account securities | 296 | 218 |
Other invested assets | 0 | 0 |
Cash equivalents | 2,518 | 2,160 |
GMIB reinsurance contract asset | 0 | 0 |
Separate Accounts assets | 114,780 | 105,159 |
Total Assets | 117,763 | 107,712 |
Liabilities | ||
Total Liabilities | 0 | 0 |
Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Fair Value | 44,030 | 40,021 |
Other equity investments | 0 | 0 |
Trading account securities | 12,408 | 14,919 |
Other invested assets | 2,744 | 1,808 |
Cash equivalents | 0 | 0 |
GMIB reinsurance contract asset | 0 | 0 |
Separate Accounts assets | 2,750 | 2,733 |
Total Assets | 61,932 | 59,481 |
Liabilities | ||
Total Liabilities | 1,992 | 687 |
Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Fair Value | 1,742 | 1,731 |
Other equity investments | 0 | 0 |
Trading account securities | 0 | 29 |
Other invested assets | 18 | 19 |
Cash equivalents | 0 | 0 |
GMIB reinsurance contract asset | 2,009 | 1,991 |
Separate Accounts assets | 383 | 374 |
Total Assets | 4,152 | 4,144 |
Liabilities | ||
Total Liabilities | 5,944 | 5,431 |
Redeemable preferred stock | ||
Assets | ||
Fair Value | 435 | 439 |
Redeemable preferred stock | Fair Value, Measurements, Recurring | ||
Assets | ||
Fair Value | 435 | 439 |
Redeemable preferred stock | Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Fair Value | 157 | 163 |
Redeemable preferred stock | Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Fair Value | 278 | 276 |
Redeemable preferred stock | Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Fair Value | 0 | 0 |
Asset- backed | ||
Assets | ||
Fair Value | 605 | 590 |
Asset- backed | Fair Value, Measurements, Recurring | ||
Assets | ||
Fair Value | 605 | 590 |
Asset- backed | Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Fair Value | 0 | 0 |
Asset- backed | Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Fair Value | 71 | 71 |
Asset- backed | Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Fair Value | 534 | 519 |
Foreign governments | ||
Assets | ||
Fair Value | 498 | 519 |
Foreign governments | Fair Value, Measurements, Recurring | ||
Assets | ||
Fair Value | 498 | 519 |
Foreign governments | Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Fair Value | 0 | 0 |
Foreign governments | Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Fair Value | 498 | 519 |
Foreign governments | Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Fair Value | 0 | 0 |
State and Political Sub-divisions | ||
Assets | ||
Fair Value | 463 | 454 |
State and Political Sub-divisions | Fair Value, Measurements, Recurring | ||
Assets | ||
Fair Value | 463 | 454 |
State and Political Sub-divisions | Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Fair Value | 0 | 0 |
State and Political Sub-divisions | Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Fair Value | 424 | 416 |
State and Political Sub-divisions | Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Fair Value | 39 | 38 |
U.S. Treasury, government and agency | ||
Assets | ||
Fair Value | 12,968 | 13,335 |
U.S. Treasury, government and agency | Fair Value, Measurements, Recurring | ||
Assets | ||
Fair Value | 12,968 | 13,335 |
U.S. Treasury, government and agency | Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Fair Value | 0 | 0 |
U.S. Treasury, government and agency | Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Fair Value | 12,968 | 13,335 |
U.S. Treasury, government and agency | Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Fair Value | 0 | 0 |
Public Corporate [Member] | Fair Value, Measurements, Recurring | ||
Assets | ||
Fair Value | 30,765 | 26,376 |
Public Corporate [Member] | Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Fair Value | 0 | 0 |
Public Corporate [Member] | Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Fair Value | 29,596 | 25,202 |
Public Corporate [Member] | Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Fair Value | 1,169 | 1,174 |
Residential Mortgage Backed Securities [Member] | ||
Assets | ||
Fair Value | 195 | 202 |
Residential Mortgage Backed Securities [Member] | Fair Value, Measurements, Recurring | ||
Assets | ||
Fair Value | 195 | 202 |
Residential Mortgage Backed Securities [Member] | Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Fair Value | 0 | 0 |
Residential Mortgage Backed Securities [Member] | Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Fair Value | 195 | 202 |
Residential Mortgage Backed Securities [Member] | Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Fair Value | 0 | 0 |
Short-term investments | Fair Value, Measurements, Recurring | ||
Assets | ||
Other invested assets | 198 | 412 |
Short-term investments | Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Other invested assets | 0 | 0 |
Short-term investments | Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Other invested assets | 198 | 412 |
Short-term investments | Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Other invested assets | 0 | 0 |
Assets of consolidated VIEs/VOEs | Fair Value, Measurements, Recurring | ||
Assets | ||
Other invested assets | 18 | 19 |
Assets of consolidated VIEs/VOEs | Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Other invested assets | 0 | 0 |
Assets of consolidated VIEs/VOEs | Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Other invested assets | 0 | 0 |
Assets of consolidated VIEs/VOEs | Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Other invested assets | 18 | 19 |
Swaps | Fair Value, Measurements, Recurring | ||
Assets | ||
Other invested assets | 360 | 423 |
Swaps | Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Other invested assets | 0 | 0 |
Swaps | Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Other invested assets | 360 | 423 |
Swaps | Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Other invested assets | 0 | 0 |
Credit default swaps | Fair Value, Measurements, Recurring | ||
Assets | ||
Other invested assets | 22 | 17 |
Credit default swaps | Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Other invested assets | 0 | 0 |
Credit default swaps | Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Other invested assets | 22 | 17 |
Credit default swaps | Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Other invested assets | 0 | 0 |
Options | Fair Value, Measurements, Recurring | ||
Assets | ||
Other invested assets | 2,164 | 956 |
Options | Fair Value, Measurements, Recurring | Level 1 | ||
Assets | ||
Other invested assets | 0 | 0 |
Options | Fair Value, Measurements, Recurring | Level 2 | ||
Assets | ||
Other invested assets | 2,164 | 956 |
Options | Fair Value, Measurements, Recurring | Level 3 | ||
Assets | ||
Other invested assets | 0 | 0 |
GMxB derivative features’ liability | Fair Value, Measurements, Recurring | ||
Liabilities | ||
Features’ liability | 5,944 | 5,431 |
GMxB derivative features’ liability | Fair Value, Measurements, Recurring | Level 1 | ||
Liabilities | ||
Features’ liability | 0 | 0 |
GMxB derivative features’ liability | Fair Value, Measurements, Recurring | Level 2 | ||
Liabilities | ||
Features’ liability | 0 | 0 |
GMxB derivative features’ liability | Fair Value, Measurements, Recurring | Level 3 | ||
Liabilities | ||
Features’ liability | 5,944 | 5,431 |
SCS, SIO, MSO and IUL indexed features’ liability | Fair Value, Measurements, Recurring | ||
Liabilities | ||
Features’ liability | 1,992 | 687 |
SCS, SIO, MSO and IUL indexed features’ liability | Fair Value, Measurements, Recurring | Level 1 | ||
Liabilities | ||
Features’ liability | 0 | 0 |
SCS, SIO, MSO and IUL indexed features’ liability | Fair Value, Measurements, Recurring | Level 2 | ||
Liabilities | ||
Features’ liability | 1,992 | 687 |
SCS, SIO, MSO and IUL indexed features’ liability | Fair Value, Measurements, Recurring | Level 3 | ||
Liabilities | ||
Features’ liability | $ 0 | $ 0 |
FAIR VALUE DISCLOSURES - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
Dec. 31, 2018 |
|
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items] | |||
Fair value adjustments on GMIB asset | $ 148 | $ 184 | |
Transfers out of Level 3 | 69 | 16 | |
Transfers into level 3 | $ 17 | $ 67 | |
Transfers out of Levels 2 and 3 to total equity (as a percent) | 0.70% | 0.40% | |
Level 3 | Corporate | Matrix pricing model | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items] | |||
Fair value of privately placed, available-for-sale corporate debt securities classified as Level 3 | $ 96 | $ 93 | |
Level 3 | Separate Accounts Assets | Third party appraisal | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items] | |||
Fair value of privately placed, available-for-sale corporate debt securities classified as Level 3 | 359 | 352 | |
Fair Value, Measurements, Nonrecurring | Level 3 | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items] | |||
Fair Value Measurements Not Included In Quantitative Information About Level 3 Fair Value Measurements | $ 796 | $ 826 |
FAIR VALUE DISCLOSURES - Level 3 Unobservable Input Reconciliation (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Total gains (losses), realized and unrealized, included in: | ||
Transfers into level 3 | $ 17 | $ 67 |
Transfers out of Level 3 | (69) | (16) |
Corporate | Level 3 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Opening Balance | 1,174 | 1,139 |
Total gains (losses), realized and unrealized, included in: | ||
Investment Income, Net | 1 | |
Net investment income (loss) | 2 | |
Other comprehensive income (loss) | 9 | (20) |
Purchases | 70 | 173 |
Sales | (33) | 116 |
Transfers into level 3 | 17 | 67 |
Transfers out of Level 3 | (69) | 16 |
Closing Balance | 1,169 | 1,229 |
Asset- backed | Level 3 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Opening Balance | 519 | 8 |
Total gains (losses), realized and unrealized, included in: | ||
Investment Income, Net | 0 | |
Net investment income (loss) | 0 | |
Other comprehensive income (loss) | 4 | 0 |
Purchases | 11 | 0 |
Sales | 0 | 1 |
Transfers into level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Closing Balance | 534 | 7 |
State and Political Sub-divisions | Level 3 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Opening Balance | 38 | 40 |
Total gains (losses), realized and unrealized, included in: | ||
Investment Income, Net | 0 | |
Net investment income (loss) | 0 | |
Other comprehensive income (loss) | 1 | (1) |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Transfers into level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Closing Balance | 39 | 39 |
Other Equity Investments | Level 3 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Opening Balance | 48 | 25 |
Total gains (losses), realized and unrealized, included in: | ||
Investment gains (losses), net | 0 | 0 |
Net derivative gains (losses) | 0 | 0 |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Nonperformance Risk | 0 | 0 |
Subtotal | 0 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Settlements | 0 | 0 |
Activity related to consolidated VIEs | (1) | 1 |
Transfers into level 3 | 5 | |
Transfers out of Level 3 | (29) | |
Closing Balance | 18 | 31 |
GMIB Reinsurance Asset | Level 3 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Opening Balance | 1,991 | 10,488 |
Total gains (losses), realized and unrealized, included in: | ||
Investment gains (losses), net | 0 | 0 |
Net derivative gains (losses) | (13) | (854) |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Nonperformance Risk | 40 | 13 |
Subtotal | 27 | (841) |
Purchases | 12 | 54 |
Sales | (21) | 27 |
Settlements | 0 | 0 |
Activity related to consolidated VIEs | 0 | 0 |
Transfers into level 3 | 0 | |
Transfers out of Level 3 | 0 | |
Closing Balance | 2,009 | 9,674 |
Separate Accounts Assets | Level 3 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Opening Balance | 374 | 349 |
Total gains (losses), realized and unrealized, included in: | ||
Investment gains (losses), net | 7 | 7 |
Net derivative gains (losses) | 0 | 0 |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Nonperformance Risk | 0 | 0 |
Subtotal | 7 | 7 |
Purchases | 4 | 3 |
Sales | 0 | 1 |
Settlements | (1) | 1 |
Activity related to consolidated VIEs | 0 | 0 |
Transfers into level 3 | 0 | |
Transfers out of Level 3 | (1) | |
Closing Balance | 383 | 357 |
GMxB derivative features liability | Level 3 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Opening Balance | (5,431) | |
Total gains (losses), realized and unrealized, included in: | ||
Investment gains (losses), net | 0 | |
Net derivative gains (losses) | 51 | |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Nonperformance Risk | (460) | |
Subtotal | (409) | |
Purchases | (107) | |
Sales | 3 | |
Settlements | 0 | |
Activity related to consolidated VIEs | 0 | |
Transfers out of Level 3 | 0 | |
GMxB Derivative Features Liability | Level 3 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Opening Balance | (4,256) | |
Total gains (losses), realized and unrealized, included in: | ||
Investment gains (losses), net | 0 | |
Net derivative gains (losses) | 436 | |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Nonperformance Risk | 49 | |
Subtotal | 485 | |
Purchases | (93) | |
Sales | (2) | |
Settlements | 0 | |
Activity related to consolidated VIEs | 0 | |
Transfers into level 3 | 0 | |
Closing Balance | $ (5,944) | $ (3,862) |
FAIR VALUE DISCLOSURES - Unrealized Gains (Losses) for Level 3 Still Held (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Change in Accounting Estimate [Line Items] | ||
Investment Gains (Losses), Net | $ (8) | $ 87 |
Level 3 | Corporate | ||
Change in Accounting Estimate [Line Items] | ||
OCI | 9 | (20) |
Level 3 | States and political subdivisions | ||
Change in Accounting Estimate [Line Items] | ||
OCI | 1 | (1) |
Level 3 | Asset-backed | ||
Change in Accounting Estimate [Line Items] | ||
OCI | 4 | 0 |
Level 3 | GMIB reinsurance contracts | ||
Change in Accounting Estimate [Line Items] | ||
Net Derivative Gains (Losses) | 0 | 0 |
Level 3 | Separate Accounts Assets | ||
Change in Accounting Estimate [Line Items] | ||
Net Derivative Gains (Losses) | 7 | 7 |
Level 3 | GMxB derivative features liability | ||
Change in Accounting Estimate [Line Items] | ||
Net Derivative Gains (Losses) | 0 | |
Level 3 | Continuing Operations | Corporate | ||
Change in Accounting Estimate [Line Items] | ||
Investment Gains (Losses), Net | 0 | 0 |
Net Derivative Gains (Losses) | 0 | 0 |
OCI | 9 | (19) |
Level 3 | Continuing Operations | States and political subdivisions | ||
Change in Accounting Estimate [Line Items] | ||
Investment Gains (Losses), Net | 0 | 0 |
Net Derivative Gains (Losses) | 0 | 0 |
OCI | 1 | (1) |
Level 3 | Continuing Operations | Asset-backed | ||
Change in Accounting Estimate [Line Items] | ||
Investment Gains (Losses), Net | 0 | |
Net Derivative Gains (Losses) | 0 | |
OCI | 4 | |
Level 3 | Continuing Operations | Subtotal | ||
Change in Accounting Estimate [Line Items] | ||
Investment Gains (Losses), Net | 0 | 0 |
Net Derivative Gains (Losses) | 0 | 0 |
OCI | 14 | (20) |
Level 3 | Continuing Operations | GMIB reinsurance contracts | ||
Change in Accounting Estimate [Line Items] | ||
Investment Gains (Losses), Net | 0 | 0 |
Net Derivative Gains (Losses) | 27 | (842) |
OCI | 0 | 0 |
Level 3 | Continuing Operations | Separate Accounts Assets | ||
Change in Accounting Estimate [Line Items] | ||
Investment Gains (Losses), Net | 7 | 7 |
Net Derivative Gains (Losses) | 0 | 0 |
OCI | 0 | 0 |
Level 3 | Continuing Operations | GMxB derivative features liability | ||
Change in Accounting Estimate [Line Items] | ||
Investment Gains (Losses), Net | 0 | 0 |
Net Derivative Gains (Losses) | (409) | 440 |
OCI | 0 | 0 |
Level 3 | Continuing Operations | Total | ||
Change in Accounting Estimate [Line Items] | ||
Investment Gains (Losses), Net | 7 | 7 |
Net Derivative Gains (Losses) | (382) | (402) |
OCI | $ 14 | $ (20) |
FAIR VALUE DISCLOSURES - Quantative Information About Level 3 (Details) |
3 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2019
USD ($)
|
Mar. 31, 2018
USD ($)
|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2017
USD ($)
|
|
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Investment Gains (Losses), Net | $ (8,000,000) | $ 87,000,000 | ||
Level 3 | Corporate | Matrix pricing model | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Assets, fair value | 96,000,000 | $ 93,000,000 | ||
Level 3 | Corporate | Market comparable companies | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Assets, fair value | $ 891,000,000 | 881,000,000 | ||
Level 3 | Corporate | Minimum | Matrix pricing model | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Spread over benchmark | 0.0015 | |||
Level 3 | Corporate | Maximum | Matrix pricing model | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Spread over benchmark | 0.0580 | |||
Level 3 | Corporate | Weighted Average | Matrix pricing model | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Spread over benchmark | 0.0109 | |||
Level 3 | Separate Accounts assets | Third party appraisal | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Assets, fair value | $ 359,000,000 | 352,000,000 | ||
Level 3 | Separate Accounts assets | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Assets, fair value | $ 1,000,000 | $ 1,000,000 | ||
Spread over benchmark | 0.0248 | 0.0248 | ||
Level 3 | GMIB reinsurance contracts | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Assets, fair value | $ 2,009,000,000 | $ 1,991,000,000 | ||
Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.01 | |||
Servicing asset, non-performance risk | 0.0052 | 0.0074 | ||
Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.0627 | |||
Servicing asset, non-performance risk | 0.0129 | 0.0159 | ||
Level 3 | GMIBNLG | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, non-performance liability | 0.010 | 0.019 | ||
Withdrawal rate | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.000 | 0.000 | ||
Withdrawal rate | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.080 | 0.080 | ||
Withdrawal rate | Level 3 | GMIBNLG | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.000 | 0.000 | ||
Withdrawal rate | Level 3 | GMIBNLG | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.12144 | 0.121 | ||
Withdrawal rate | Level 3 | GWBL/GMWB | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.000 | 0.000 | ||
Withdrawal rate | Level 3 | GWBL/GMWB | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.070 | 0.070 | ||
Withdrawal rate | Level 3 | GIB | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0 | 0.000 | ||
Withdrawal rate | Level 3 | GIB | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.080 | 0.080 | ||
EBITDA multiple | Level 3 | Corporate | Minimum | Market comparable companies | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Equity security, measurement input | 3.9 | 4.1 | ||
EBITDA multiple | Level 3 | Corporate | Maximum | Market comparable companies | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Equity security, measurement input | 25.5 | 37.8 | ||
EBITDA multiple | Level 3 | Corporate | Weighted Average | Market comparable companies | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Equity security, measurement input | 12.7 | 12.1 | ||
Discount rate | Level 3 | Corporate | Minimum | Market comparable companies | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Equity security, measurement input | 0.061 | 0.064 | ||
Discount rate | Level 3 | Corporate | Maximum | Market comparable companies | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Equity security, measurement input | 0.165 | 0.165 | ||
Discount rate | Level 3 | Corporate | Weighted Average | Market comparable companies | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Equity security, measurement input | 0.106 | 0.107 | ||
Discount rate | Level 3 | Separate Accounts assets | Third party appraisal | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.064 | 0.065 | ||
Discount rate | Level 3 | Separate Accounts assets | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.048 | 0.051 | ||
Cash flow multiples | Level 3 | Corporate | Minimum | Market comparable companies | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Equity security, measurement input | 1.6 | 1.8 | ||
Cash flow multiples | Level 3 | Corporate | Maximum | Market comparable companies | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Equity security, measurement input | 18.0 | 18.0 | ||
Cash flow multiples | Level 3 | Corporate | Weighted Average | Market comparable companies | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Equity security, measurement input | 11.4 | 11.4 | ||
Cap rate | Level 3 | Separate Accounts assets | Third party appraisal | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.044 | 0.044 | ||
Exit capitalization rate | Level 3 | Separate Accounts assets | Third party appraisal | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.055 | 0.056 | ||
Utilization rate | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0 | 0.000 | ||
Utilization rate | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.160 | 0.160 | ||
Utilization rate | Level 3 | GMIBNLG | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.000 | 0.000 | ||
Utilization rate | Level 3 | GMIBNLG | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.160 | 1.000 | ||
Utilization rate | Level 3 | GWBL/GMWB | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 1.00 | 1.00 | ||
Utilization rate | Level 3 | GIB | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0 | 0.000 | ||
Utilization rate | Level 3 | GIB | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.160 | 0.160 | ||
Equity volatility | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.070 | 0.100 | ||
Equity volatility | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.320 | 0.340 | ||
Equity volatility | Level 3 | GMIBNLG | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.200 | |||
Equity volatility | Level 3 | GMIBNLG | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.008 | 0.008 | ||
Equity volatility | Level 3 | GMIBNLG | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.262 | 0.262 | ||
Equity volatility | Level 3 | GWBL/GMWB | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.070 | 0.100 | ||
Equity volatility | Level 3 | GWBL/GMWB | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.320 | 0.340 | ||
Equity volatility | Level 3 | GIB | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.070 | 0.100 | ||
Equity volatility | Level 3 | GIB | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.320 | 0.340 | ||
Equity volatility | Level 3 | GMAB | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.070 | 0.100 | ||
Equity volatility | Level 3 | GMAB | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.320 | 0.340 | ||
Forfeiture rate | Level 3 | GMIBNLG | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.0055 | |||
Forfeiture rate | Level 3 | GMIBNLG | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.021 | |||
Lapse rate | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.010 | |||
Lapse rate | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.0627 | |||
Lapse rate | Level 3 | GWBL/GMWB | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.005 | 0.005 | ||
Lapse rate | Level 3 | GWBL/GMWB | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.057 | 0.057 | ||
Lapse rate | Level 3 | GIB | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.005 | 0.005 | ||
Lapse rate | Level 3 | GIB | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.057 | 0.057 | ||
Lapse rate | Level 3 | GMAB | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.005 | 0.010 | ||
Lapse rate | Level 3 | GMAB | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.110 | 0.057 | ||
Age 0-40 | Mortality Rate | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.0001 | 0.0001 | ||
Age 0-40 | Mortality Rate | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.0018 | 0.0018 | ||
Age 0-40 | Mortality Rate | Level 3 | GMIBNLG | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.0001 | 0.0001 | ||
Age 0-40 | Mortality Rate | Level 3 | GMIBNLG | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.0019 | 0.0019 | ||
Age 41-60 | Mortality Rate | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.0007 | 0.0007 | ||
Age 41-60 | Mortality Rate | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.0054 | 0.0054 | ||
Age 41-60 | Mortality Rate | Level 3 | GMIBNLG | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.0006 | 0.0006 | ||
Age 41-60 | Mortality Rate | Level 3 | GMIBNLG | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.0053 | 0.0053 | ||
Age 61-115 | Mortality Rate | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.0042 | 0.0042 | ||
Age 61-115 | Mortality Rate | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing asset, measurement input | 0.420 | 0.420 | ||
Age 61-115 | Mortality Rate | Level 3 | GMIBNLG | Minimum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.0041 | 0.0041 | ||
Age 61-115 | Mortality Rate | Level 3 | GMIBNLG | Maximum | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Servicing liability, measurement input | 0.412 | 0.412 | ||
GIB | Level 3 | GIB | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Embedded Derivative, Fair Value of Embedded Derivative Liability | $ (44) | $ (48,000,000) | ||
GMIBNLG | Level 3 | GMIBNLG | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Embedded Derivative, Fair Value of Embedded Derivative Liability | 5,847 | 5,341,000,000 | ||
GMxB derivative features liability | Level 3 | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Net Derivative Gains (Losses) | 0 | |||
Assets, fair value | (5,431,000,000) | |||
Separate Accounts assets | Level 3 | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Net Derivative Gains (Losses) | 7,000,000 | 7,000,000 | ||
Assets, fair value | 383,000,000 | 357,000,000 | 374,000,000 | $ 349,000,000 |
State and Political Sub-divisions | Level 3 | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
OCI | 1,000,000 | (1,000,000) | ||
Assets, fair value | 39,000,000 | 39,000,000 | 38,000,000 | 40,000,000 |
Corporate | Level 3 | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
OCI | 9,000,000 | (20,000,000) | ||
Assets, fair value | 1,169,000,000 | 1,229,000,000 | 1,174,000,000 | 1,139,000,000 |
GMIB reinsurance contracts | Level 3 | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Net Derivative Gains (Losses) | 0 | 0 | ||
Assets, fair value | 2,009,000,000 | 9,674,000,000 | 1,991,000,000 | $ 10,488,000,000 |
GWBL/GMWB | Level 3 | GWBL/GMWB | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Embedded Derivative, Fair Value of Embedded Derivative Liability | 137 | 130,000,000 | ||
GMAB | Level 3 | GMAB | Discounted cash flow | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Embedded Derivative, Fair Value of Embedded Derivative Liability | 4 | $ 7,000,000 | ||
Continuing Operations | GMxB derivative features liability | Level 3 | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Investment Gains (Losses), Net | 0 | 0 | ||
Net Derivative Gains (Losses) | (409,000,000) | 440,000,000 | ||
OCI | 0 | 0 | ||
Continuing Operations | Separate Accounts assets | Level 3 | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Investment Gains (Losses), Net | 7,000,000 | 7,000,000 | ||
Net Derivative Gains (Losses) | 0 | 0 | ||
OCI | 0 | 0 | ||
Continuing Operations | State and Political Sub-divisions | Level 3 | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Investment Gains (Losses), Net | 0 | 0 | ||
Net Derivative Gains (Losses) | 0 | 0 | ||
OCI | 1,000,000 | (1,000,000) | ||
Continuing Operations | Corporate | Level 3 | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Investment Gains (Losses), Net | 0 | 0 | ||
Net Derivative Gains (Losses) | 0 | 0 | ||
OCI | 9,000,000 | (19,000,000) | ||
Continuing Operations | Subtotal | Level 3 | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Investment Gains (Losses), Net | 0 | 0 | ||
Net Derivative Gains (Losses) | 0 | 0 | ||
OCI | 14,000,000 | (20,000,000) | ||
Continuing Operations | GMIB reinsurance contracts | Level 3 | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Investment Gains (Losses), Net | 0 | 0 | ||
Net Derivative Gains (Losses) | 27,000,000 | (842,000,000) | ||
OCI | 0 | 0 | ||
Continuing Operations | Total | Level 3 | ||||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | ||||
Investment Gains (Losses), Net | 7,000,000 | 7,000,000 | ||
Net Derivative Gains (Losses) | (382,000,000) | (402,000,000) | ||
OCI | $ 14,000,000 | $ (20,000,000) |
FAIR VALUE DISCLOSURES - Carrying Values and Fair Values of Financial Instruments (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
---|---|---|
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Mortgage loans on real estate | $ 12,100 | $ 11,818 |
Loans to affiliates | 600 | 600 |
Policyholders’ liabilities: Investment contracts | 48,593 | 46,403 |
Policy loans | 3,253 | 3,267 |
Loans from affiliates | 0 | 572 |
Separate Accounts liabilities | 118,130 | 108,487 |
Carrying Value | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Mortgage loans on real estate | 12,100 | 11,818 |
FHLBNY Funding Agreements | 4,001 | 4,002 |
Loans to affiliates | 600 | 600 |
Policyholders’ liabilities: Investment contracts | 1,983 | 1,974 |
Policy loans | 3,253 | 3,267 |
Loans from affiliates | 572 | |
Separate Accounts liabilities | 8,173 | 7,406 |
Fair Value | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Mortgage loans on real estate | 12,002 | 11,478 |
FHLBNY Funding Agreements | 4,011 | 3,956 |
Loans to affiliates | 610 | 603 |
Policyholders’ liabilities: Investment contracts | 2,094 | 2,015 |
Policy loans | 4,064 | 3,944 |
Loans from affiliates | 572 | |
Separate Accounts liabilities | 8,173 | 7,406 |
Fair Value | Level 1 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Mortgage loans on real estate | 0 | 0 |
FHLBNY Funding Agreements | 0 | 0 |
Loans to affiliates | 0 | 0 |
Policyholders’ liabilities: Investment contracts | 0 | 0 |
Policy loans | 0 | 0 |
Loans from affiliates | 0 | |
Separate Accounts liabilities | 0 | 0 |
Fair Value | Level 2 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Mortgage loans on real estate | 0 | 0 |
FHLBNY Funding Agreements | 4,011 | 3,956 |
Loans to affiliates | 610 | 603 |
Policyholders’ liabilities: Investment contracts | 0 | 0 |
Policy loans | 0 | 0 |
Loans from affiliates | 572 | |
Separate Accounts liabilities | 0 | 0 |
Fair Value | Level 3 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Mortgage loans on real estate | 12,002 | 11,478 |
FHLBNY Funding Agreements | 0 | 0 |
Loans to affiliates | 0 | 0 |
Policyholders’ liabilities: Investment contracts | 2,094 | 2,015 |
Policy loans | 4,064 | 3,944 |
Loans from affiliates | 0 | |
Separate Accounts liabilities | $ 8,173 | $ 7,406 |
LEASES - Balance Sheet Classification (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Jan. 01, 2019 |
---|---|---|
Leases [Abstract] | ||
Operating lease asset | $ 328 | $ 347 |
Operating lease liability | $ 422 | $ 439 |
LEASES - Lease Costs (Details) $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2019
USD ($)
| |
Leases [Abstract] | |
Operating lease cost | $ 53 |
Variable operating lease cost | 3 |
Sublease income | (4) |
Short-term lease expense | $ 1 |
LEASES - Lease Maturities (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Jan. 01, 2019 |
Dec. 31, 2018 |
---|---|---|---|
Lessee, Lease, Description [Line Items] | |||
Leases not yet commenced, amount | $ 10 | ||
Operating Leases: | |||
2019 | 86 | ||
2020 | 89 | ||
2021 | 84 | ||
2022 | 81 | ||
2023 | 76 | ||
Thereafter | 84 | ||
Total lease payments | 500 | ||
Less: Interest | (78) | ||
Present value of lease liabilities | $ 422 | $ 439 | |
Lease obligation under ASC 840 | |||
2019 | $ 81 | ||
2020 | 74 | ||
2021 | 69 | ||
2022 | 67 | ||
2023 | 63 | ||
Thereafter | $ 66 | ||
Minimum | |||
Lessee, Lease, Description [Line Items] | |||
Operating leases not yet commenced, term | 5 years | ||
Maximum | |||
Lessee, Lease, Description [Line Items] | |||
Operating leases not yet commenced, term | 10 years |
LEASES - Supplemental Lease Information (Details) $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2019
USD ($)
| |
Leases [Abstract] | |
Weighted-average remaining operating lease term (years) | 6 years |
Weighted-average discount rate for operating leases | 3.15% |
Operating cash flows from operating leases | $ 21 |
Leased assets obtained in exchange for new operating lease liabilities | $ 1 |
LEASES - Narrative (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Jan. 01, 2019 |
---|---|---|
Lessee, Lease, Description [Line Items] | ||
Leases not yet commenced, amount | $ 10 | |
Weighted-average remaining operating lease term (years) | 6 years | |
Operating lease liability | $ 422 | $ 439 |
Minimum | ||
Lessee, Lease, Description [Line Items] | ||
Weighted-average remaining operating lease term (years) | 1 year | |
Maximum | ||
Lessee, Lease, Description [Line Items] | ||
Weighted-average remaining operating lease term (years) | 12 years |
RELATED PARTY TRANSACTIONS - TEXTUAL (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Dec. 28, 2018 |
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Senior Surplus Notes | |||
Related Party Transaction [Line Items] | |||
Extraordinary cash dividend | $ 572 | ||
Related party transaction, rate (as a percent) | 3.75% | ||
Related party expense | $ 4 | ||
AllianceBernstein | Affiliated Entity | |||
Related Party Transaction [Line Items] | |||
Related party expense | $ 24 | $ 21 |
EQUITY - Cumulative Gains (Losses) (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
Mar. 31, 2018 |
Dec. 31, 2017 |
---|---|---|---|---|
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Defined benefit pension plans | $ 7 | $ 5 | ||
Accumulated other comprehensive income | 12,370 | $ 12,428 | 18,492 | $ 19,492 |
Less: Accumulated other comprehensive (income) loss attributable to discontinued operations, net of noncontrolling interest | 0 | (24) | ||
Unrealized gains (losses) on investments | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Unrealized gains (losses) on investments | 280 | (129) | ||
Total accumulated other comprehensive income (loss) from continuing operations | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Accumulated other comprehensive income | 273 | (134) | ||
Accumulated other comprehensive income (loss) attributable to AXA Equitable | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Accumulated other comprehensive income | $ 273 | $ (491) | $ (158) | $ 598 |
EQUITY - Components of OCI, Net of Taxes (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ||
Net unrealized gains (losses) arising during the period | $ 1,243 | $ (984) |
(Gains) losses reclassified into net income (loss) during the period | 6 | (71) |
Net unrealized gains (losses) on investments | 1,249 | (1,055) |
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other | 485 | (313) |
Less: Reclassification adjustments to Net income (loss) for: | 764 | (742) |
Amortization of net (gains) losses included in net periodic cost | 0 | (4) |
Changes in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment | 0 | (4) |
Total other comprehensive income (loss), net of income taxes from continuing operations | 764 | (746) |
Other comprehensive income (loss) from discontinued operations, net of income taxes | 0 | (10) |
Other comprehensive income (loss) attributable to AXA Equitable | 764 | (756) |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Change in unrealized gains (losses), net of adjustments, tax | 200 | (197) |
Change in defined benefit plans, tax | 0 | 0 |
Net unrealized gains (losses) on investments | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Reclassification from AOCI, current period, tax | $ 1 | $ (19) |
COMMITMENT AND CONTINGENT LIABILITIES - Obligations Under Funding Agreements (Details) $ / policy in Millions, $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2019
USD ($)
|
Dec. 31, 2018
USD ($)
|
Feb. 29, 2016
$ / policy
|
|
Restructuring Cost and Reserve [Line Items] | |||
Funding Agreement, Difference Related To Remaining Amortization | $ 11 | $ 12 | |
Unaccrued amounts of reasonably possible range of losses | 95 | ||
Advances from Federal Home Loan Banks | 3,990 | ||
Proceeds from FHLBank Borrowings, Financing Activities | 4,470 | ||
Payments of FHLBank Borrowings, Financing Activities | 4,470 | ||
Federal Home Loan Bank of New York Short-Term Funding Agreements Maturing in Less than One Month | |||
Restructuring Cost and Reserve [Line Items] | |||
Advances from Federal Home Loan Banks | 1,640 | ||
Proceeds from FHLBank Borrowings, Financing Activities | 4,470 | ||
Payments of FHLBank Borrowings, Financing Activities | 4,470 | ||
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Less than Five Years | |||
Restructuring Cost and Reserve [Line Items] | |||
Advances from Federal Home Loan Banks | 1,569 | ||
Proceeds from FHLBank Borrowings, Financing Activities | 0 | ||
Payments of FHLBank Borrowings, Financing Activities | 0 | ||
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Greater than Five Years | |||
Restructuring Cost and Reserve [Line Items] | |||
Advances from Federal Home Loan Banks | 781 | ||
Proceeds from FHLBank Borrowings, Financing Activities | 0 | ||
Payments of FHLBank Borrowings, Financing Activities | 0 | ||
Federal Home Loan Bank of New York Long-Term Funding Agreements | |||
Restructuring Cost and Reserve [Line Items] | |||
Advances from Federal Home Loan Banks | 2,350 | ||
Proceeds from FHLBank Borrowings, Financing Activities | 0 | ||
Payments of FHLBank Borrowings, Financing Activities | $ 0 | ||
Brach Family Foundation Litigation | |||
Restructuring Cost and Reserve [Line Items] | |||
Liability for future policy benefits, amount per policy | $ / policy | 1 |
COMMITMENT AND CONTINGENT LIABILITIES - Narrative (Details) $ / policy in Millions, $ in Millions |
Mar. 31, 2019
USD ($)
|
Feb. 29, 2016
$ / policy
|
---|---|---|
Loss Contingencies [Line Items] | ||
Unaccrued amounts of reasonably possible range of losses | $ 95 | |
Brach Family Foundation Litigation | ||
Loss Contingencies [Line Items] | ||
Liability for future policy benefits, amount per policy | $ / policy | 1 | |
AXA | ||
Loss Contingencies [Line Items] | ||
Equity commitment | 877 | |
Mortgage loans on real estate | 325 | |
Affiliated Entity | AXA | ||
Loss Contingencies [Line Items] | ||
Equity commitment | 258 | |
Letter of Credit | ||
Loss Contingencies [Line Items] | ||
Remaining borrowing capacity | $ 19 |
DISCONTINUED OPERATIONS - Transactions Prior to Distribution (Details) - Alliance Bernstein - Discontinued Operations $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2018
USD ($)
| |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Total investment management and service fees | $ 822 |
Base fees | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Total investment management and service fees | 568 |
Performance-based fees | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Total investment management and service fees | 6 |
Research services | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Total investment management and service fees | 114 |
Distribution services | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Total investment management and service fees | 108 |
Shareholder services | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Total investment management and service fees | 20 |
Other | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Total investment management and service fees | $ 6 |
DISCONTINUED OPERATIONS - Income Statement Disclosures (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Net derivative gains (losses) | $ (1,555) | $ (815) |
Net investment income (loss) | 904 | 509 |
Investment management and service fees | 248 | 254 |
Other income | 10 | 22 |
Total revenues | 690 | 1,139 |
Compensation and benefits | 82 | 149 |
Distribution-related payments | 157 | 160 |
Interest expense | 4 | 9 |
Other operating costs and expenses | 184 | 250 |
Total benefits and other deductions | 1,680 | 1,512 |
Net income from discontinued operations, net of taxes | 0 | 29 |
Less: Net income attributable to the noncontrolling interest | (2) | 1 |
Net income (loss) attributable to AXA Equitable | $ (830) | (263) |
Alliance Bernstein | Discontinued Operations | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Net derivative gains (losses) | 2 | |
Net investment income (loss) | 39 | |
Investment management and service fees | 803 | |
Other income | 2 | |
Total revenues | 846 | |
Compensation and benefits | 344 | |
Distribution-related payments | 110 | |
Interest expense | 2 | |
Other operating costs and expenses | 189 | |
Total benefits and other deductions | 645 | |
Income from discontinued operations, before income taxes | 201 | |
Income tax expense | (17) | |
Net income from discontinued operations, net of taxes | 184 | |
Less: Net income attributable to the noncontrolling interest | (155) | |
Net income (loss) attributable to AXA Equitable | $ 29 |
REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Balance Sheet Disclosures (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
Mar. 31, 2018 |
Dec. 31, 2017 |
---|---|---|---|---|
Assets: | ||||
Deferred policy acquisition costs | $ 4,338 | $ 5,011 | ||
Total Assets | 211,239 | 199,952 | ||
Liabilities: | ||||
Future policy benefits and other policyholders' liabilities | 30,294 | 29,808 | ||
Other liabilities | 1,600 | 1,460 | ||
Total Liabilities | 198,821 | 187,485 | ||
Equity: | ||||
Retained earnings | 4,268 | 5,098 | ||
Total equity attributable to AXA Equitable | 12,358 | 12,416 | ||
Total Equity | 12,370 | 12,428 | $ 18,492 | $ 19,492 |
Total Liabilities, Redeemable Noncontrolling Interest and Equity | $ 211,239 | $ 199,952 | ||
As Previously Reported | ||||
Assets: | ||||
Deferred policy acquisition costs | 4,826 | |||
Total Assets | 222,424 | |||
Liabilities: | ||||
Future policy benefits and other policyholders' liabilities | 28,374 | |||
Current and deferred income taxes | 1,728 | |||
Other liabilities | 3,041 | |||
Total Liabilities | 202,767 | |||
Equity: | ||||
Retained earnings | 8,824 | |||
Total equity attributable to AXA Equitable | 15,545 | |||
Total Equity | 18,633 | |||
Total Liabilities, Redeemable Noncontrolling Interest and Equity | 222,424 | |||
Discontinued Operations Adjustment | ||||
Assets: | ||||
Deferred policy acquisition costs | 0 | |||
Total Assets | 0 | |||
Liabilities: | ||||
Future policy benefits and other policyholders' liabilities | 0 | |||
Current and deferred income taxes | (432) | |||
Other liabilities | (1,941) | |||
Total Liabilities | 0 | |||
Equity: | ||||
Retained earnings | 0 | |||
Total equity attributable to AXA Equitable | 0 | |||
Total Equity | 0 | |||
Total Liabilities, Redeemable Noncontrolling Interest and Equity | 0 | |||
As Adjusted | ||||
Assets: | ||||
Deferred policy acquisition costs | 4,826 | |||
Total Assets | 222,424 | |||
Liabilities: | ||||
Future policy benefits and other policyholders' liabilities | 28,374 | |||
Current and deferred income taxes | 1,296 | |||
Other liabilities | 1,100 | |||
Total Liabilities | 202,767 | |||
Equity: | ||||
Retained earnings | 8,824 | |||
Total equity attributable to AXA Equitable | 15,545 | |||
Total Equity | 18,633 | |||
Total Liabilities, Redeemable Noncontrolling Interest and Equity | 222,424 | |||
Impact of Revisions | ||||
Assets: | ||||
Deferred policy acquisition costs | (119) | |||
Total Assets | (119) | |||
Liabilities: | ||||
Future policy benefits and other policyholders' liabilities | (10) | |||
Current and deferred income taxes | (38) | |||
Other liabilities | 70 | |||
Total Liabilities | 22 | |||
Equity: | ||||
Retained earnings | (141) | |||
Total equity attributable to AXA Equitable | (141) | |||
Total Equity | (141) | |||
Total Liabilities, Redeemable Noncontrolling Interest and Equity | (119) | |||
As Revised | ||||
Assets: | ||||
Deferred policy acquisition costs | 4,707 | |||
Total Assets | 222,305 | |||
Liabilities: | ||||
Future policy benefits and other policyholders' liabilities | 28,364 | |||
Current and deferred income taxes | 1,258 | |||
Other liabilities | 1,170 | |||
Total Liabilities | 202,789 | |||
Equity: | ||||
Retained earnings | 8,683 | |||
Total equity attributable to AXA Equitable | 15,404 | |||
Total Equity | 18,492 | |||
Total Liabilities, Redeemable Noncontrolling Interest and Equity | $ 222,305 |
REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Income Statement and Comprehensinve Income Disclosures (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Revenues: | ||
Policy charges and fee income | $ 859 | $ 861 |
Net derivative gains (losses) | (1,555) | (817) |
Total Revenues | 690 | 1,139 |
Commissions | 157 | 160 |
Interest expense | 4 | 9 |
Benefits and other deductions: | ||
Policyholders’ benefits | 819 | 480 |
Interest credited to policyholders’ account balances | 269 | 255 |
Other operating costs and expenses | 184 | 250 |
Compensation and benefits | 82 | 149 |
Amortization of deferred policy acquisition costs | 165 | 209 |
Total benefits and other deductions | 1,680 | 1,512 |
Income (loss) from operations, before income taxes | (990) | (373) |
Income tax (expense) benefit from continuing operations | 162 | 80 |
Net income (loss) | (293) | |
Net income (loss) | (828) | (264) |
Less: Net (income) loss attributable to the noncontrolling interest | (2) | 1 |
Net income (loss) attributable to AXA Equitable | (830) | (263) |
Statements of Comprehensive Income (Loss): | ||
Net income (loss) | (828) | (264) |
Comprehensive income (loss) attributable to AXA Equitable | $ (64) | (1,020) |
As Previously Reported | ||
Revenues: | ||
Policy charges and fee income | 869 | |
Net derivative gains (losses) | (777) | |
Total Revenues | 2,031 | |
Commissions | 371 | |
Interest expense | 11 | |
Benefits and other deductions: | ||
Policyholders’ benefits | 489 | |
Interest credited to policyholders’ account balances | 338 | |
Other operating costs and expenses | 440 | |
Compensation and benefits | 456 | |
Amortization of deferred policy acquisition costs | 10 | |
Total benefits and other deductions | 2,115 | |
Income (loss) from operations, before income taxes | (84) | |
Income tax (expense) benefit from continuing operations | 44 | |
Net income (loss) | (40) | |
Net income (loss) | (40) | |
Net income (loss) attributable to AXA Equitable | (194) | |
Statements of Comprehensive Income (Loss): | ||
Net income (loss) | (40) | |
Comprehensive income (loss) | (789) | |
Comprehensive income (loss) attributable to AXA Equitable | (950) | |
Gross DAC Adjustment | ||
Revenues: | ||
Policy charges and fee income | 0 | |
Net derivative gains (losses) | 0 | |
Total Revenues | 0 | |
Commissions | (101) | |
Interest expense | 0 | |
Benefits and other deductions: | ||
Policyholders’ benefits | 0 | |
Interest credited to policyholders’ account balances | 0 | |
Other operating costs and expenses | (1) | |
Compensation and benefits | (33) | |
Amortization of deferred policy acquisition costs | 135 | |
Total benefits and other deductions | 0 | |
Income (loss) from operations, before income taxes | 0 | |
Income tax (expense) benefit from continuing operations | 0 | |
Net income (loss) | 0 | |
Net income (loss) | 0 | |
Net income (loss) attributable to AXA Equitable | 0 | |
Statements of Comprehensive Income (Loss): | ||
Net income (loss) | 0 | |
Discontinued Operations Adjustment | ||
Revenues: | ||
Policy charges and fee income | 0 | |
Net derivative gains (losses) | (2) | |
Total Revenues | (846) | |
Commissions | (110) | |
Interest expense | (2) | |
Benefits and other deductions: | ||
Policyholders’ benefits | 0 | |
Interest credited to policyholders’ account balances | 0 | |
Other operating costs and expenses | (189) | |
Compensation and benefits | (344) | |
Amortization of deferred policy acquisition costs | 0 | |
Total benefits and other deductions | (645) | |
Income (loss) from operations, before income taxes | (201) | |
Income tax (expense) benefit from continuing operations | 17 | |
Net income (loss) | (184) | |
Net income (loss) | (155) | |
Net income (loss) attributable to AXA Equitable | 0 | |
Statements of Comprehensive Income (Loss): | ||
Net income (loss) | (155) | |
Comprehensive income (loss) | (162) | |
Comprehensive income (loss) attributable to AXA Equitable | (1) | |
As Adjusted | ||
Revenues: | ||
Policy charges and fee income | 869 | |
Net derivative gains (losses) | (779) | |
Total Revenues | 1,185 | |
Commissions | 160 | |
Interest expense | 9 | |
Benefits and other deductions: | ||
Policyholders’ benefits | 489 | |
Interest credited to policyholders’ account balances | 338 | |
Other operating costs and expenses | 250 | |
Compensation and benefits | 79 | |
Amortization of deferred policy acquisition costs | 145 | |
Total benefits and other deductions | 1,470 | |
Income (loss) from operations, before income taxes | (285) | |
Income tax (expense) benefit from continuing operations | 61 | |
Net income (loss) | (224) | |
Net income (loss) | (195) | |
Net income (loss) attributable to AXA Equitable | (194) | |
Statements of Comprehensive Income (Loss): | ||
Net income (loss) | (195) | |
Comprehensive income (loss) | (951) | |
Comprehensive income (loss) attributable to AXA Equitable | (951) | |
Impact of Revisions | ||
Revenues: | ||
Policy charges and fee income | (8) | |
Net derivative gains (losses) | (38) | |
Total Revenues | (46) | |
Commissions | 0 | |
Interest expense | 0 | |
Benefits and other deductions: | ||
Policyholders’ benefits | (9) | |
Interest credited to policyholders’ account balances | (83) | |
Other operating costs and expenses | 0 | |
Compensation and benefits | 70 | |
Amortization of deferred policy acquisition costs | 64 | |
Total benefits and other deductions | 42 | |
Income (loss) from operations, before income taxes | (88) | |
Income tax (expense) benefit from continuing operations | 19 | |
Net income (loss) | (69) | |
Net income (loss) | (69) | |
Net income (loss) attributable to AXA Equitable | (69) | |
Statements of Comprehensive Income (Loss): | ||
Net income (loss) | (69) | |
Comprehensive income (loss) | (69) | |
Comprehensive income (loss) attributable to AXA Equitable | (69) | |
As Revised | ||
Revenues: | ||
Policy charges and fee income | 861 | |
Net derivative gains (losses) | (817) | |
Total Revenues | 1,139 | |
Commissions | 160 | |
Interest expense | 9 | |
Benefits and other deductions: | ||
Policyholders’ benefits | 480 | |
Interest credited to policyholders’ account balances | 255 | |
Other operating costs and expenses | 250 | |
Compensation and benefits | 149 | |
Amortization of deferred policy acquisition costs | 209 | |
Total benefits and other deductions | 1,512 | |
Income (loss) from operations, before income taxes | (373) | |
Income tax (expense) benefit from continuing operations | 80 | |
Net income (loss) | (293) | |
Net income (loss) | (264) | |
Net income (loss) attributable to AXA Equitable | (263) | |
Statements of Comprehensive Income (Loss): | ||
Net income (loss) | (264) | |
Comprehensive income (loss) | (1,020) | |
Comprehensive income (loss) attributable to AXA Equitable | $ (1,020) |
REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Statement of Equity Disclosures (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Beginning of year | $ 12,428 | $ 19,492 |
Net income (loss) | (830) | (263) |
End of year | 12,370 | 18,492 |
As Previously Reported | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Net income (loss) | (194) | |
End of year | 18,633 | |
Discontinued Operations Adjustment | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Net income (loss) | 0 | |
End of year | 0 | |
As Adjusted | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Net income (loss) | (194) | |
End of year | 18,633 | |
Impact of Revisions | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Net income (loss) | (69) | |
End of year | (141) | |
As Revised | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Net income (loss) | (263) | |
End of year | 18,492 | |
AXA Equitable Equity | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Beginning of year | 12,416 | 16,397 |
End of year | 12,358 | 15,404 |
AXA Equitable Equity | As Previously Reported | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
End of year | 15,545 | |
AXA Equitable Equity | As Adjusted | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
End of year | 15,545 | |
AXA Equitable Equity | Impact of Revisions | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
End of year | (141) | |
AXA Equitable Equity | As Revised | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
End of year | 15,404 | |
Retained Earnings | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Beginning of year | 5,098 | 8,938 |
End of year | $ 4,268 | 8,683 |
Retained Earnings | As Previously Reported | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Beginning of year | 9,010 | |
Net income (loss) | (194) | |
End of year | 8,824 | |
Retained Earnings | Discontinued Operations Adjustment | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Beginning of year | 0 | |
Net income (loss) | 0 | |
End of year | 0 | |
Retained Earnings | As Adjusted | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Beginning of year | 9,010 | |
Net income (loss) | (194) | |
End of year | 8,824 | |
Retained Earnings | Impact of Revisions | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Beginning of year | (72) | |
Net income (loss) | (69) | |
End of year | (141) | |
Retained Earnings | As Revised | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Beginning of year | 8,938 | |
Net income (loss) | (263) | |
End of year | $ 8,683 |
REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Cash Flow Disclosures (Details) - USD ($) $ in Millions |
3 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
||||||
Cash flow from operating activities: | |||||||
Net income (loss) | [1] | $ (828) | $ (109) | ||||
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: | |||||||
Interest credited to policyholders’ account balances | 269 | 255 | |||||
Policy charges and fee income | (859) | (861) | |||||
Net derivative (gains) losses | 1,555 | 815 | |||||
Equity (income) loss from limited partnerships | [2] | (11) | (39) | ||||
Changes in: | |||||||
Capitalization of deferred policy acquisition costs | [2] | (145) | (135) | ||||
Future policy benefits | 41 | (198) | |||||
Current and deferred income taxes | 54 | 80 | |||||
Other, net | (36) | 12 | |||||
Net cash provided by (used in) operating activities | (148) | (17) | |||||
Proceeds from the sale/maturity/prepayment of: | |||||||
Trading account securities | 3,376 | 1,683 | |||||
Real estate joint ventures | 1 | 140 | |||||
Short-term investments | [2] | 747 | 688 | ||||
Payment for the purchase/origination of: | |||||||
Short-term investments | [2] | (681) | (377) | ||||
Cash settlements related to derivative instruments | (978) | (503) | |||||
Other, net | 97 | (407) | |||||
Net cash provided by (used in) investing activities | (694) | (983) | |||||
Policyholders’ account balances: | |||||||
Deposits | 2,271 | 1,898 | |||||
Withdrawals | (1,048) | (1,081) | |||||
Transfers (to) from Separate Accounts | 445 | 452 | |||||
Net Cash Provided by (Used in) Financing Activities | 1,142 | 1,380 | |||||
Transfer of assets to reinsurer | [1] | (604) | |||||
(Settlement) issuance of long-term debt | [1] | (202) | |||||
Net (income) loss attributable to the noncontrolling interest | $ 2 | (1) | |||||
As Previously Reported | |||||||
Cash flow from operating activities: | |||||||
Net income (loss) | (40) | ||||||
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: | |||||||
Interest credited to policyholders’ account balances | 338 | ||||||
Policy charges and fee income | (869) | ||||||
Net derivative (gains) losses | 777 | ||||||
Amortization and depreciation | 0 | ||||||
Amortization of deferred sales commission | 7 | ||||||
Other depreciation and amortization | (23) | ||||||
Amortization of other intangibles | 8 | ||||||
Equity (income) loss from limited partnerships | 0 | ||||||
Distributions from joint ventures and limited partnerships | 25 | ||||||
Changes in: | |||||||
Reinsurance recoverable | 2 | ||||||
Deferred policy acquisition costs | 10 | ||||||
Capitalization of deferred policy acquisition costs | 0 | ||||||
Future policy benefits | (191) | ||||||
Current and deferred income taxes | (52) | ||||||
Other, net | (122) | ||||||
Net cash provided by (used in) operating activities | (21) | ||||||
Proceeds from the sale/maturity/prepayment of: | |||||||
Trading account securities | 1,606 | ||||||
Real estate joint ventures | 0 | ||||||
Short-term investments | 0 | ||||||
Other | 54 | ||||||
Payment for the purchase/origination of: | |||||||
Short-term investments | 0 | ||||||
Cash settlements related to derivative instruments | (14) | ||||||
Change in short-term investments | 396 | ||||||
Other, net | (560) | ||||||
Net cash provided by (used in) investing activities | (639) | ||||||
Policyholders’ account balances: | |||||||
Deposits | 2,366 | ||||||
Withdrawals | (1,322) | ||||||
Transfers (to) from Separate Accounts | (115) | ||||||
Net Cash Provided by (Used in) Financing Activities | 1,040 | ||||||
Transfer of assets to reinsurer | 0 | ||||||
(Settlement) issuance of long-term debt | 0 | ||||||
Presentation Reclassifications | |||||||
Cash flow from operating activities: | |||||||
Net income (loss) | 0 | ||||||
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: | |||||||
Interest credited to policyholders’ account balances | 0 | ||||||
Policy charges and fee income | 0 | ||||||
Net derivative (gains) losses | 0 | ||||||
Amortization and depreciation | 137 | ||||||
Amortization of deferred sales commission | (7) | ||||||
Other depreciation and amortization | 23 | ||||||
Amortization of other intangibles | (8) | ||||||
Equity (income) loss from limited partnerships | (39) | ||||||
Distributions from joint ventures and limited partnerships | (25) | ||||||
Changes in: | |||||||
Reinsurance recoverable | 0 | ||||||
Deferred policy acquisition costs | (10) | ||||||
Capitalization of deferred policy acquisition costs | (135) | ||||||
Future policy benefits | 0 | ||||||
Current and deferred income taxes | 0 | ||||||
Other, net | 64 | ||||||
Net cash provided by (used in) operating activities | 0 | ||||||
Proceeds from the sale/maturity/prepayment of: | |||||||
Trading account securities | 0 | ||||||
Real estate joint ventures | 140 | ||||||
Short-term investments | 688 | ||||||
Other | (140) | ||||||
Payment for the purchase/origination of: | |||||||
Short-term investments | (377) | ||||||
Cash settlements related to derivative instruments | 0 | ||||||
Change in short-term investments | (311) | ||||||
Other, net | 0 | ||||||
Net cash provided by (used in) investing activities | 0 | ||||||
Policyholders’ account balances: | |||||||
Deposits | 0 | ||||||
Withdrawals | 0 | ||||||
Transfers (to) from Separate Accounts | 0 | ||||||
Net Cash Provided by (Used in) Financing Activities | 0 | ||||||
Transfer of assets to reinsurer | 0 | ||||||
(Settlement) issuance of long-term debt | 0 | ||||||
Impact of Revisions | |||||||
Cash flow from operating activities: | |||||||
Net income (loss) | (69) | ||||||
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: | |||||||
Interest credited to policyholders’ account balances | (83) | ||||||
Policy charges and fee income | 8 | ||||||
Net derivative (gains) losses | 38 | ||||||
Amortization and depreciation | 64 | ||||||
Amortization of deferred sales commission | 0 | ||||||
Other depreciation and amortization | 0 | ||||||
Amortization of other intangibles | 0 | ||||||
Equity (income) loss from limited partnerships | 0 | ||||||
Distributions from joint ventures and limited partnerships | 0 | ||||||
Changes in: | |||||||
Reinsurance recoverable | (149) | ||||||
Deferred policy acquisition costs | 0 | ||||||
Capitalization of deferred policy acquisition costs | 0 | ||||||
Future policy benefits | (7) | ||||||
Current and deferred income taxes | 132 | ||||||
Other, net | 70 | ||||||
Net cash provided by (used in) operating activities | 4 | ||||||
Proceeds from the sale/maturity/prepayment of: | |||||||
Trading account securities | 77 | ||||||
Real estate joint ventures | 0 | ||||||
Short-term investments | 0 | ||||||
Other | 0 | ||||||
Payment for the purchase/origination of: | |||||||
Short-term investments | 0 | ||||||
Cash settlements related to derivative instruments | (489) | ||||||
Change in short-term investments | (85) | ||||||
Other, net | 153 | ||||||
Net cash provided by (used in) investing activities | (344) | ||||||
Policyholders’ account balances: | |||||||
Deposits | (468) | ||||||
Withdrawals | 241 | ||||||
Transfers (to) from Separate Accounts | 567 | ||||||
Net Cash Provided by (Used in) Financing Activities | 340 | ||||||
Transfer of assets to reinsurer | 202 | ||||||
(Settlement) issuance of long-term debt | (604) | ||||||
As Revised | |||||||
Cash flow from operating activities: | |||||||
Net income (loss) | (109) | ||||||
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: | |||||||
Interest credited to policyholders’ account balances | 255 | ||||||
Policy charges and fee income | (861) | ||||||
Net derivative (gains) losses | 815 | ||||||
Amortization and depreciation | 201 | ||||||
Amortization of deferred sales commission | 0 | ||||||
Other depreciation and amortization | 0 | ||||||
Amortization of other intangibles | 0 | ||||||
Equity (income) loss from limited partnerships | (39) | ||||||
Distributions from joint ventures and limited partnerships | 0 | ||||||
Changes in: | |||||||
Reinsurance recoverable | (147) | ||||||
Deferred policy acquisition costs | 0 | ||||||
Capitalization of deferred policy acquisition costs | (135) | ||||||
Future policy benefits | (198) | ||||||
Current and deferred income taxes | 80 | ||||||
Other, net | 12 | ||||||
Net cash provided by (used in) operating activities | (17) | ||||||
Proceeds from the sale/maturity/prepayment of: | |||||||
Trading account securities | 1,683 | ||||||
Real estate joint ventures | 140 | ||||||
Short-term investments | 688 | ||||||
Other | (86) | ||||||
Payment for the purchase/origination of: | |||||||
Short-term investments | (377) | ||||||
Cash settlements related to derivative instruments | (503) | ||||||
Change in short-term investments | 0 | ||||||
Other, net | (407) | ||||||
Net cash provided by (used in) investing activities | (983) | ||||||
Policyholders’ account balances: | |||||||
Deposits | 1,898 | ||||||
Withdrawals | (1,081) | ||||||
Transfers (to) from Separate Accounts | 452 | ||||||
Net Cash Provided by (Used in) Financing Activities | 1,380 | ||||||
Transfer of assets to reinsurer | 202 | ||||||
(Settlement) issuance of long-term debt | (604) | ||||||
Discontinued Operations | Alliance Bernstein | |||||||
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: | |||||||
Net derivative (gains) losses | (2) | ||||||
Policyholders’ account balances: | |||||||
Net (income) loss attributable to the noncontrolling interest | $ 155 | ||||||
|
B*>-MTZ16T&MW8L
M0KBGHIZ&=BDRT&D1I-6B'DP+1=2XL$59XAALP%<(IJ5%1P)F:VG1*<^&S<4&
MH9[ @"C0V"%4PI@^H@&B+#ZR"Z3(!$P*7!K#.(=31 !I1)GJ89B:0T
M&V'SACA'PV,XPMBG 1OQ
M-_!K+L\B3047;)K*2J@X*W"X8MAF.EL1V#,7IY+N%!P<+L\ES047WO4\-$)%
MG:@=.#9O(PX'_,P5?B8*+KPKLA(JS(K.%U5]YF8Z/9).!O41A].IGHI RP5W
MX=TM)2!%M";!$T)'_$UGA"J6+9=;8&HB)R'"G,#=BF6;L4[@[A&6S>FTT!++
MYH)2R\M8(<+[')T9.D*R.9T:6B+97#!J(B?QD$XY 9A,,^'J$87-@V+S$L+F@TW)&9>[<@5]SQ:_-F!&X>H1?
M<^#7O,2ON2#3\K#4CP$&=LU'V#4'=LU+[)H+*BUGM*\?@F[^'3M/\0MI&=(V?C\65C
M_VMC/*"4W16.4(L?;#$4U#X
F][+5<+3$]4H)^^\ T@P9W=)7QV-;-SXX6)YVHH9?X']W1XL6
MFUG*5H%VK='$0I71F^W^D(3X&/"GA<$MSB14 )*BMYYHR86E*+$Z[BW.N[#>+/?3[!U )\ ? 8<8AXV
M)HK*'X47>6K-0.S8^TZ$)]X>.?:F",[8BGB'XAUZKSE/]BF[!J(IYC3&\$7,
M=HY@R#ZGX&LI3OP_.%^'[U85[B)\]T'A[3I!LDJ01(+D \'=IQ+78@Z?DK!%
M3Q78.DZ3(X7I=9SDA7<>V'L>W^0]?)SV[\+6K7;D8CR^;.Q_98P'E+*YP1%J
M\(/-AH3*A^,=GNTX9J/A33?](#9_X_P?4$L#!!0 ( "Y)KDZH49<>M@$
M -(# 9 >&PO=V]R:W-H965T,B6*
MRN^88V5N](C,U/N>A2=.#]3WI@K.V(IXY\5;[[V4-/N6DTL@FF..4PQ=Q:1+
M!/'L2PJZE>)(_X/3;?AN4^$NPG=K^#[9)L@V";)(D/U#D'XJ<2OFLTJRZJD$
MT\9ILJC2@XJ3O/(N WL3'Y%\A$_3_L!,RY5%9^W\R\;^-UH[\%*2*S]"G?]@
MBR&@<>'XU9_--&:3X70__R"R?./R+U!+ P04 " N2:Y.W+E#ZK8! #2
M P &0 'AL+W=O
M3E,Y&5KT\X-#EE
1'XTTVF@U[2X>DBH>VKKCZQZW1WJV5/9
M-.6^?RKHI2R;O!TR^=+:WN;9YO*BR%^:[L\N^M7Y::GSBZ8\#D^"+2Z/HZW^
M!U!+ P04 " N2:Y..7Y8MQ$# ! #0 &0 'AL+W=OG)DYGMITTM#MHNF5GWPX [;+3LQN$]F?Y!;/X 4$L#
M!!0 ( "Y)KDXR\*;., ( (,& 9 >&PO=V]R:W-H965T
8>]#(P\A
M]T8F6@FT&)D/C<"/C8PA$X<$6AO.&OJ?/^S0WBY@\(GCWH(>G/>M!3+,!?1:
M=8G965^#W,GHI1*JX_56NZMV[:M6/UC?P.767)CO,N;^_H'8N:BX